CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP027781	Clostridium botulinum strain MAP 5 chromosome, complete genome	17 crisprs	WYL,csa3,DEDDh,DinG,cas3,cas6,cmr1gr7,cas10,cmr3gr5,cmr4gr7,cmr5gr11,cmr6gr7,cas8b1,cas7b,cas5,cas4,cas1,cas2,cas14i,RT	1	33	3	0

Results visualization

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP027781_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_1

84797-84951

Orphan

Consensus_repeat	Method
TTTTTTATCATTAGGAACCTTCTTTCTCTTAATCTAATTTCCCTTTTTTA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP027781_1

>merge|NZ_CP027781|1|84797-84951|CRISPRCasFinder
TTTTTTATCATTAGGAACCTTCTTTCTCTTAATCTAATTTCCCTTTTTTAAAGGATTTACCGCAAAAAATACTCCTTTTAAAGCACTCCCATAAGTTTTTTCAAGTTTTTTATCATTAGGAACCTTCTTTCTCTTAATCTAATTTCCCTTATTTA

>NZ_CP027781|1|1|84797-84951|CRISPRCasFinder
TTTTTTATCATTAGGAACCTTCTTTCTCTTAATCTAATTTCCCTTTTTTA	AAGGATTTACCGCAAAAAATACTCCTTTTAAAGCACTCCCATAAGTTTTTTCAAG
TTTTTTATCATTAGGAACCTTCTTTCTCTTAATCTAATTTCCCTTATTTA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106898875.1\|90843_91419_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_030035916.1\|94253_94982_-\|FliA/WhiG-family-RNA-polymerase-sigma-factor	unknown	unknown	gnl\|CDD\|274153
NZ_CP027781.1\|WP_072586632.1\|92641_93409_-\|flagellar-biosynthesis-protein-FlgG	unknown	unknown	gnl\|CDD\|183768
NZ_CP027781.1\|WP_003495172.1\|93474_93591_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106898868.1\|78131_78731_-\|V-type-ATP-synthase-subunit-E	unknown	unknown	gnl\|CDD\|167649
NZ_CP027781.1\|WP_106898871.1\|81686_83366_-\|B12-binding-domain-containing-radical-SAM-protein	unknown	unknown	gnl\|CDD\|379119
NZ_CP027781.1\|WP_106898874.1\|89082_90726_+\|putative-manganese-dependent-inorganic-diphosphatase	unknown	unknown	gnl\|CDD\|237843
NZ_CP027781.1\|WP_080443594.1\|83340_83916_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106898870.1\|81204_81531_-\|ATPase	unknown	unknown	gnl\|CDD\|234750
NZ_CP027781.1\|WP_003495197.1\|76816_77125_-\|V-type-ATP-synthase-subunit-F	unknown	unknown	gnl\|CDD\|179293
NZ_CP027781.1\|WP_106898869.1\|79259_81218_-\|V-type-ATP-synthase-subunit-I	unknown	unknown	gnl\|CDD\|235600
NZ_CP027781.1\|WP_045887466.1\|94995_95655_-\|flagellar-protein	unknown	unknown	gnl\|CDD\|227868
NZ_CP027781.1\|WP_003484527.1\|78746_79235_-\|V-type-ATP-synthase-subunit-K	unknown	unknown	gnl\|CDD\|235830
NZ_CP027781.1\|WP_106898866.1\|75024_76803_-\|V-type-ATP-synthase-subunit-A	unknown	unknown	gnl\|CDD\|235248
NZ_CP027781.1\|WP_106898876.1\|91803_92595_-\|flagellar-basal-body-rod-protein-FlgG	unknown	unknown	gnl\|CDD\|183767
NZ_CP027781.1\|WP_106898878.1\|95669_96530_-\|MinD/ParA-family-protein	unknown	unknown	gnl\|CDD\|349758
NZ_CP027781.1\|WP_106898867.1\|77117_78119_-\|V-type-ATP-synthase-subunit-C	unknown	unknown	gnl\|CDD\|234917
NZ_CP027781.1\|WP_030035885.1\|73646_75032_-\|V-type-ATP-synthase-subunit-B	unknown	unknown	gnl\|CDD\|235251
NZ_CP027781.1\|WP_106898873.1\|86172_88719_-\|ATPase	unknown	unknown	gnl\|CDD\|319781
NZ_CP027781.1\|WP_106898877.1\|93668_94226_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_030035916.1\|94253_94982_-\|FliA/WhiG-family-RNA-polymerase-sigma-factor	gnl\|CDD\|274153	TIGR02479, RNA_polymerase_sigma_factor_WhiG, RNA polymerase sigma factor, FliA/WhiG family. Most members of this family are the flagellar operon sigma factor FliA, controlling transcription of bacterial flagellar genes by RNA polymerase. An exception is the sigma factor WhiG in the genus Streptomyces, involved in the production of sporulating aerial mycelium.	3.4491e-90
NZ_CP027781.1\|WP_072586632.1\|92641_93409_-\|flagellar-biosynthesis-protein-FlgG	gnl\|CDD\|183768	PRK12818, flgG, flagellar basal body rod protein FlgG; Reviewed.	6.29599e-132
NZ_CP027781.1\|WP_106898868.1\|78131_78731_-\|V-type-ATP-synthase-subunit-E	gnl\|CDD\|167649	PRK03963, PRK03963, V-type ATP synthase subunit E; Provisional.	7.56486e-12
NZ_CP027781.1\|WP_106898871.1\|81686_83366_-\|B12-binding-domain-containing-radical-SAM-protein	gnl\|CDD\|379119	pfam13311, DUF4080, Protein of unknown function (DUF4080). A family of uncharacterized proteins found by clustering human gut metagenomic sequences.	3.52755e-54
NZ_CP027781.1\|WP_106898874.1\|89082_90726_+\|putative-manganese-dependent-inorganic-diphosphatase	gnl\|CDD\|237843	PRK14869, PRK14869, putative manganese-dependent inorganic diphosphatase.	0
NZ_CP027781.1\|WP_106898870.1\|81204_81531_-\|ATPase	gnl\|CDD\|234750	PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed.	0.000192846
NZ_CP027781.1\|WP_003495197.1\|76816_77125_-\|V-type-ATP-synthase-subunit-F	gnl\|CDD\|179293	PRK01395, PRK01395, V-type ATP synthase subunit F; Provisional.	6.43658e-58
NZ_CP027781.1\|WP_106898869.1\|79259_81218_-\|V-type-ATP-synthase-subunit-I	gnl\|CDD\|235600	PRK05771, PRK05771, V-type ATP synthase subunit I; Validated.	8.6862e-172
NZ_CP027781.1\|WP_045887466.1\|94995_95655_-\|flagellar-protein	gnl\|CDD\|227868	COG5581, COG5581, c-di-GMP-binding protein [Signal transduction mechanisms].	4.37199e-24
NZ_CP027781.1\|WP_003484527.1\|78746_79235_-\|V-type-ATP-synthase-subunit-K	gnl\|CDD\|235830	PRK06558, PRK06558, V-type ATP synthase subunit K; Validated.	1.76875e-63
NZ_CP027781.1\|WP_106898866.1\|75024_76803_-\|V-type-ATP-synthase-subunit-A	gnl\|CDD\|235248	PRK04192, PRK04192, V-type ATP synthase subunit A; Provisional.	0
NZ_CP027781.1\|WP_106898876.1\|91803_92595_-\|flagellar-basal-body-rod-protein-FlgG	gnl\|CDD\|183767	PRK12817, flgG, flagellar basal body rod protein FlgG; Reviewed.	1.11433e-149
NZ_CP027781.1\|WP_106898878.1\|95669_96530_-\|MinD/ParA-family-protein	gnl\|CDD\|349758	cd02038, FlhG-like, MinD-like ATPase FlhG. FlhG is a member of the SIMIBI superfamily. FlhG (also known as YlxH) is a major determinant for a variety of flagellation patterns. It effects location and number of bacterial flagella during C-ring assembly.	1.29434e-91
NZ_CP027781.1\|WP_106898867.1\|77117_78119_-\|V-type-ATP-synthase-subunit-C	gnl\|CDD\|234917	PRK01198, PRK01198, V-type ATP synthase subunit C; Provisional.	7.66086e-106
NZ_CP027781.1\|WP_030035885.1\|73646_75032_-\|V-type-ATP-synthase-subunit-B	gnl\|CDD\|235251	PRK04196, PRK04196, V-type ATP synthase subunit B; Provisional.	0
NZ_CP027781.1\|WP_106898873.1\|86172_88719_-\|ATPase	gnl\|CDD\|319781	cd02089, P-type_ATPase_Ca_prok, prokaryotic P-type Ca(2+)-ATPase similar to Synechococcus elongatus sp. strain PCC 7942 PacL and Listeria monocytogenes LMCA1. Ca(2+) transport ATPase is a plasma membrane protein which pumps Ca(2+) ion out of the cytoplasm. This prokaryotic subfamily includes the Ca(2+)-ATPase Synechococcus elongatus PacL, Listeria monocytogenes Ca(2+)-ATPase 1 (LMCA1) which has a low Ca(2+) affinity and a high pH optimum (pH about 9) and may remove Ca(2+) from the microorganism in environmental conditions when e.g. stressed by high Ca(2+) and alkaline pH, and the Bacillus subtilis putative P-type Ca(2+)-transport ATPase encoded by the yloB gene, which is expressed during sporulation. This subfamily belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.	0

>NZ_CP027781.1|WP_080443594.1|83340_83916_-|hypothetical-protein
MGIINEIVINMENEIFRGNLLDVGTDNYGIIYNIYKQYNEDSNLEYINGAEEKENIKEGYYDNCILLFSFSNIFFKKNRMSLIRDIYRYLKEGGNVYIWDIDKKLKETFNGKIKILLPGEKVKNISIKDLNLLKDSSIDTTIKLLDPYFEIKDLKSSDGVYYIKGKKKINTNTKEDEKRKEEINESTISSH
>NZ_CP027781.1|WP_106898871.1|81686_83366_-|B12-binding-domain-containing-radical-SAM-protein
MKALLVAINSKYIHSNLALRYLRANTEDLNYECMLKEFTINDRKENILEKIIMEKADLVAFSCYIWNLEYVEELANLIKLVKPSTEIIFGGPEVSYDSESFLRRVPGEYIIKGEGEETFREFIKCKIENKSLDKVKGLYIKTLNGIKYTGERHNISMNSVVFPYKKEEDLKNKIVYYEASRGCPFKCKYCLSSTLHGVRFHDIERVKKEIKFLVDKNVKLIKFVDRTFNCNHKFAMEVWEYIINLDTDATFHFEISADLLTKEELDILSKSKEGRIQFEVGVQTTNNEVLKNINRHVNFETIKEKVEELKKLKNIKQHLDLIAGLPGEDYNSFKNSFNDVYSIEPEEIQLGFLKLLKGSPMRLEAEKWGMVYSPYPPYEILSTKDISYEELLILKKVEGVVDKYYNSGKFNNILKYFMGEFKKPFDFYYRLAMFCNDKGYFDRNISGPQYYKVFLEFNEEFLNKNSEFLKEIIKYDYLKFNKKQWLPEFLIRDIDKKIKRYLKDKVLQNGVQISDNIHVEKFFIDIEKFIRSDIKEKREIYVIFDEKERENIVFLGNKE
>NZ_CP027781.1|WP_106898870.1|81204_81531_-|ATPase
MAKDAIKEIKAAEEEANKIINDAKLEGREIIKKAEENALKEYKDIINKSSLEAKRIMDEVESKANGEATLIFKEGKEKADEILNVSNDLLDKAVNLVVERIVKFNGNS
>NZ_CP027781.1|WP_106898869.1|79259_81218_-|V-type-ATP-synthase-subunit-I
MAIVKMNKFTLLAFESHKEKLLEELQSFEGVQFINLQNDALIEEDESLKLLDKDSVGSKYSEYAANLSKLKFVLDFLKEYVTQASGLKALLQDKKSLSYSTLNEKIKTIDWKSTYDDLKMKEDRLNYLSNERTKVDAEINSLLPWKKFDAKFKNLKELKQTSYFIGTISKQYKEDFQNEFQDNLQNKYIEFINEDNEDLYIFALVLKEEEEKAKELFKNYGFSSLTLVYEDSPKAVIENFNIKISEIDKEVEKINTEIKTYESKIEEIQIAYEYFNNLIIRLNASENFLKSEKVIAICGWNTLDTNEELENIIKKAIGNDYYLSFTEVNEDDDVEEVPIKLKNNGFASAFESVVEMYSLPLYKEIDPTPILSIFYFLFFGMMLSDAGYGLIMVIVSSIALKKVKDTAKRNTFKLFLFAGISTVIWGAMYGGWFGDLFSNYLGIKIPYLIDPAKGITQILILSVIFGLIHIFVGLGLKAYILIRSGQLKDAIYDVLTWYFVLIGAILMLVGVASSVGKILLIIGFVGLLLTQGRSAPTLGGKIGGGIYGVYGSTSYLGDVVSYSRLLALGLATGFIANALNLIVNLIPSPFSYIISPILFVALHLFNLLVNALGSYVHTARLQYLEFFNKFYEGGGKKFTPYKLSDQYLKITK
>NZ_CP027781.1|WP_003484527.1|78746_79235_-|V-type-ATP-synthase-subunit-K
MTFMNFLTENGGLIFALLGAALATGLAGIGSAKGIGIVGEAASGLMTEEPEKFGKTFILVALPGTQGLYGFVITLMILLNIGILGGKAPTLANGFAYFMAALPIALAGWKSAIAQGKAAAAGVQILAKKPNDVMKGVIYAVMVETYALLGFVASLFMVLNIK
>NZ_CP027781.1|WP_106898868.1|78131_78731_-|V-type-ATP-synthase-subunit-E
MSSINNLTGKILEEAKVKKEEFIKEAKEDGKKILDKKTAEAKVIEKNTIEKAERESVIRRERILSNAELKVRNEKLQSKQKVIEKVLEKSLEKLSSLSKEEYLSYIKERILALPIDGDEKIIINLKDKLLITEDFINEINSELVKKGKLGNLSLSDETRDFKAGFILEKNGIEINNSFEALISSMKDELEYEVARVLFN
>NZ_CP027781.1|WP_106898867.1|77117_78119_-|V-type-ATP-synthase-subunit-C
MDALLFTQVIPRIRVLETRLLDKTKLDRMIDSSSPLEALKILEETEYSIFMSKVKRPEDYEILLSNELKRVYHLLYEISPVKSLVNMMSLKYDYHNIKVMIKGKILNKDFTDIIIPVGNVPIEKLKTFIDNEYYRDLNPIMRKAIEDAFEDFGANKDPQKIDIILDKYMFEQMLSLNKEIGDEFLDKYLKSLIDLNNIKTLLRVKKQNKDKNFFTSVIISGGFIDKDKLIALLNDSVENIPAKLSYTDYGEVLRAGIDAYSKTGSINIFEKLSDNFIMEYMKRAKYISFGPEPIISYLYAKENEIKVIRIIMIGKLNNMKSEIIRERLRDIYV
>NZ_CP027781.1|WP_003495197.1|76816_77125_-|V-type-ATP-synthase-subunit-F
MYKIGVVGDKDSILAFKALGIDVYPVTEPDEARITINKMAAEKYAIIFVTEQIAKDLEETIERYNRELIPAVILIPSNQGSLNIGMQRINDNVEKAVGVNIL
>NZ_CP027781.1|WP_106898866.1|75024_76803_-|V-type-ATP-synthase-subunit-A
MNLKTGRILKISGPLVVAEGMEEANIYDVVKVGEKRLIGEIIEMREDRASIQVYEETAGLAPGDPVITTGEPLSVELGPGLIEAMFDGIQRPLNVIKDKAGDFITRGVEVHSLDRDRKWHFTPVKKAGDTVEAGDVIGTVQETSIVEHKIMVPYGIKGTIETIEEGDFTIVDTVAKVKDGDKLSDLMMMQKWPVRKGRPYGRKLNPAQPMITGQRVIDTFFPVTKGGTACVPGPFGSGKTVVQHQLAKWADAQIVVYIGCGERGNEMTDVLNEFPELKDPKTGEPLMKRTVLIANTSNMPVAAREASIYTGITIGEYFRDMGYSIALMADSTSRWAEALREMSGRLEEMPGDEGYPAYLGSRAAEFYERAGNVLSLGSEEREGALTVIGAVSPPGGDLSEPVTQATLRIVKVFWGLDAQLAYRRHFPAINWLNSYSLYIEKISPWMDENVASDWTALRIKAMSLLQEEASLEEIVRLVGIDALSEKDRLKLEVAKSLREDYLQQNAFHEVDTYASLEKQYKMLKLVLFFYDEAERALNAGVYLKELLDLEVRDKIARSKYISEENIKNIDAIFNELSEVIDELISKGGIMNA
>NZ_CP027781.1|WP_030035885.1|73646_75032_-|V-type-ATP-synthase-subunit-B
MLKEYRTVKEVVGPLMLVDQVEGVSFDELVEIELHNGEKRRGRVLEINKDKALVQLFEGSAGINIKGAKVKFLGKPLELGVSEDMLGRVFDGLGNPKDGGPKIIPDEKRDISGIPINPVARNYPDEFIQTGVSAIDGLNTLVRGQKLPVFSGSGLPHAELAAQIARQAKVLNSDSKFAVVFAAIGTTFEEAQYFIDDFTKTGAIDRAVLFINLANDPAIERIATPRMALTTAEYLAFEKGMHVLVIMTDITNYCEALREVSAARKEVPGRRGYPGYLYTDLSTLYERAGRILGKEGSITQIPILTMPEDDKTHPIPDLTGYITEGQIILSRELYKKGIMPPIDVLPSLSRLKDKGIGKGKTREDHADTMNQLFAAYAQGKQAKELSVILGESALSDADKLYAKFADAFEGEYVSQGFTTNRTIEETLNLGWKLLTILPKSELKRIRDEYLEKYLNKAEESK
>NZ_CP027781.1|WP_106898873.1|86172_88719_-|ATPase
MNESKIDLYRGLTTREAQRRIKKYGPNVLKKKKKVSPFKIFLEQFNDFIIWVLIAATLISGFMGEKADAITILIIVIMNAILGFVQEFKTEKSLEALNELSSPTAKVIRDSSVKVINAEELVIGDLVILESGDRIPADCILVEQSSFMVDESLLTGESLGVEKNSNSKNSSIYMGTVVLKGRAKAKVVETGMSTEMGKIAEMLDDIQVEKSPLKEKLSSLGKVLVVLCIIICVIVTLTGIWRGQDKYEMFLLGVSLAVAAIPEGLPAIVTVALALGVSRMLKRNALVRKLPAVETLGCTSIICSDKTGTLTENNMTVKKIYYDNKTYNLDNKNFPENLILKKIFTYCNDFNLDMKEKDINKSVLGDPTETALVKAFFRGKNEIKSFTDKGRRIYDNPFDSDRKMMSVIVQDGSGETCYVKGAPERVIKKCKYILINGEIEELTDKHRHEVERAIEKMSYAALRCIAGAYKREGLTRSASVEKDLIFVGVAGIIDPPRREVKDAVLKCKMAGIKPIMITGDHKNTAYAIGKELDICKSEKEVLEGEEIDKLNDKELNKKLDTITVFARVSPNHKLRIVKEFKNKNKIVAMTGDGVNDAPAVKEADIGISMGITGTDVTKEASSMILLDDNFATIVASVEEGRVIYDNIRKFIRYLLSCNLGEVLTMFIASLLYLPTPLLPIQILFVNLATDGLPAIALGVDPADTDIMSEKPRPKNESIFARGLREKIIIRGSLIGVCTVLSFMAGSYYGFTLETCRTLALSTLIMSQLIHVFECRSERHSIFEIKYFTNIYLVGAVAISVAMLISILYIPFMQNIFHTVALNLAQWLIVIFFSGTIAFINSLYLYMKK
>NZ_CP027781.1|WP_106898874.1|89082_90726_+|putative-manganese-dependent-inorganic-diphosphatase
MKDLIYITGHRNPDSDSICASLGYADFKKQLGYKNIVSGRLGELNNETKFVLDYFNVEAPTLIDTVKTQVYDLDIDKVTPISKDLSLKKAWTIMEENNVKTLPVQDEEGKLIGLASLSNISSTYMGVWQKDILAKSNANIEDIIDTLNAKVYYKKEEKQKFIGNLVVAAMEAKDIKNYVKEGDIVILGNREDAQETALDCKAHLLVVTGSHKVSDKILNKAKDLRCSILVSKEDTFTTSVLITQSIPVSYIMTSSDIISFKLSDFVEDIKEVMLKTRFRSYPVVDQNNKIVGTISRYHLISPKKKKVILVDHNEMGQSVPGLEEAEIMEIIDHHRIGGVNTASPIFFRNQPVGSTSTIIANMFFENNITPSKEIAGVLASAIISDTLLFKSPTSTELDKTILGKLAKIAEIDPKNYSVEMFKAGTSLKGKTVEGLFHEDFKNFTIGGGKIGVSQVSTMDPSSFDPLKEDMLNLMETKIKKEGYEGLVLVLTDLLKEGSYIYVVGPKKETIASAFGKSLGKDNSLYAEGVLSRKKQVIPPITNAIENK
>NZ_CP027781.1|WP_106898875.1|90843_91419_-|hypothetical-protein
MNSNIYDRKKHSYKNRPYYCPINNMWFYPYMYMNPYTSYMVNPFMTPYMDPYMNAYMTPSYYRNMCSCNDRAQCEATRAYDENNYNFTKEDIYANQYEEEKKKIYYEEDSLDDIVIFNEKDRNEHNEKEEKLDKAQQNTFDSDSKSTFTEKKDIQLEEVDKGEERDESKEKESYRSVKINMRKVPLKEITD
>NZ_CP027781.1|WP_106898876.1|91803_92595_-|flagellar-basal-body-rod-protein-FlgG
MLRALWNSKSGLIAQQNKLDSISNNLANVNTVGYKREDVSFQELVQETLKRKGYPTSDRPEIQTGTGVKATNWIRDTHQQGILLNTGNKTDLAIDGQGFFRVIMPDGNYAYERSGNFVIDRNGMLVDENGNRLEIQLQQPAGSQILNRIGGFNKNNINIAEDGSISAKDIDGINKMIGKINIYNAVGSDAFVSIGRNLYIPQEGVNVFVNNDVSMLQGFLENSNVDAGKEMTEMIITQRAFELSSRGIKTADEMWGIVNNLRK
>NZ_CP027781.1|WP_072586632.1|92641_93409_-|flagellar-biosynthesis-protein-FlgG
MIRSLYTAVSGMISLEAKQDTISSNLSNASTVGYKSTNLAFKKFEDVLMENYDKKLGNKNIKNVIGGLSMGNKIDEVNNLFTQGIIQDTGKPTDFALEGRGFFTIENNGRNYYTRDGHFHVDTRGYLVNDSGYNVMGINRNTGAREAIFVGNKTIGTDASGNISLNGVPSYSFQVADFNDYNSLKKIGDNLFEGNNPQNINGIVRQNSLEKSNVNVTNEMVNMLTTMRSFETNQKMVQAIDETLGKTVNEVGAAR
>NZ_CP027781.1|WP_003495172.1|93474_93591_-|hypothetical-protein
MIGVKINYNLSKSQIESKARDLGMEYPQEMKVIDKTKK
>NZ_CP027781.1|WP_106898877.1|93668_94226_-|hypothetical-protein
MVAFLLIVIGSILIFINFKAIKKEKGSFSETLKGSIENIDEYKEEMGLIRKEFAETLIDVQKEMEYLKKELNVLKHTYENNIETEDFYKKNHSTNYPKESEGNLLKPKYIDSKNVENISKEINKKNIQKDILTNDNDKNSSKDDNSIKVNEVSKLLEEGHAVEEICEILNMGKGEVILIKELYLK
>NZ_CP027781.1|WP_030035916.1|94253_94982_-|FliA/WhiG-family-RNA-polymerase-sigma-factor
MAIADNNLYVKEEIVKKYIPLVKYIASRVIIGKTKYIEYEDLVSYGMIGLMDALNKFDESKGMKFSTYASIRIKGSMIDELRRNSPISKGAMDKLNRYNEAIERLQKKLNKEPNLIQIADELNISLKEVSEIENYINYISVISLEDLIFSSEDEVPLIGTIKDEKSPSPEKHVEENEQLDYLAKAIELLNEKDRLVVTLYYYEELTLKEIGKILSVSESRVCQLHSRAIIHLKKAMTKLKYN
>NZ_CP027781.1|WP_045887466.1|94995_95655_-|flagellar-protein
MNNKYEFKINNKVEIEWDDGYYKSIIQDVNEDTIYITIPANEGKYLPLNYNDKITVFYFDGEKIFKFKTIVTGRKVDKILLIALKRPEKMNRIQRRNFVRISLILKTYAALIDTKRDLKEIYYSNKCNTEFDFFDADIVDISGGGLKLSTKKEIEFDEEIIVNIPFEKENIAVKGKIIRKQKENEKYIYGVKFLDIDVLTREKIIKFIFSKMRKQVHRL
>NZ_CP027781.1|WP_106898878.1|95669_96530_-|MinD/ParA-family-protein
MLDQAEKLRQLVNNKDRTVNSPKIITVTSGKGGVGKSNFVVNLAITLQKMGKKVLILDADIGMGNDDVLMGVVPRYSIYDIIFNNKIIEEVLIKGPFGVKLLPAGTAITNLEGITEGQIERFIKNLSTLEELDYIIMDTGAGVNRSVLGFIACSDELIILTTPEPTAITDAYSLLKAVSHFNIKQKAKLIVNKTIDQEDGKITYNKFKNAVNRFLRIDLEYLGSIQEDRKAIQAVRRQIPFVLAYPNCDASGDIVNIAKNILGNVKDYNNNVSIEGFFKKLFSIFS

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_2

601008-601299

Orphan

III-B

Consensus_repeat	Method
ATTTAAATACATCTTATGTTAATGTTCAA	CRISPRCasFinder
ATTTAAATACATCTNATGTTAATGTTCAA	CRT

4 spacers

The CRISPR arrays of NZ_CP027781_2

>merge|NZ_CP027781|2|601008-601299|CRISPRCasFinder,CRT
ATTTAAATACATCTTATGTTAATGTTCAATATACGATATATTAAAGCCTAAAATAGCAGCTATAACATTTAAATACATCTCATGTTAATGTTCAACATAAAAGAATTTACAGACACTCTAAATAAAAGTACATTTAAATACATCTAATGTTGATGTTCAATCGCAACTGGATTAGCTAAATGCATCTATGTTACAAAATCTAAATACATCTCATGTTAATGTTCAACGAAAAATGGTTCTCTCACATTCATTTCTAATTCATAATTTAAATACATCCCATGTTAATGTTCAA

>NZ_CP027781|2|2|601008-601299|CRISPRCasFinder
ATTTAAATACATCTTATGTTAATGTTCAA	TATACGATATATTAAAGCCTAAAATAGCAGCTATAAC
ATTTAAATACATCTCATGTTAATGTTCAA	CATAAAAGAATTTACAGACACTCTAAATAAAAGTAC
ATTTAAATACATCTAATGTTGATGTTCAA	TCGCAACTGGATTAGCTAAATGCATCTATGTTACAAA
ATCTAAATACATCTCATGTTAATGTTCAA	CGAAAAATGGTTCTCTCACATTCATTTCTAATTCATA
ATTTAAATACATCCCATGTTAATGTTCAA

>NZ_CP027781|2|1|601008-601299|CRT
ATTTAAATACATCTTATGTTAATGTTCAA	TATACGATATATTAAAGCCTAAAATAGCAGCTATAAC
ATTTAAATACATCTCATGTTAATGTTCAA	CATAAAAGAATTTACAGACACTCTAAATAAAAGTAC
ATTTAAATACATCTAATGTTGATGTTCAA	TCGCAACTGGATTAGCTAAATGCATCTATGTTACAAA
ATCTAAATACATCTCATGTTAATGTTCAA	CGAAAAATGGTTCTCTCACATTCATTTCTAATTCATA
ATTTAAATACATCCCATGTTAATGTTCAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106899217.1\|589759_590632_-\|hydroxymethylbilane-synthase	unknown	unknown	gnl\|CDD\|234612
NZ_CP027781.1\|WP_106899221.1\|594970_595933_-\|cobalamin-biosynthesis-protein	unknown	unknown	gnl\|CDD\|234919
NZ_CP027781.1\|WP_106899218.1\|590600_591263_-\|precorrin-2-dehydrogenase	unknown	unknown	gnl\|CDD\|235504
NZ_CP027781.1\|WP_106899229.1\|608490_609039_-\|biotin-transporter-BioY	unknown	unknown	gnl\|CDD\|224187
NZ_CP027781.1\|WP_106899219.1\|591695_592394_-\|cobalt-ABC-transporter-permease	unknown	unknown	gnl\|CDD\|274139
NZ_CP027781.1\|WP_106899216.1\|587996_589457_-\|uroporphyrinogen-III-C-methyltransferase	unknown	unknown	gnl\|CDD\|273643
NZ_CP027781.1\|WP_106899220.1\|593653_594742_-\|aspartate-aminotransferase	unknown	unknown	gnl\|CDD\|180542
NZ_CP027781.1\|WP_106899215.1\|586931_587906_-\|porphobilinogen-synthase	unknown	unknown	gnl\|CDD\|236450
NZ_CP027781.1\|WP_106899222.1\|596190_597672_-\|cobyric-acid-synthase-CobQ	unknown	unknown	gnl\|CDD\|234838
NZ_CP027781.1\|WP_106899224.1\|601515_602073_-\|bifunctional-adenosylcobinamide-kinase/adenosylcobinamide-phosphate-guanylyltransferase	unknown	unknown	gnl\|CDD\|235612
NZ_CP027781.1\|WP_106899227.1\|605192_605849_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|223325
NZ_CP027781.1\|WP_106899223.1\|600130_600895_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133381
NZ_CP027781.1\|WP_106899230.1\|609376_610408_-\|two-component-sensor-histidine-kinase	unknown	unknown	gnl\|CDD\|223715
NZ_CP027781.1\|WP_106899214.1\|585472_586795_-\|cobyrinic-acid-a,c-diamide-synthase	unknown	unknown	gnl\|CDD\|234896
NZ_CP027781.1\|WP_106899228.1\|606513_608265_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|276807
NZ_CP027781.1\|WP_106899231.1\|610404_611076_-\|DNA-binding-response-regulator	unknown	unknown	gnl\|CDD\|223816
NZ_CP027781.1\|WP_106901451.1\|601359_601512_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106899232.1\|611365_613726_+\|sulfate-ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|213222
NZ_CP027781.1\|WP_106899226.1\|604375_605017_-\|hydrolase	unknown	unknown	gnl\|CDD\|224790
NZ_CP027781.1\|WP_106899225.1\|602355_603939_-\|LexA-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|234688

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106899217.1\|589759_590632_-\|hydroxymethylbilane-synthase	gnl\|CDD\|234612	PRK00072, hemC, porphobilinogen deaminase; Reviewed.	1.22407e-146
NZ_CP027781.1\|WP_106899221.1\|594970_595933_-\|cobalamin-biosynthesis-protein	gnl\|CDD\|234919	PRK01209, cobD, cobalamin biosynthesis protein.	1.43209e-149
NZ_CP027781.1\|WP_106899218.1\|590600_591263_-\|precorrin-2-dehydrogenase	gnl\|CDD\|235504	PRK05562, PRK05562, NAD(P)-dependent oxidoreductase.	3.36897e-104
NZ_CP027781.1\|WP_106899229.1\|608490_609039_-\|biotin-transporter-BioY	gnl\|CDD\|224187	COG1268, BioY, Uncharacterized conserved protein [General function prediction only].	4.01857e-42
NZ_CP027781.1\|WP_106899219.1\|591695_592394_-\|cobalt-ABC-transporter-permease	gnl\|CDD\|274139	TIGR02454, Uncharacterized_protein_MJ1089, cobalt ECF transporter T component CbiQ. This model represents the CbiQ component of the cobalt-specific ECF-type. CbiQ is now recognized as the T component of energy-coupling factor (ECF)-type transporters. The S component confers specificity (CbiM-N for cobalt systems), which CbiO is the ABC-family ATPase. In general, proteins found by this model reside next to the other putative subunits of the complex, identified as CbiN, CbiO, or CbiM. Note that the designation of cobalt transporter has been spread excessively among ECF system transporters with many other specificities. [Transport and binding proteins, Cations and iron carrying compounds].	1.74987e-27
NZ_CP027781.1\|WP_106899216.1\|587996_589457_-\|uroporphyrinogen-III-C-methyltransferase	gnl\|CDD\|273643	TIGR01469, Uroporphyrinogen-III_C-methyltransferase, uroporphyrin-III C-methyltransferase. This model represents enzymes, or enzyme domains, with uroporphyrin-III C-methyltransferase activity. This enzyme catalyzes the first step committed to the biosynthesis of either siroheme or cobalamin (vitamin B12) rather than protoheme (heme). Cobalamin contains cobalt while siroheme contains iron. Siroheme is a cofactor for nitrite and sulfite reductases and therefore plays a role in cysteine biosynthesis; many members of this family are CysG, siroheme synthase, with an additional N-terminal domain and with additional oxidation and iron insertion activities. [Biosynthesis of cofactors, prosthetic groups, and carriers, Heme, porphyrin, and cobalamin].	7.19075e-120
NZ_CP027781.1\|WP_106899220.1\|593653_594742_-\|aspartate-aminotransferase	gnl\|CDD\|180542	PRK06358, PRK06358, threonine-phosphate decarboxylase; Provisional.	1.59531e-88
NZ_CP027781.1\|WP_106899215.1\|586931_587906_-\|porphobilinogen-synthase	gnl\|CDD\|236450	PRK09283, PRK09283, porphobilinogen synthase.	0
NZ_CP027781.1\|WP_106899222.1\|596190_597672_-\|cobyric-acid-synthase-CobQ	gnl\|CDD\|234838	PRK00784, PRK00784, cobyric acid synthase.	0
NZ_CP027781.1\|WP_106899224.1\|601515_602073_-\|bifunctional-adenosylcobinamide-kinase/adenosylcobinamide-phosphate-guanylyltransferase	gnl\|CDD\|235612	PRK05800, cobU, adenosylcobinamide kinase/adenosylcobinamide-phosphate guanylyltransferase; Validated.	1.07626e-82
NZ_CP027781.1\|WP_106899227.1\|605192_605849_-\|hypothetical-protein	gnl\|CDD\|223325	COG0247, GlpC, Fe-S oxidoreductase [Energy production and conversion].	2.46363e-06
NZ_CP027781.1\|WP_106899223.1\|600130_600895_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133381	cd01106, HTH_TipAL-Mta, Helix-Turn-Helix DNA binding domain of the transcription regulators TipAL, Mta, and SkgA. Helix-turn-helix (HTH) TipAL, Mta, and SkgA transcription regulators, and related proteins, N-terminal domain. TipAL regulates resistance to and activation by numerous cyclic thiopeptide antibiotics, such as thiostrepton. Mta is a global transcriptional regulator; the N-terminal DNA-binding domain of Mta interacts directly with the promoters of mta, bmr, blt, and ydfK, and induces transcription of these multidrug-efflux transport genes. SkgA has been shown to control stationary-phase expression of catalase-peroxidase in Caulobacter crescentus. These proteins are comprised of distinct domains that harbor an N-terminal active (DNA-binding) site and a regulatory (effector-binding) site. The conserved N-terminal domain of these transcription regulators contains winged HTH motifs that mediate DNA binding. These proteins share the N-terminal DNA binding domain with other transcription regulators of the MerR superfamily that promote transcription by reconfiguring the spacer between the -35 and -10 promoter elements. Unique to this family, is a TipAL-like, lineage specific Bacilli subgroup, which has five conserved cysteines in the C-terminus of the protein.	3.20776e-48
NZ_CP027781.1\|WP_106899230.1\|609376_610408_-\|two-component-sensor-histidine-kinase	gnl\|CDD\|223715	COG0642, BaeS, Signal transduction histidine kinase [Signal transduction mechanisms].	1.85544e-60
NZ_CP027781.1\|WP_106899214.1\|585472_586795_-\|cobyrinic-acid-a,c-diamide-synthase	gnl\|CDD\|234896	PRK01077, PRK01077, cobyrinate a,c-diamide synthase.	0
NZ_CP027781.1\|WP_106899228.1\|606513_608265_-\|hypothetical-protein	gnl\|CDD\|276807	sd00010, SLR, Sel1-like repeat. Sel1-like repeats (SLRs) share similar alpha-helical conformations with Tetratricopeptide repeats (TPRs), but with different consensus sequence lengths and superhelical topologies. SLRs contain 36 to 44 amino acids and are present in bacteria and eukaryotes but not in archaea. SLR proteins are involved in a variety of functions, and many serve as adaptor proteins for the assembly of macromolecular complexes. The SLR family was named after the Caenorhabditis elegans Sel1 protein which is predicted to fold into 11 SLRs, a transmembrane domain, and an N-terminal signal sequence. The human Sel1L protein contains an additional fibronectin type-II domain and an N-terminal PEST sequence. Its downregulation is associated with the development of breast and pancreatic carcinomas.	2.41185e-42
NZ_CP027781.1\|WP_106899231.1\|610404_611076_-\|DNA-binding-response-regulator	gnl\|CDD\|223816	COG0745, OmpR, Response regulators consisting of a CheY-like receiver domain and a winged-helix DNA-binding domain [Signal transduction mechanisms / Transcription].	3.30745e-66
NZ_CP027781.1\|WP_106899232.1\|611365_613726_+\|sulfate-ABC-transporter-ATP-binding-protein	gnl\|CDD\|213222	cd03255, ABC_MJ0796_LolCDE_FtsE, ATP-binding cassette domain of the transporters involved in export of lipoprotein and macrolide, and cell division protein. This family is comprised of MJ0796 ATP-binding cassette, macrolide-specific ABC-type efflux carrier (MacAB), and proteins involved in cell division (FtsE), and release of lipoproteins from the cytoplasmic membrane (LolCDE). They are clustered together phylogenetically. MacAB is an exporter that confers resistance to macrolides, while the LolCDE system is not a transporter at all. An FtsE null mutants showed filamentous growth and appeared viable on high salt medium only, indicating a role for FtsE in cell division and/or salt transport. The LolCDE complex catalyzes the release of lipoproteins from the cytoplasmic membrane prior to their targeting to the outer membrane.	1.49335e-111
NZ_CP027781.1\|WP_106899226.1\|604375_605017_-\|hydrolase	gnl\|CDD\|224790	COG1878, COG1878, Kynurenine formamidase [Amino acid transport and metabolism].	4.35219e-66
NZ_CP027781.1\|WP_106899225.1\|602355_603939_-\|LexA-family-transcriptional-regulator	gnl\|CDD\|234688	PRK00215, PRK00215, transcriptional repressor LexA.	4.11887e-32

>NZ_CP027781.1|WP_106899223.1|600130_600895_+|MerR-family-transcriptional-regulator
MHYKVKEVADMAGISVRMLHHYDKIGLLKPESVSAAGYRLYSDENLDRLQQILFFKELNFHLQEIKIILDSPNFSKKEALETHRQFLLEKKIRLEKIIQSVDKTISSIEGGIKMNKKEVLGVFDMTEIEEHQKKYSEEVKNKYGNTSPYKESNEKTSKYTKEDWNNIMKDWDIIYKKLASLMDKNPASSEVQEAIHQFRQHISKNFYDCTPEIFKGLGEIYVNDERFTDNIDKYKVGLSKFLREAINVYCDNIK
>NZ_CP027781.1|WP_106899222.1|596190_597672_-|cobyric-acid-synthase-CobQ
MAKIMIQGTASSVGKSLIVAALCRIFKQDGYSVCPFKSQNMSLNSYITLDGKEMGRAQVLQAYAAGLEPEVYMNPILLKPTSDKKCQIIVNGKVYGNSTAMGYHNLKLKFKDMLKEHFNKLEEDFDIVVMEGAGSPAEINLRDRDIVNMGMAELIDAPVLLVGDIDKGGVFASLAGTMLLLRDGEKERVKGTIINKFRGDVEILKPGLDMLEDIVHIPCLGVVPYTRLQLEDEDGAVEFNKKAYAPIDIAVIKMPHISNFTDLDALKSEEDVSIRFITSKEEFKEPDLLIIPGSKNTIEDLLYLRQCGLEERIKEYSRDGKIIGICGGYQVLGSKIKDPYKVETDLGEIDGLNLLDMETIFEEEKVTTRVSARLLDEETENAVYGYEIHMGISKYGKNVTPLFKIYDKNGEKVDYFDGAINRKGNIMGTYIHGIFDGVAFREKIINELRVKKGLNKKKSQVYEHMREKELDKLADIVRQSLDMEKIYSIIGIK
>NZ_CP027781.1|WP_106899221.1|594970_595933_-|cobalamin-biosynthesis-protein
MYLNVTANFVDIIIAVFIDWIIGDPHWFPHPVIYIGRLINFLEKKFRAKVKNEENLKLYGEIIVAIVCFASFLIPFMILQAFKFNFYIYHGLNILIIWTTLAAKCLHEEAIKIYHALYKENIEDARLKLSYIVGRETKDLIENEIIRADVETVAENASDGIIAPLFYAIIGGAPLAMMYKGINTMDSMLGYLNDEYKYIGFFPAKVDDVFNFVPARLTGILMCISAPIVGGNPFKSFKIMIRDRKNHKSPNCAYPEGATAAALKIQLGGTNVYFGQVVEKPTIGDKIKELAPIHIKESIKLMYASEALMIVMWVIIFKLF
>NZ_CP027781.1|WP_106899220.1|593653_594742_-|aspartate-aminotransferase
MHGGDIYTEGILKGKELIDFSSNINPLGLPDSFKDNLQEALNWVQIYPDIQYRNLKRNLIDYLSFFLDYFYKEKVGKLNIKEENLVLGNGAVEIIDLAISNLKSISILVPSFVEYELCAKKWNVQIDYCNLNEDMTYNYKNIKKSLEKTEGIILGNPNNPNGSVIDKEKFIYILDYCEKNNKIVILDEAFIEFTGKNSFSFLNLCERYKCIFIIRALTKFFSMPGIRFGYGISFNNEFLNKIREKQNPWNINCFAEIAVKYVLKDEEFIEKSINYIEKEKIFIYENLKKCDLFQDVYSTYSNFILCKLKDITGEQLKQRLLDKGFVLRVCKDFKTLNNDYVRFAIKTRELNQALVNTLKEIK
>NZ_CP027781.1|WP_106899219.1|591695_592394_-|cobalt-ABC-transporter-permease
MLRTIMLLSKTSELSNIHPLEKAILSIIPIVILGFTQNYIIVFCNILFFLFMNLISKNNKKIFTKITLEVTAFAAISSITFVFDYGIVYTLTLIFKSVSAGLCLSFFSLTTPIDDMLYCLGKKEYLKDMCDIAKGMERFLVVINDEYNILYSSIKSRGGFDTFKLKIRNTGKMAALLFINTLSRWKIIKEGLDSRGYVGYVPYLDRDFDFSYIRFLSILSYIILMLLLVIFF
>NZ_CP027781.1|WP_106899218.1|590600_591263_-|precorrin-2-dehydrogenase
MEWINLQEKYNFIALKSRRIRILIVGGGRAAFIKGKAFLDRECSLYILAPKFSKDVLNLKTYNNVEFIKNNYDKKYILDKHLVVIATEDEEVNNEIRNNCDELSKLYIDCSDKDKSLCFNSFQRESKTMVLALNNKIGCPKATSFIGEKIKRDLEKYDNYIEYVTYIRSITKNNPMKDEIIDFMCSNDFHFFFEKGYGNLILSMFYGGMDFEFCNSHKKK
>NZ_CP027781.1|WP_106899217.1|589759_590632_-|hydroxymethylbilane-synthase
MNFVIATRRSKLAQVQTEIIIDLLNKKHDIECEKLLIETIGDKILEVSLDKIGGKGLFVKDIEVAMLEQRADAAVHSMKDVPYEMPKGFEIIAIPEREDVRDAFISLDNIKFKDLREGAKIGTSSRRRAAQLKLLRPDLDIVPIRGNVQTRIEKIKKENLDGIILAVAGLKRVNLDHLITDYFDTKEMVPAIGQGALGIEVMEEHPKKELFKDLDHYNSKICVLAERAFMRELDGDCHSTIGAYASIKDNIMYIIGIFERKNKIIKKEITGTKDQYEKLGIALAEHILKD
>NZ_CP027781.1|WP_106899216.1|587996_589457_-|uroporphyrinogen-III-C-methyltransferase
MSKVYLIGAGPGDEELITLKAIRALKKCTAVMYDRLANGELLKYLAPSCEIYYCGKEPGCHYKSQDEINKMLVKLAKEGHIVGRIKGGDPYVFGRGGEEALDILEENIEFEVIPGVTSPVSVLNYAGIPITHRGISRGFHIFTAMTKDKLDIDWKSVANIGGTLVFLMGLGRLELITKGLIENGIDKESKIAVVMKGTTSKQKKVIGNLENIVEKVKEAKLESPVIIVVGEVVSFSDKLNWYEKKPLFGRNICITRTKEQAKELKVQLLDLGAEVTEINSIEIKNTEDNLKSYLSKLKEYDYIALTSVNAVKIFFDYLIRENIDIRNINAKFAAIGPATSEAIRMRGIMPSVKSKHFVAESLFEEMRKHIQKGDKILVPRSKDARPFLVDALRKEGCIVDEVHIYETLCGQCTYTERFENADTVLFTSPSTVRNMISMVDIDSIKEKDIIAIGPITAKELDKNNIKCSICDEYSINGIIDKLLDLN
>NZ_CP027781.1|WP_106899215.1|586931_587906_-|porphobilinogen-synthase
MFRRHRRLRENEAIRAMVRETVIREEDFIYPMFVVEGKNIKEEISSLPGNYHYSIDRLEELVEEVKKSGIKGIMIFGVPDHKDECGSAAFDDNGIVQKGIRRLKKLMPELYIVADVCMCQYTSHGHCGIIHGHNVDNDESLKYLAKISLSYAKAGADMIAPSDMMDGRVYAIRKILDENNFKHVGIMAYSAKYCSAFYGPFREAANSAPQFGDRKTYQMDPANGREAMLEIEDDINEGADIVMVKPALPYLDVIRMAKDRFEFPLAAYNVSGEYAMVKAAAKQGLIDERRVALEMLTSIKRAGADIIITYYAFEASAWLKEDRK
>NZ_CP027781.1|WP_106899214.1|585472_586795_-|cobyrinic-acid-a,c-diamide-synthase
MRSIIISSNSSGGGKTTVTLGLMKALIKKGYKVQGYKVGPDYIDPAFHSYVTENSSRNLDLFLMGEDGVKASYSRGKGDLGVIEGVMGLYDGKGIDTEYSTAHLSKVLNLPVVLVLTPKAQSATLCAEIMGILNYEKINIVGVIFNKVSEIYYKLLKRLVEENCGLKVFGYVPKEEKLELKSRHLGLIQSSEIKDLEEKIDICSELILKYVDIENLINHFEKTEKYKDNFYLENKNLNIGIPYDKAFSFYYKENIELLENIGNIKYFSPMKDEKLPEYLDFLYIGGGYPEVFIKELRENKSMLSSINKALNNGLPCYAECGGLMYLTEGIEDLEGDYKKTVGFFKGKCHMTKRLQNFGYAEIEVEKENKILPKGLKINCHEFHKSYVDLKEDKIYELIKNLYDDSTKKWSCGYIKNNTLAAYAHVHFFGNMDFIKKLFNR
>NZ_CP027781.1|WP_106901451.1|601359_601512_+|hypothetical-protein
MLKKLFQPFAIFYRGRYKAYLKAYISMPRIDSKIKCGWKILLLIIRLISY
>NZ_CP027781.1|WP_106899224.1|601515_602073_-|bifunctional-adenosylcobinamide-kinase/adenosylcobinamide-phosphate-guanylyltransferase
MKEKNKIVLITGGVRSGKSEFAESLLQNEESVLYIATAKITDKEMEHRVEKHKKRRNSAWKTYEGYKDLGKIIKDYDEKNILLDCVTVMTTNLMFHKEIDYENIKEEELDRILESIKKEFYDLIISVNEENKNIILVTNEVGYSIVPAYKLGRIFRDFQGIINKFIAYLSDEVYLVTCGIPLKIK
>NZ_CP027781.1|WP_106899225.1|602355_603939_-|LexA-family-transcriptional-regulator
MKLESGQSRIVKSKHLGYGLLRGSLGTGKTTAAIYRGIYLKNQYCMYDKDKVLILSKNEENLNYIKNIYDDAEKTGVQYITLFSYIEDKLYFSVIYKIINKYFWEYIENNNLRYELVSEKEKRTIIEECINDVKAEYKDLKYIDIKYSKFFLEEIQWIKDCMYYELEEYKSADRIGRKTKKGEGPQRIIKNSKVREAIFKIMLLYNEKLKDKNLVDYSDVVSIALKEAFQNKENKFNHIIVDEAQNFTKLELKFIEALGKKNIYSSILFVADKEKSSNPKGWITKGRKLNNLQLGFELKRFNLNKKISMDIKNIDDYKITKKVSNIFMENVDVSNIANDNFQDKVLDKNQWHKDKVSYDMDKFEYVDIKHRRSYEFFRDLGSNEEIIVEDQGSKEEYKEDELARLPVFNDIAAGEPILMNPCVEGEFNIPKYWVRGIKDCFILKVKGDSMIGANIEDGDHVVIKRQQMAENKDIVAVNLEGSATLKRLLIKKSGAVLMPENKKYKPIEILEEGASIIGVAVGIIKGK
>NZ_CP027781.1|WP_106899226.1|604375_605017_-|hydrolase
MKVIDLTHTISKNMPVYPGTEKPKLEVKSTYDKDGFKETLLTMFSHTGTHMDSPAHLFPERTNLDSFLPEQFIGKGLVIDCSDLKEGEKIDMKYIDCVKEKANKADFILFHTGWDRYWRTDFYFKDYPCITEEIVQYLIYNKKKGVGVDAMGIDPISDGNLTIHRKLFLKTDIVVIENLTRLGEVGNELFTFCALPIKYENSDGAPIRAIAIL
>NZ_CP027781.1|WP_106899227.1|605192_605849_-|hypothetical-protein
MTKTYFNPGCALSIYKPEIENKILKFLNENYGEVTLHKICCHHNPQLEAGSLIINVCAGCDRRFRSLYEGISTISLWEVLDGLNAFQYPDYKGLKLSVHDACPVREKPQVHKAVRNLLKKMNIDVVETKFSGTNSICCGDDFYPKLPIEKVHQKMKERADSMPCNEVCVYCVSCIKSMYIGGKTPRHLIDLLIGQTTEPQIWDTVKWHEQLQDYIDKH
>NZ_CP027781.1|WP_106899228.1|606513_608265_-|hypothetical-protein
MDRFSFLKIEWPEIYQSICNAEEKSKKDSNTTLIKLAQTVELITKYILKENHIETNTELLDSINLLKDCNNLNSYMVDLFYKIIVVSNKAIYEDYSDQIIAKSFLDKMFEILVWFAIEYGKRDYRKVDLSNMRPKDKDIFNKYIKSKSYNDAEKNIENETIIKPFTINNEEFFKEENNTDINRYEQDVFETKEEFYKRIKEHEIFSLGRIFIEESNINETDKVVAFPFYIYKSIQIKIPIIDMLYIEKAEFENLSIEEEEYTVFSKLDVIDDKICIDINNIYIEVNNNECKVHAVVLDISYYESYEKYRNIIYSKKPIPIGMIKLNKNKYDINKNEMPITIKYYDWIKKYILNTKAYIEIDRYEAKTLYKEDLYYTLSGKLDIFNKKLLIRDYYIQSKSLDKNFKIKLYNSDPMNKLRCLVDKEEIFAMNTIGEMYYKEQNYKEAMYWYKKASDKGNATSMSNIGFMYYNGKGVEQDYKKAIEWYSKASQAGNFTAMGNIGFMYYNGQGVKQDYKKAMYWYEKSYKEGNSGVMRNIGSMYYEGKGVIKDYRKAMQCYKKASQIDNFNFIKNISDMYYEERERK
>NZ_CP027781.1|WP_106899229.1|608490_609039_-|biotin-transporter-BioY
MKKKLETRDMIYSALFATIIGVSSYIIIPLPISPVPITAQSLAVMLAGCVLTPIQVVLSMITFLLMGVIGIPVFSGGRAGIGIIVGKTGGYLIGFLIGAIIISILVRKNKYLFNMLIACFVGGIVVVHILGSAWLGQVTSIGIKKAFLLGSAPFIPGDLIKAVVAVFIGRKLSKSMKRSRIQ
>NZ_CP027781.1|WP_106899230.1|609376_610408_-|two-component-sensor-histidine-kinase
MMNNKISVKMVVAFSLIVFFIVTSAVVISALVVVFLSRFNVFTQPNPLILLGWLGIISIMVSTAIAQIIGKKVLSPISDLNKATKEVAKGNFNTRLSENSWTDEIREMAHSFNIMTHELGNIETLRDDFISNVSHEFKTPISAIEGYATLLQDDELSDEERREYIHKILISTKRLSSLSGNILQITELENQKILPLEQKYYLDEQIRQTILLFEYQWTKKNITLDINLDNITYIGSKELLAQVWQNILGNAIKFSHQNGTIKVTLTQTNEEVLITIKDNGIGMSEKVKDRVFEKFYQGDSSHYSEGNGLGLALVKRIIDICEGTIEISSHEGVGTDFTVRLPK
>NZ_CP027781.1|WP_106899231.1|610404_611076_-|DNA-binding-response-regulator
MFKVLVVEDDPALRKLFCTVLNKNGYKSIEAKDGHSALDVLYKEYIDLIISDIMMPNMDGYTLTKLIRESNNNVPILMITAKETFSDKQEGFKVGTDDYMVKPIDVNEMILRVGALLRRSQIINERKIVIGETTFLYDFLSVKYNNKELVLPQKEFYLIYKLVSTPNKIFTRQQLMDEIWGIESETDPRTVDVHINRLRDRFKDNKDFNIITIRGLGYKVVKQ
>NZ_CP027781.1|WP_106899232.1|611365_613726_+|sulfate-ABC-transporter-ATP-binding-protein
MLQIKDLKKVYTTGEFKQTALDGVSIDFRQSEFVAILGPSGSGKTTLLNMLGGLDQYDSGDMIINGLSTEKFGESDWDTYRNNSVGFIFQSYNLIPHLSIVDNVEMGMTLSGVPKSEKRQKAAYVLEKVGLGNHIHKKPNQLSGGQMQRVAIARALANDPEIILADEPTGALDTQTSEQIMDLIKEIAKDKLVIMVTHNPELAEEYADRIVSFSDGKIVSDTNPFVSENNLNDYKPKKTSMNFLTALKLSGNNIVTKKWRTALTAFASSIGIIGVALVLSLSNGFNKQINEFEKDSLSNYPISIEQNSMSLEMSPSSKSKDKEKTEFPNKSMIYPYDSSEDAAVHANAISTEYVDYIKKIDSSLINGISYTRNVNMNILKKQDGKVVSMNTSAAAFSTYPSKGDSFETDYLKSYYDVLAGSYPKNEKELVLVVDKYNQVDTSILEALGFSADSKNINFDSMIGTEYRLIYNDDYYTQSGKYFTVNGDTTNLENLYNNKNAVTLKISGIIRIKEDANVSNLSTGIVYSDQLAQDFIENAKNSKIVLAQKEAKYNVMNGNLLTEKTSTTTAAVHGAPNMTANITSNVETKDDVLASLGATSSPTSISIYPVNFEAKDNITTYLDDWNKELKKEDQIVYTDMASMITSLTGNIMDGITIVLVAFAGISLVVSMIMIGIIIYISVLERTKEIGVLRALGARKKDITRVFNAETFIIGFCSGGLGIAITYLLTIPVNSILYKFTDLNNVAQLNPLHAIALVITSIILTMIGGAIPSKMAAKKDPVIALRSE

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_3

2323061-2323168

Unclear

Consensus_repeat	Method
AGGACTTGAACCTACGACACTTCGGGT	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP027781_3

>merge|NZ_CP027781|3|2323061-2323168|CRISPRCasFinder
AGGACTTGAACCTACGACACTTCGGGTATGAACCGAATGCTCTAGCCAGCTGAGCTATTCCGCCACAATGGTTGCGGGGGCAGGACTTGAACCTACGACCTTCGGGTT

>NZ_CP027781|3|3|2323061-2323168|CRISPRCasFinder
AGGACTTGAACCTACGACACTTCGGGT	ATGAACCGAATGCTCTAGCCAGCTGAGCTATTCCGCCACAATGGTTGCGGGGGC
AGGACTTGAACCTACGACCTTCGGGTT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_030032519.1\|2327258_2328794_-\|polysaccharide-biosynthesis-protein	unknown	unknown	gnl\|CDD\|240529
NZ_CP027781.1\|WP_106900419.1\|2315644_2316640_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|380193
NZ_CP027781.1\|WP_106900422.1\|2317844_2318309_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|366234
NZ_CP027781.1\|WP_106900426.1\|2325798_2327244_-\|nucleoside-triphosphate-pyrophosphohydrolase	unknown	unknown	gnl\|CDD\|226465
NZ_CP027781.1\|WP_106900423.1\|2318497_2319109_+\|TetR/AcrR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224228
NZ_CP027781.1\|WP_106900421.1\|2317367_2317811_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379098
NZ_CP027781.1\|WP_106900427.1\|2329676_2330687_-\|peptidylprolyl-isomerase	unknown	unknown	gnl\|CDD\|234605
NZ_CP027781.1\|WP_106900425.1\|2324671_2324962_-\|sporulation-protein-YabP	unknown	unknown	gnl\|CDD\|274341
NZ_CP027781.1\|WP_106900418.1\|2313534_2315622_-\|carbohydrate-binding-protein	unknown	unknown	gnl\|CDD\|274507
NZ_CP027781.1\|WP_003361721.1\|2325079_2325319_-\|RNA-binding-S4-domain-containing-protein	unknown	unknown	gnl\|CDD\|224109
NZ_CP027781.1\|WP_030032513.1\|2324258_2324657_-\|spore-cortex-biosynthesis-protein-YabQ	unknown	unknown	gnl\|CDD\|131939
NZ_CP027781.1\|WP_106900424.1\|2319105_2321673_+\|pyruvate,-phosphate-dikinase	unknown	unknown	gnl\|CDD\|235751
NZ_CP027781.1\|WP_106900420.1\|2317053_2317383_+\|transposase	unknown	unknown	gnl\|CDD\|366690
NZ_CP027781.1\|WP_003488225.1\|2328926_2329478_-\|stage-V-sporulation-protein-T	unknown	unknown	gnl\|CDD\|131898
NZ_CP027781.1\|WP_106900415.1\|2310282_2310651_+\|regulator	unknown	unknown	gnl\|CDD\|129116
NZ_CP027781.1\|WP_003495818.1\|2323894_2324164_-\|septum-formation-initiator-family-protein	unknown	unknown	gnl\|CDD\|368217
NZ_CP027781.1\|WP_030032516.1\|2325392_2325671_-\|HU-family-DNA-binding-protein	unknown	unknown	gnl\|CDD\|259853
NZ_CP027781.1\|WP_106900417.1\|2311282_2313373_+\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|226350
NZ_CP027781.1\|WP_003361716.1\|2323428_2323833_-\|RNA-binding-protein-S1	unknown	unknown	gnl\|CDD\|235614
NZ_CP027781.1\|WP_106900416.1\|2310663_2310918_+\|glutaredoxin	unknown	unknown	gnl\|CDD\|226919

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_030032519.1\|2327258_2328794_-\|polysaccharide-biosynthesis-protein	gnl\|CDD\|240529	cd13124, MATE_SpoVB_like, Stage V sporulation protein B, also known as Stage III sporulation protein F, and related proteins. The integral membrane protein SpoVB has been implicated in the biosynthesis of the peptidoglycan component of the spore cortex in Bacillus subtilis. This model represents a subfamily of the multidrug and toxic compound extrusion (MATE)-like proteins. Proteins from the MATE family are involved in exporting metabolites across the cell membrane and are often responsible for multidrug resistance (MDR).	2.9325e-138
NZ_CP027781.1\|WP_106900419.1\|2315644_2316640_-\|hypothetical-protein	gnl\|CDD\|380193	NF033189, internalin_A, class 1 internalin InlA. Internalins, as found in the intracellular human pathogen Listeria monocytogenes, are paralogous surface or secreted proteins with an N-terminal signal peptide, leucine-rich repeats, and usually a C-terminal LPXTG processing and cell surface anchoring site. See PMID:17764999 for a general discussion of internalins. Members of this family are internalin A (InlA), a class 1 (LPXTG-type) internalin.	4.31166e-29
NZ_CP027781.1\|WP_106900422.1\|2317844_2318309_+\|hypothetical-protein	gnl\|CDD\|366234	pfam00665, rve, Integrase core domain. Integrase mediates integration of a DNA copy of the viral genome into the host chromosome. Integrase is composed of three domains. The amino-terminal domain is a zinc binding domain pfam02022. This domain is the central catalytic domain. The carboxyl terminal domain that is a non-specific DNA binding domain pfam00552. The catalytic domain acts as an endonuclease when two nucleotides are removed from the 3' ends of the blunt-ended viral DNA made by reverse transcription. This domain also catalyzes the DNA strand transfer reaction of the 3' ends of the viral DNA to the 5' ends of the integration site.	1.6163e-16
NZ_CP027781.1\|WP_106900426.1\|2325798_2327244_-\|nucleoside-triphosphate-pyrophosphohydrolase	gnl\|CDD\|226465	COG3956, COG3956, Protein containing tetrapyrrole methyltransferase domain and MazG-like (predicted pyrophosphatase) domain [General function prediction only].	0
NZ_CP027781.1\|WP_106900423.1\|2318497_2319109_+\|TetR/AcrR-family-transcriptional-regulator	gnl\|CDD\|224228	COG1309, AcrR, Transcriptional regulator [Transcription].	5.17121e-14
NZ_CP027781.1\|WP_106900421.1\|2317367_2317811_+\|hypothetical-protein	gnl\|CDD\|379098	pfam13276, HTH_21, HTH-like domain. This domain contains a predicted helix-turn-helix suggesting a DNA-binding function.	5.81316e-09
NZ_CP027781.1\|WP_106900427.1\|2329676_2330687_-\|peptidylprolyl-isomerase	gnl\|CDD\|234605	PRK00059, prsA, peptidylprolyl isomerase; Provisional.	7.96024e-142
NZ_CP027781.1\|WP_106900425.1\|2324671_2324962_-\|sporulation-protein-YabP	gnl\|CDD\|274341	TIGR02892, conserved_hypothetical_protein, sporulation protein YabP. Members of this protein family are the YabP protein of the bacterial sporulation program, as found in Bacillus subtilis, Clostridium tetani, and other spore-forming members of the Firmicutes. In Bacillus subtilis, a yabP single mutant appears to sporulate and germinate normally (), but is in an operon with yabQ (essential for formation of the spore cortex), it near-universal among endospore-forming bacteria, and is found nowhere else. It is likely, therefore, that YabP does have a function in sporulation or germination, one that is either unappreciated or partially redundant with that of another protein. [Cellular processes, Sporulation and germination].	9.49604e-31
NZ_CP027781.1\|WP_106900418.1\|2313534_2315622_-\|carbohydrate-binding-protein	gnl\|CDD\|274507	TIGR03296, hypothetical_protein, M6 family metalloprotease domain. This model describes a metalloproteinase domain, with a characteristic HExxH motif. Examples of this domain are found in proteins in the family of immune inhibitor A, which cleaves antibacterial peptides, and in other, only distantly related proteases. This model is built to be broader and more inclusive than pfam05547.	4.46211e-39
NZ_CP027781.1\|WP_003361721.1\|2325079_2325319_-\|RNA-binding-S4-domain-containing-protein	gnl\|CDD\|224109	COG1188, COG1188, Ribosome-associated heat shock protein implicated in the recycling of the 50S subunit (S4 paralog) [Translation, ribosomal structure and biogenesis].	3.46592e-24
NZ_CP027781.1\|WP_030032513.1\|2324258_2324657_-\|spore-cortex-biosynthesis-protein-YabQ	gnl\|CDD\|131939	TIGR02893, Spore_protein_YabQ, spore cortex biosynthesis protein YabQ. YabQ, a protein predicted to span the membrane several times, is found in exactly those genomes whose species perform sporulation in the style of Bacillus subtilis, Clostridium tetani, and others of the Firmicutes. Mutation of this sigma(E)-dependent gene blocks development of the spore cortex. The length of the C-terminal region, including some hydrophobic regions, is rather variable between members. [Cellular processes, Sporulation and germination].	1.23084e-25
NZ_CP027781.1\|WP_106900424.1\|2319105_2321673_+\|pyruvate,-phosphate-dikinase	gnl\|CDD\|235751	PRK06241, PRK06241, phosphoenolpyruvate synthase; Validated.	7.41512e-170
NZ_CP027781.1\|WP_106900420.1\|2317053_2317383_+\|transposase	gnl\|CDD\|366690	pfam01527, HTH_Tnp_1, Transposase. Transposase proteins are necessary for efficient DNA transposition. This family consists of various E. coli insertion elements and other bacterial transposases some of which are members of the IS3 family.	4.95336e-05
NZ_CP027781.1\|WP_003488225.1\|2328926_2329478_-\|stage-V-sporulation-protein-T	gnl\|CDD\|131898	TIGR02851, stage_V_sporulation_protein_T, stage V sporulation protein T. Members of this protein family are the stage V sporulation protein T (SpoVT), a protein of the sporulation/germination program in Bacillus subtilis and related species. The amino-terminal 50 amino acids are nearly perfectly conserved across all endospore-forming bacteria. SpoVT is a DNA-binding transcriptional regulator related to AbrB (See pfam04014). [Regulatory functions, DNA interactions, Cellular processes, Sporulation and germination].	6.01844e-94
NZ_CP027781.1\|WP_106900415.1\|2310282_2310651_+\|regulator	gnl\|CDD\|129116	TIGR00004, RutC_family_protein, reactive intermediate/imine deaminase. This protein was described initially as an inhibitor of protein synthesis intiation, then as an endoribonuclease active on single-stranded mRNA, endoribonuclease L-PSP. Members of this family, conserved in all domains of life and often with several members per bacterial genome, appear to catalyze a reaction that minimizes toxic by-products from reactions catalyzed by pyridoxal phosphate-dependent enzymes. [Cellular processes, Other].	1.69714e-57
NZ_CP027781.1\|WP_003495818.1\|2323894_2324164_-\|septum-formation-initiator-family-protein	gnl\|CDD\|368217	pfam04977, DivIC, Septum formation initiator. DivIC from B. subtilis is necessary for both vegetative and sporulation septum formation. These proteins are mainly composed of an amino terminal coiled-coil.	1.19599e-07
NZ_CP027781.1\|WP_030032516.1\|2325392_2325671_-\|HU-family-DNA-binding-protein	gnl\|CDD\|259853	cd13831, HU, histone-like DNA-binding protein HU. This subfamily includes HU and HU-like domains. HU is a conserved nucleoid-associated protein (NAP) which binds non-specifically to duplex DNA with a particular preference for targeting nicked and bent DNA. It is highly basic and contributes to chromosomal compaction and maintenance of negative supercoiling, thus often referred to as histone-like protein. HU can induce DNA bends, condense DNA in a fiber and also interact with single stranded DNA. It contains two homologous subunits, alpha and beta, typically forming homodimers (alpha-alpha and beta-beta), except in E. coli and other enterobacteria, which form heterodimers (alpha-beta). In E. coli, HU binds uniformly to the chromosome, with a preference for damaged or distorted DNA structures and can introduce negative supercoils into closed circular DNA in the presence of topoisomerase I. Anabaena HU (AHU) shows preference for A/T-rich region in the center of its DNA binding site.	2.67658e-40
NZ_CP027781.1\|WP_106900417.1\|2311282_2313373_+\|AAA-family-ATPase	gnl\|CDD\|226350	COG3829, RocR, Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms].	7.26562e-136
NZ_CP027781.1\|WP_003361716.1\|2323428_2323833_-\|RNA-binding-protein-S1	gnl\|CDD\|235614	PRK05807, PRK05807, RNA-binding protein S1.	4.19396e-78
NZ_CP027781.1\|WP_106900416.1\|2310663_2310918_+\|glutaredoxin	gnl\|CDD\|226919	COG4545, COG4545, Glutaredoxin-related protein [Posttranslational modification, protein turnover, chaperones].	1.39975e-16

>NZ_CP027781.1|WP_106900424.1|2319105_2321673_+|pyruvate,-phosphate-dikinase
MIYYILPLAHKQATLEMVGGKGMSLSKLMTAGIPVPDGFHVTTASYQSFVEMNRIQPHINKLLDGIDSNNTSQLEDVSTQIGMLFHNGEIPQEVSAAIKTAYAVLGNIAVAVRSSATAEDLPDASFAGQQETYLNIQGENEVLAAVKRCWASLWTARAIAYRVKNDIKQEIVALAVVVQKLAFSDASGVMFTLNPINGRRSEMIINAAWGLGESVVSSLVTPDTIVVDKNAERIVSYEVANKEIMTVRTSDGTEEIPVPERLRKKHALTRNQAMRLTQLGKKIEKYYQMPMDVEWALEKDKLYIVQARPITVLPPEWTLPEKDVIYTKGSLAEHLPNPVTPLFATLGLEIVNRASALLWVDMFGKSAKKLLPENGAYTIINGYVYLSAKSKPLLIAVKSLSPRSLRRALTNSVARWEAARKEFEDVIKQWEEKPMHMLNAHQIMEGIQTVFYAACIYFTRIQLTLPAASISETLFTKLFQGAARRAGMTDTSVFLLGFDTIALQAEKNLWNLSEWVKQNSTLNLYLQNNPTTKIAEDFMSSVLPAEVSQEVWIEWKNRINQYFKEFGRTAYEFDFAYSTPQETLTPTFESIKTFVEGKGESPFLRQAAFEKRRKQAEEEILQHIGSSRKKLFLKLLHWAQETAPMRENAIYLMGMGHPLIRRMFQEISARLIRGGVTSHLDDIYWLTKSELEKLIVQLEENIPLSDRSNAILARKTELKKYQGYVPPAQLPEKNAKSTSHAPQKQKDGKTVLRGIGTSSGVVTARACVLNSPADFENFQPGSVLVAVTTTPAWTPLFASASAIVTDIGGPLSHSSIVAREYGIPAVMATHTATRSIESGQMITVDGSEGTVTING
>NZ_CP027781.1|WP_106900423.1|2318497_2319109_+|TetR/AcrR-family-transcriptional-regulator
MPKGIMLTPEQQAERREEIIRVTLRLIEKNGFQKTSMREIAVLANMGKSSLYDFFKTKDEIVVYAVEKKIEETIQKVHRIIADESSPEQCLRKIMLNHIGVPKQYRTVLMWLNTESDYLEEEYRKRLKAARYAYQDIIKSVIENGVTAGIFRKTNADLMARLLINSVIAIIYTSRPSASPEKMLDETMNIFLHGIMNDGGELL
>NZ_CP027781.1|WP_106900422.1|2317844_2318309_+|hypothetical-protein
MLNIIDIFDRNIVDYHIGFHCEAKDATALLRKSLIRRDLFAEGATQPVIRTDNGPQFISYKFKECCEEFKLHHERIPVKTPNKNAHVESFHRILEDECFKNNEFQSYTEAYEIVNDFINFYNNTRLHSSLSYMTLNEFYHLYFGEQLTNIEVRV
>NZ_CP027781.1|WP_106900421.1|2317367_2317811_+|hypothetical-protein
MKDKVTVAKKYIEQNYNAVVVLKTVGLSRSTYYYNLSIEGKEKYKPVGGNPKGYSLTSKGEKICDDEIKEYILQAIEGDAINYDYRKIMHYLKRQYGLIINHKKVYRLCKELDILKNQRAIKPKVKRSIAANRIITDSNQLWEMDIK
>NZ_CP027781.1|WP_106900420.1|2317053_2317383_+|transposase
MRGRSYIKELKELILNEVKEVGNVSLVSRKHGISKSTIFTWIKNSKQKDEIKVKPGRKALIEGKNNFEKEITEITQENDTLKKILGEKDLEIAILKDLIKKANPQLKIK
>NZ_CP027781.1|WP_106900419.1|2315644_2316640_-|hypothetical-protein
MKKKKIFLIIFCLIIITSTILIYNHNKTKVTSTETNIQKVQSQKNSSQSKEKNAKNSKNNSANKETSKEEEKNDAQNKENETPTVIKNNNSKNLDQVKNLDKISSLEIVDSSIEKIDKLKGKDNIKTLKIVHCNVKDLEVVSTLKNLENLEIVDCKLSNVSIIKDLKRLKRLDISNNEISNLNGLENLTNLKELYMANNNIANLKPIHNLLKLTNLDISDNKITSIKELKNMKSIKELNICNNSISNLEGIENMSKITGLWASNNKINNISILSDKNEIVNLALDNNKISDISTITNFKKLKSLKLDKNNISNYKPLKDIYKDLVDPDFSI
>NZ_CP027781.1|WP_106900418.1|2313534_2315622_-|carbohydrate-binding-protein
MKKNLLPKLVLPILVASSTIIGANSTKVSAAPIKDAEIKLTQPDGQVIQCYASGDEFYNYFHDSDGRAILKDEKTGYYVYGKYVKDEVQPSRERVTEANIENLKQIDSDSRVNMKDVKLPKDKIQERRKLLNADKPAQRTTNTGKLNNIVIFIKFSDQDEFKTSLSKYDNEFNSKDQVSVNNYFKEISYDKLDINTTFYPKPNKNTILSYTDSHPRSYYTNVPESQRAAKEQTLLKNAVESVRNQIPSDLNVDSDNDGKVDNVCFIIKGATTEWSSLLWPHKWNMFHHDVRINGKRIDTYNFQLEDHLNTQGVGVLSHEMFHTLGAPDLYHYHQESRCTNDPVGPWDIMASTSHTPQSTGAYMKMNYGKWIDDIKEINKPGKYSINKIGNEANNSYIIKSPNSDKEYFVVEYRKREGKYDSNLHGEGLLVYRINTAFAGKGNMDGADIGGTGIGGDEVYLYRPNGSLNNIGDLIKAPLGYNRSSIDSKELFLSNGRDSGISLRNISTLGDIANFDVVINGQTGDGEIGDEKLPLKYNVNFDDTKTLSKTEDISGECVYGKKINNIELYLNGSKYMDAERGRLNDSENKYKGYDLSKAAFKFSVDFSKFSDGNYPYEIRVTTEDGQKISIKQGYLKVKKQTGGTEDKDIKEWKPNTSYKVGDIVTYNNYKYKCLQAHNAIVTWEPSKTPALWARIY
>NZ_CP027781.1|WP_106900417.1|2311282_2313373_+|AAA-family-ATPase
MRKLWRNHEGIMKKTMSVVALDARAGEFYAKEINELFGEYVEIASYNVSDGSAVGTLPKADLFVISTDAYGSAEEVARHVPIDSLTMGIEVSYRWSTLQNLSMIPKGTRALFVNMTDTMAREAIAQLQQLGVNHIRFIPFYPGAVLEEPVDMAVTPEEERYIPQSVKKVLNIGHRSCTSGMMIEIALRMGLEQLLETEKFQNYFQAMATNNYSFNQIYARSRRLESQFHILMEILDEGLVGVNEKGEIFACNKKACQIAKIEEDLVIGRCGEKVFPYIPFYSALKDKKEIPPKVIKLGGVNVSIEVIPVLRQKKCIGAFATLQEFSELESKQNELRSQLLKKGYCAKYTFNDVIGESDSICQTKGILKRMAATESPVLIVGETGTGKELLAHAVHCASKRSKGPFIAINVAAMPENLLESELFGYEEGAFTGAKKGGRPGLFEFAHGGTLFLDEVEGMSQAMQVKLLRVLQEGEVMRVGGSRIVSVDVRIVAATNESLEEKVEEGSFRKDLYYRLNTLTVVVPLLQERGEDVFLLMEHFKEELRGDFKLSEEVKDFLRQYSWPGNIRELHNTVEYFAYTGKQVIDMDDLPPTIFHGRTSRPVNVEKKERLQEVVLPFWFVLEQLYMAAERNEFIGRDKLLLKAKKQYLLLSQKEIRDILKDMEKKGFVKIGKGRGGSRITLKGKEYWQSRDKSLDK
>NZ_CP027781.1|WP_106900416.1|2310663_2310918_+|glutaredoxin
MKITVIGSHLCPDTLAALNKLSAVEADIDFKDILSCHADLKEYLRLRDTNALYEEIRGTESLGIPCFVLENNEITMDIKKVLEG
>NZ_CP027781.1|WP_106900415.1|2310282_2310651_+|regulator
MKIIETIKAPGAIGPYSQGYEVNGIVYTSGQIPVNPENGEIAKEISEQAKQSCENVGAILKAAGTGFEKVFKTTCFLADMGDFVDFNEVYAKYFVSKPARSCIAVKTLPKGVLCEIEAMAVK
>NZ_CP027781.1|WP_003361716.1|2323428_2323833_-|RNA-binding-protein-S1
MTLNAGSILEGTVVNITNFGAFVEIEGKTGLVHISEVSDSYVKDIREYLKEQDKVKVKVISIDDKGKISLSIKQAMQQKKSCKPAEIDWSREKSKKNEVNFEDRLSKFLKDSEERFQDLKKHQDSRGRGSKKSY
>NZ_CP027781.1|WP_003495818.1|2323894_2324164_-|septum-formation-initiator-family-protein
MKKINVKKLILFLAIVYIAVIFINQQITMHKIRDQISEKKIELKEVKEKNQKLQDEVKLSKSKDYIEKLARERLRLIKKGETPVINNTQ
>NZ_CP027781.1|WP_030032513.1|2324258_2324657_-|spore-cortex-biosynthesis-protein-YabQ
MVISISKQLGLLIFSFLSGLITGVFFDIYRSIRMDKNLSPIIKIIEDILFWCLAAIAIFIFLLYNNCAFIGIYVYLWIAIGLYIYIFFISKYLNPIFIYVVQNINRFFRIAINIIVYPFKILIYKIKSNKMH
>NZ_CP027781.1|WP_106900425.1|2324671_2324962_-|sporulation-protein-YabP
MEKKEFKNDDKISNLNLESRKKLILSGINEVISFNEEEIMLKTTLGDLDIKGSNLKMNKLDVQNGDVVIVGTINSCAYLNNQSKANRSNIFSKLFK
>NZ_CP027781.1|WP_003361721.1|2325079_2325319_-|RNA-binding-S4-domain-containing-protein
MRLDKFLKVSRIIKRRTVAKEACENERVLVNSKIAKPGTEVKEGDLLEIQYANKTMKYEIISVLEHVKKEDAENMYKII
>NZ_CP027781.1|WP_030032516.1|2325392_2325671_-|HU-family-DNA-binding-protein
MNKSELITSMAEKSKLTKKDAEAALKAFIESVEEALEGGEKVQLVGFGTFETRERAERVGRNPRTKEEITIPASIAPVFKAGKELKEKVNKK
>NZ_CP027781.1|WP_106900426.1|2325798_2327244_-|nucleoside-triphosphate-pyrophosphohydrolase
MINIIGLGPGSKESITLGTIDSLKTVDKVFLRTEKHPTVEYINKLGITYETFDGEYEVGESFDDVYNSIAKSLIEASKDYSDIIYAVPGHPLVAEKSVDILIKLCRQNNIKFKILPAVSFVDALMESLLLDPVEGLKIIDAFDIKNQVMDKRIGTIITQVYDKFIASEVKLNLMNYYKDDTEIFFVRAAGIEGLEEIRKIPLYELDRQHNIDHLTSVYIPKVSNNNYDFVDLLDIMDKLRGEDGCPWDKEQTHTSLKKYLIEESYEVIEAIDNKDVDMLIEELGDVLLQVVFHSQIGKEDGFFEIKDVIQSICDKMINRHPHVFSDLEINNSNEVLENWDKIKSMEQGNETYTDSIRHIAKTLPALMRADKVQKKAAKVGFDWENIEDAMKKIIEEYKEIEDVYKSKNKVKILEEIGDLLFSVVNVARFLDIDPENALNYSIDKFINRFQYIEDEAIAMGRNLDNMSLEEMDELWKEAKNK
>NZ_CP027781.1|WP_030032519.1|2327258_2328794_-|polysaccharide-biosynthesis-protein
MKKQSLIKGTFILGSAGIIAKFLGLFFRWPLQMLIGDEGIGYYQMSYPLYMFFIAAASGIPVAVSKLVSERNAVRDEGGIISVLKEAMIFMFIMGMGFTIILLLFSKDIIRFLKWDTRSYYSLIGISLAPFFISIMSVFRGFFQGMQNMNYTAISQVIEQLGRVIFGVGLAYILLPMGIEYSAGGAAIGAAAGGLLGGIYLFFKYLSVKKEFRVKKVKRNFKIMNTILYMAIPISIGSAVGTIMSLIDSALVPQKLLEAGFTYKQSTILYGQLTGKAFTLVNVPLTLSVSLCAALVPIIAEDYILNRKMEVLKKVELAIKISMVIAIPSCLGLNFMAKPILNLIFPGQEAGYEILKYLALSIPFIVLCQTSTAILQGVGRYIRPIVNLCIGCIFKIVITLILVPMSNINIYGAVIGTIAGYVISAVLNMMALKKSLNISINYYEIMIKPLIASTIMIIAVVFIYFYAYNYTISSKIACLIAVFLGMIIYFIIIGLIGILDYTYIKRKIIKR
>NZ_CP027781.1|WP_003488225.1|2328926_2329478_-|stage-V-sporulation-protein-T
MKATGIVRRIDDLGRVVIPKEIRRTLRIREGDPLEIFTDREGGVILKKYSPIGDLSEFSKGYTDSLQQTIGNIVMICDKDTIISISGAPKKEYLEKKISYDLEKIIEERKTVYFGDDNKAVSIYDDEDIDEKYSAQVISPIIAEGDTVGAVIIVSKEGGKKFNELEMKLAETASSFLGKQMEE
>NZ_CP027781.1|WP_106900427.1|2329676_2330687_-|peptidylprolyl-isomerase
MKSAKKLLSVLCLGIFILTFTACDMVEKTPEAKAKSTIAKVNGEKIQRKDLEENPRLKQVVNQMKMQYGEEFENSEQGKEAIKEQKKQILDELITEKVLLQKGKELKVIPKDEELNKEVDKKFNEIKAVYNNDEKKFEETLKSTGFTKETLKEYLKSQIIIEKVINEATKDVKVEDKDVKKYYNENQSMFTEKPNTMNVSHILVKTEDEAKKVKKRLDSKEDFAKVAKEVSQDPGSKDKGGLLGDINYNDANFDPTFMKAAIALKQGAVSNPVHTQFGYHIIKINSKKEYPVKKFDAVKEDIKKELKMEKQKEAYTKKIEEWKKASKIKTYEKNLL

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_4

2621626-2622047

TypeIII

III-B

Consensus_repeat	Method
ATTGAACATTAACATGAGATGTATTTAAAT	CRISPRCasFinder
GTTGAACATTAACATGAGATGTATTTAAAT	PILER-CR
TAACATGAGATGTATTTAAAT	CRT

6 spacers

cas6,cmr1gr7,cas10,cmr3gr5,cmr4gr7,cmr5gr11,cmr6gr7

The CRISPR arrays of NZ_CP027781_4

>merge|NZ_CP027781|4|2621626-2622047|CRISPRCasFinder,PILER-CR,CRT
ATTGAACATTAACATGAGATGTATTTAAATGGCTTTACAAATTACTCCTGTAAAGCTATTAGAGGTTGAACATTAACATGAGATGTATTTAAATGTTTTCAAAGAACTTATTTGTATTGTGACTATAAATGTTGAACAATAACATGAGATGTATTTAAATTCGCTACAATATTCACTTATAATTACATGATATGGGTTGAACAATAACATGAGATGTATTTAAATCATTTAAAAGTAATGAATTTGGCGAAGTAAGAACAATGTTGAACATTAACATGAGATGTATTTAAATATGTTTTTAACTGTATTATAAAAAGCACAGTGTGTGTTGAACATTAACATGAGATGTATTTAAATTATAAGAAGTCTGTAAATCTAATAAATTTATATTGTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|4|4|2621626-2622047|CRISPRCasFinder
ATTGAACATTAACATGAGATGTATTTAAAT	GGCTTTACAAATTACTCCTGTAAAGCTATTAGAG
GTTGAACATTAACATGAGATGTATTTAAAT	GTTTTCAAAGAACTTATTTGTATTGTGACTATAAAT
GTTGAACAATAACATGAGATGTATTTAAAT	TCGCTACAATATTCACTTATAATTACATGATATGG
GTTGAACAATAACATGAGATGTATTTAAAT	CATTTAAAAGTAATGAATTTGGCGAAGTAAGAACAAT
GTTGAACATTAACATGAGATGTATTTAAAT	ATGTTTTTAACTGTATTATAAAAAGCACAGTGTGT
GTTGAACATTAACATGAGATGTATTTAAAT	TATAAGAAGTCTGTAAATCTAATAAATTTATATT
GTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|4|1|2621627-2621982|PILER-CR
TTGAACATTAACATGAGATGTATTTAAATG	GCTTTACAAATTACTCCTGTAAAGCTATTAGAGG
TTGAACATTAACATGAGATGTATTTAAATG	TTTTCAAAGAACTTATTTGTATTGTGACTATAAATG
TTGAACAATAACATGAGATGTATTTAAATT	CGCTACAATATTCACTTATAATTACATGATATGGG
TTGAACAATAACATGAGATGTATTTAAATC	ATTTAAAAGTAATGAATTTGGCGAAGTAAGAACAATG
TTGAACATTAACATGAGATGTATTTAAATA	TGTTTTTAACTGTATTATAAAAAGCACAGTGTGTG
TTGAACATTAACATGAGATGTATTTAAAT

>NZ_CP027781|4|2|2621635-2622046|CRT
TAACATGAGATGTATTTAAAT	GGCTTTACAAATTACTCCTGTAAAGCTATTAGAGGTTGAACAT
TAACATGAGATGTATTTAAAT	GTTTTCAAAGAACTTATTTGTATTGTGACTATAAATGTTGAACAA
TAACATGAGATGTATTTAAAT	TCGCTACAATATTCACTTATAATTACATGATATGGGTTGAACAA
TAACATGAGATGTATTTAAAT	CATTTAAAAGTAATGAATTTGGCGAAGTAAGAACAATGTTGAACAT
TAACATGAGATGTATTTAAAT	ATGTTTTTAACTGTATTATAAAAAGCACAGTGTGTGTTGAACAT
TAACATGAGATGTATTTAAAT	TATAAGAAGTCTGTAAATCTAATAAATTTATATTGTTGAACAA
TAACATGAGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900594.1\|2614637_2615537_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	unknown	unknown	gnl\|CDD\|238623
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	unknown	unknown	gnl\|CDD\|270622
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378897
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|213357
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	unknown	unknown	gnl\|CDD\|274468
NZ_CP027781.1\|WP_106900600.1\|2625654_2626029_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900602.1\|2627782_2628970_+\|hypothetical-protein	cmr1gr7	mkCas0086_cmr1gr7_CAS-III-B	unknown
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|369561
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_021106869.1\|2610912_2611686_+\|benzoyl-CoA-reductase-subunit-BadG	unknown	unknown	gnl\|CDD\|224835
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	unknown	unknown	gnl\|CDD\|99750
NZ_CP027781.1\|WP_106900592.1\|2611966_2612182_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	unknown	unknown	gnl\|CDD\|223605
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	unknown	unknown	gnl\|CDD\|378573

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	gnl\|CDD\|238623	cd01298, ATZ_TRZ_like, TRZ/ATZ family contains enzymes from the atrazine degradation pathway and related hydrolases. Atrazine, a chlorinated herbizide, can be catabolized by a variety of different bacteria. The first three steps of the atrazine dehalogenation pathway are catalyzed by atrazine chlorohydrolase (AtzA), hydroxyatrazine ethylaminohydrolase (AtzB), and N-isopropylammelide N-isopropylaminohydrolase (AtzC). All three enzymes belong to the superfamily of metal dependent hydrolases. AtzA and AtzB, beside other related enzymes are represented in this CD.	0
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	gnl\|CDD\|270622	cd00180, PKc, Catalytic domain of Protein Kinases. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.	1.34529e-24
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	gnl\|CDD\|378897	pfam12638, Staygreen, Staygreen protein. This family of proteins have been implicated in chlorophyll degradation. Intriguingly members of this family are also found in non-photosynthetic bacteria.	7.30783e-84
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	gnl\|CDD\|213357	cd12823, Mrs2_Mfm1p-like, Saccharomyces cerevisiae inner mitochondrial membrane Mg2+ transporters Mfm1p and Mrs2p-like family. A eukaryotic subfamily belonging to the Escherichia coli CorA-Salmonella typhimurium ZntB_like family (EcCorA_ZntB-like) family of the MIT superfamily of essential membrane proteins involved in transporting divalent cations (uptake or efflux) across membranes. This functionally diverse subfamily includes the inner mitochondrial membrane Mg2+ transporters Saccharomyces cerevisiae Mfm1p/Lpe10p, Mrs2p, and human MRS2/ MRS2L. It also includes a family of Arabidopsis thaliana proteins (AtMGTs) some of which are localized to distinct tissues, and not all of which can transport Mg2+. Structures of the intracellular domain of two EcCorA_ZntB-like family transporters: Vibrio parahaemolyticus and Salmonella typhimurium ZntB form funnel-shaped homopentamers, the tip of the funnel is formed from two C-terminal transmembrane (TM) helices from each monomer, and the large opening of the funnel from the N-terminal cytoplasmic domains. The GMN signature motif of the MIT superfamily occurs just after TM1, mutation within this motif is known to abolish Mg2+ transport through Salmonella typhimurium CorA, and Mrs2p. Natural variants such as GVN and GIN, as in some ZntB family proteins, may be associated with the transport of different divalent cations, such as zinc and cadmium. The functional diversity of MIT transporters may also be due to minor structural differences regulating gating, substrate selection, and transport.	0.00480426
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	gnl\|CDD\|274468	TIGR03173, pbuX, xanthine permease. All the seed members of this model are observed adjacent to genes for either xanthine phosphoribosyltransferase (for the conversion of xanthine to guanine, GenProp0696) or genes for the conversion of xanthine to urate and its concomitant catabolism (GenProp0640, GenProp0688, GenProp0686 and GenProp0687). A number of sequences scoring higher than trusted to this model are found in different genomic contexts, and the possibility exist that these transport related compounds in addition to or instead of xanthine itself. The outgroup to this family are sequences which are characterized as uracil permeases or are adjacent to established uracil phosphoribosyltransferases.	5.12474e-138
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	gnl\|CDD\|369561	pfam07859, Abhydrolase_3, alpha/beta hydrolase fold. This catalytic domain is found in a very wide range of enzymes.	4.63453e-89
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	9.12195e-20
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	gnl\|CDD\|99750	cd06259, YdcF-like, YdcF-like. YdcF-like is a large family of mainly bacterial proteins, with a few members found in fungi, plants, and archaea. Escherichia coli YdcF has been shown to bind S-adenosyl-L-methionine (AdoMet), but a biochemical function has not been idenitified. The family also includes Escherichia coli sanA and Salmonella typhimurium sfiX, which are involved in vancomycin resistance; sfiX may also be involved in murein synthesis.	1.38244e-41
NZ_CP027781.1\|WP_021106869.1\|2610912_2611686_+\|benzoyl-CoA-reductase-subunit-BadG	gnl\|CDD\|224835	COG1924, COG1924, Activator of 2-hydroxyglutaryl-CoA dehydratase (HSP70-class ATPase domain) [Lipid metabolism].	4.4475e-97
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	gnl\|CDD\|223605	COG0531, PotE, Amino acid transporters [Amino acid transport and metabolism].	4.49897e-27
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	gnl\|CDD\|378573	pfam11155, DUF2935, Domain of unknown function (DUF2935). This family of proteins with unknown function appears to be restricted to Firmicutes. The structure of this protein has been solved and each domain is composed of four alpha helices. A metal cluster composed of iron and magnesium lies between the two domains.	1.91074e-12

>NZ_CP027781.1|WP_106900597.1|2620839_2621292_-|hypothetical-protein
MSKLNPEKLSVEFRDGVTNTEPILGRRYTLTHSDITAELFLTIGLTYAYDKIDVMRDEVLGEWIEKEKNYLFHVYLHVDGNNPIVTGVRNHIFRRELPLALEAIRYGDRKFFISHPKLDNSSIIVHFISSYPSFDRVEKWGTFSDYSLKK
>NZ_CP027781.1|WP_106900596.1|2619604_2620651_+|alpha/beta-hydrolase
MEVNEVKKVIKVVSVILVMLVAVGFFIIKNLTETKDGKLNMYVAANLQLYKILNPKSLNSKSIEETRGALNKQSTRWSNKPIPFSNIKNLDIKMNNEKIPVRIYTPEKGSNFPMIIYSHGAFWIGGNVDTIDGVCRKLSQNTKAIVISVNYRLAPENPFPAGLNDVYNVLQWTYKNAKSINGDEKHIAVVGDSAGGNLSAAVSSMSRDKNGPPITCQVLIYPSTNIFELNSKSWSYFSNSLNVSTEDMEKYISIYVPKKEDRKNPYASPLLSKDFSKLPDTLVVTAEIDPLRDEGEAYANKLKESGVKAEVTRYKGITHGFITMDKITNKADEALNQISLYIQKEFQK
>NZ_CP027781.1|WP_003485222.1|2618940_2619369_-|DUF2935-domain-containing-protein
MYCYTYVNQFACIFNELELWTHISSEHPTFLKTVASLSKINLPKSAVDKLDDIHKRFLGLYNDVVYLKKALRANPMLYYQSIGNIKRIINKFMFYDTQALSFYPELLEFGKENKVWQELVNHIIHEQHFMLELFKNLILQIG
>NZ_CP027781.1|WP_106900595.1|2617524_2618877_+|amidohydrolase
MNQILIKNGYIITMDCSKRIFEKGDILVEDSKIIAIGNVESELIKSNVEIIDANGKIIMPGLVNTHVHLSQQLARGLADDVDLLTWLRKRIWPYESNMDLEDSYISSLACCTELIRSGVTTFCEAGGQEVDGMGKAVEEAGLRGILCRSTMDCGDGLPLKWQETTEESLEKQVELLERWNGKGDGRIKYWFGLRTIFNTTDKLITKTKELADKYKVGIHMHVAEIEEEVRYAEATRGETTVQHLAKLGVLDKNFLAVHTVWLTEQEIDLFKLHNVKVSHNPGAAMKVVLGFAHIPEMLEKGINVSIGTDGAPSNNRMDMFDEMHLTSLIHKGRRLNPKVVPADEVLEMATMNGAKCALWENEIGSLEVGKKADLIIINPKSIGNLPMHDPIGNIVYSMHSSDVESSMCNGKWLMKNKVLLTIDEEDIIREAQEKATALVKKAGIVLPKRF
>NZ_CP027781.1|WP_003493868.1|2615974_2617318_+|purine-permease
MKNTKDTNLIVGIDEKISLRYAFFLGLQHVFAMDLYIVPIILAGILSLDAQNTAYFIQMSFIAAGIATLIQTGLCMRLPIMQGPSYIPIGALAAIGSKLGLQAMVGSLIPGSLFLMILGYPLRFLSKIISKFIPHIVGGTVIVIVGISLMPVAMTNIFTAPGNLKINCILALISSALLVSCMMIGRKSNKFGKAVRLTSVMISLIGGTIAASLLGVVDFTPVTKAAWFSFPKLLPFGKPVFDLKAILTMLFIYAVILVETSGTWFAVSAVTGSELTDEGLNRGAVGEGIGCFVGALFGGTPMTGYSTNAGIIAVTGVGSRMAIIAGGIILVALGMLPKLMNVIACIPSAVVSGVFAVVCVIIAMNGFKSIQHEEFDERNMLLIGLPILLALGTTVLPKDILNSLPSLANYIFSSGITVGALAAVILNILLPKAPVEVSKSQEYEEAV
>NZ_CP027781.1|WP_106900594.1|2614637_2615537_-|hypothetical-protein
MSNKRNLQSIRSFYLCILIFNIVYSSIFHLNNKGFNIKLFGDLTMRSVVLFTFNSILFLCIVIAVEKKINIAEKIKTKVSMRIKPLYLVNMFFITYILVCIFLLKNLDLILSSFVMEIIYIGILILTKKIIALELTDRQLQWQKACGYIDESCEKSSFLWRFKIWYSPHINVPFKNRWKGLSRLLYDLALVYGIFISRGNLFSLLLLILLLPDVLSWIEGLLGLQTSLTGMCTGITEHHSKNSHVVYHKVYVTDYKNKREITFYVDGPLFIHENSNMTVVHGTFSKRVLYVEGLNLDIR
>NZ_CP027781.1|WP_106900593.1|2612974_2614297_-|amino-acid-permease
MLEKKYGLWTTVSMVIGIVIGSGVFFKADNILIASGGNVKTALLAWLVGAISMIFGALVFAECANRFERSNGIVDYAEGMLSEKFAYLIGWFNGIIYYPAIAAVLAWAAGNYTAILFNKDGNFVWIMAAIYMIGIYILNYISPILSGKFQIASTAIKLVPLMLIAILGTFQGLNNGILIENFSKVSTIGDSGSGFAAAVLGAAFAYEGWIIATTINGEIKDAKNTLPKALVFGSLVIVIIYILYFLGIVGMIPTETILKQGDNTVNVAARTVFGNFGASILTIFIIVSCLGTLNGLILGGSRSFYSLAIRGQGIKPEAFSKLDSKTNIPTNSTIANFILICIYLVVWYMNFKGLFPNKMFVDISELPIALIYGIYIIIYIAYMMKMKDLSFIKRFVIPSLALMGALIVVYGGLSKPSVIIDLGISVFVFLSGLLFYNKKK
>NZ_CP027781.1|WP_096043671.1|2612172_2612907_+|protein-kinase-family-protein
MVIKFFKRDTKYLPEQKIHGYTVLKILGEGRFGICYLVQSNNKQYILKQLKTKMLKKIGSKVIYEQEILKNINHNCIPKFIKTLQFEKFFGYVLEYKEGKTFEEIICEDEYVFKREEIYDICIQIIEILKYLHKSGIVHRDIRIPNTIYYKKKVNLVDFGLARWINNKRYTENVDFSYLGDFLLHLYYTSFQCKTFKGKPWYEELDLFSEEMNFLKRLLGIEKKYKNIEEVERDFLLLKSNYNK
>NZ_CP027781.1|WP_106900592.1|2611966_2612182_+|hypothetical-protein
MSILSKIFNLVNSSSNGYHKNKHRGSSYYKKHHRSKSGFLGSMMSVFSSKSRSYSHSYKRHSRRKKYSSWS
>NZ_CP027781.1|WP_021106869.1|2610912_2611686_+|benzoyl-CoA-reductase-subunit-BadG
MYTMGLDIGSTTSKGVIIKDGEEIVASVLVPVGTGTSGPLKLIKELKEKSNLTEKDIEKTVVTGYGRIQYKDADKQISELSCHAKGVAFLIPGARTIIDIGGQDAKAMKLNDKGKLINFIMNDKCAAGTGRFLDVMAGVLETDVSKLGEISEKSTKEVSISSTCTVFAESEVISHLSANAKKEDIVAGIHTSVVRRVSTLAMRVGIEDQVVMVGGVARNKGIVKAMEKELGHDIKVPELAQLTGALGAAIYAFEETK
>NZ_CP027781.1|WP_106900598.1|2623432_2624026_+|YdcF-family-protein
MIVLYIILCSILVCFIVEYTVICSRFKIASYNKGQKQDVIIVLGYHVKKDGDVSPILRERINKAAKLYHEGIAGVIICSGAAVANDYIEADVMANALIELGVPACNIIREKLAKNTYENLVNSKKIMQDRELNTAVIVSSPWHLRKASSYAFRLKMDHTVEKSKFPHEYLIIGVGMIYLYLYTQMFINNLRYHKCKQ
>NZ_CP027781.1|WP_106900599.1|2624945_2625635_+|CRISPR-associated-endoribonuclease-Cas6
MEFWELIATVMLKKDIYFEDCGYIIGKNINKSMLLDKNLKEMHPQKQYKNYVFNSFYPIERDKFYKKDRLYIFNIRGLSKEFIYKIETCLCNLESNDFNVISTSKKEIKQRYIKELYTQTPLIITVDDKPWLQNEGDLDLFKQRLEDNLEKKYKNFFNEDIDVKGKFIKSIEFKNRKPMHYNYKNGIKLLANKVSMLIEDNEEAQKIAFLARATGLGEKNSSIGAGFCK
>NZ_CP027781.1|WP_106900600.1|2625654_2626029_+|hypothetical-protein
MSKTLRFEIVSGVNKGYFHTNSQSESLDLVGGIWQKIAKEEFEKNNIYVSAVIKPSKTVYNQEWGCPENGEETVVLTGVANEEFVDDIEKWKDAVIKLAKELKNQLKQSTLTCEFIETELHYFK
>NZ_CP027781.1|WP_106900601.1|2626063_2627770_+|hypothetical-protein
MTKEIISSHIFVFPFRWDVVKDEACLDTCIDSRLNVEKFIKYLKDINQWEEDINISNIIENKEVENDLDYNTYAYFYDNVRKAIYGKQNLIKKNKNISVDLKNSKYYVGRLFNKKISNTIVRCLNYKNIDANSIYEIHVEKRDDSGTIVFDEHYKLKIKSIKLKVYDTGVATLSYFLDNYEWKNEEDILRINDYGRRIYPQHIPLNTVRNNFLAKKISLKLQNRTIEENFDYGVKEKPTKISKIIMGILGERFISSDKDLEKRKCLNKEEIIFVKPVIDDRMFVICYYNNNFFSRVLTKYDKDEYLKNDFWYQFLFVDNGGATCKDEEMKKELLSKSTYTRWKSYGTLFGISRYSFVILCDESGFSKNVLYNHINTIYYEMILLALVQRASILRFSDETSRIASFERKNIYEQIKKLQEYYIRFVNTIYFREVTAQEQGIELYDKVVELMRIDTEVKRLDEEIDEIQRYINLETNDRTNILLNVITFVGIGVSVISLISSLFSNNKQIGDLTWLVTWQYVPFVMVLLVISVIKKYVNDNKVIKIIMWVITLVAVYIVLDYKFIKLFIK
>NZ_CP027781.1|WP_106900602.1|2627782_2628970_+|hypothetical-protein
MSKVKIELKQHTPLIHFQSEQPGAILRATEVKPKLDKFLKKYAFSGGFEEYKQYLIGYKVGEKDKIWDFGDKQAFDYKLTIYTENPNKIQKIDIKGAMQALYFAGRSNNGNVKGILTNEDIILEFFTFHKGLMEIIKNNIEGFFCINNFGTRQNKGFGSFYLKKPINEVDKLIDRICTHDKTNIYLNIKYNKGDYFQIFEDISVIYPLMKSGLNFPKWPKSYHKSFLFKYMLNKDIGNEKRFIKENFFSPWKRIENDNKEKRYVRAMLGICDGIEFRDSERTGKVKYNSNIERFQSPILFKIINNELFIIPKKIPKEMFYNKFKFSNEFKSGRESKVNKEIIYTPKEDEFNLENFLSGFADYFNNHIKVSNVNNVFENKIRKAKLRRIDIKQVVK
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_5

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_5

2622299-2623181

TypeIII

III-B

Consensus_repeat	Method
ATTGAACATTAACATGAGATGTATTTAAAT	PILER-CR
ATTGAACATTAACATGAGATGTATTTAAAT	CRISPRCasFinder
ATTGAACATTAACATGAGATGTATTTAAAT	CRT

13 spacers

cas6,cmr1gr7,cas10,cmr3gr5,cmr4gr7,cmr5gr11,cmr6gr7

The CRISPR arrays of NZ_CP027781_5

>merge|NZ_CP027781|5|2622299-2623181|PILER-CR,CRISPRCasFinder,CRT
ATTGAACATTAACATGAGATGTATTTAAATGAAAAATAACTTTTGAAGACACTATAGGATTTAAATTGAACATTAACATGAGATGTATTTAAATTCTATTGGTGTAACTTCATCATATTTTGAATCAGATTGAACATTAACATGAGATGTATTTAAATAGATTCACCCAAGGCAGACAAAGGCATTATTTGGGTTATTGAACATTAACATGAGATGTATTTAAATTAGCAAAAGAAGTTGAAAGCAATACACCAGTTTTAAATTGAACATTAACATGAGATGTATTTAAATTCCTTAGTCTTTACAAGTCTTCCATCTATAGACTTGATTGAACATTAACATGAGATGTATTTAAATTAATATTCCGGCCACCTATCTTTCCAATTGACAGATTGAACATTAACATGAGATGTATTTAAATCTTATGAAGGAAATGGAATTTTATAAGAAACAAAATATTGAACATTAACATGAGATGTATTTAAATTAATAAGTCAATTACATTAGTTCAATATCAAGCTGGAGATTGAACATTAACATGAGATGTATTTAAATTAATCTAGCTTATTTAATGATTTAACATAAGCACCTATTGAACATTAACATGAGATGTATTTAAATTAAAGAACTGCTATTGCTAATGTGCACCAATTTTCATTGAACATTAACATGAGATGTATTTAAATCTTGCTATTCGCAAAGTTCCAAGTTGGCCGTGCCAAATTGAACATTAACATGAGATGTATTTAAATAATTGCAGATATTCTTAAAATAACACGCTCTGCTGTATTGAACATTAACATGAGATGTATTTAAATCTTTTTTAACCTTGCTTAACTTCACCCATACTTGGTTGAACAATAACAAGGGATGCATTTAAATT

>NZ_CP027781|5|2|2622299-2623116|PILER-CR
ATTGAACATTAACATGAGATGTATTTAAAT	GAAAAATAACTTTTGAAGACACTATAGGATTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCTATTGGTGTAACTTCATCATATTTTGAATCAG
ATTGAACATTAACATGAGATGTATTTAAAT	AGATTCACCCAAGGCAGACAAAGGCATTATTTGGGTT
ATTGAACATTAACATGAGATGTATTTAAAT	TAGCAAAAGAAGTTGAAAGCAATACACCAGTTTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCCTTAGTCTTTACAAGTCTTCCATCTATAGACTTG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATATTCCGGCCACCTATCTTTCCAATTGACAG
ATTGAACATTAACATGAGATGTATTTAAAT	CTTATGAAGGAAATGGAATTTTATAAGAAACAAAAT
ATTGAACATTAACATGAGATGTATTTAAAT	TAATAAGTCAATTACATTAGTTCAATATCAAGCTGGAG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATCTAGCTTATTTAATGATTTAACATAAGCACCT
ATTGAACATTAACATGAGATGTATTTAAAT	TAAAGAACTGCTATTGCTAATGTGCACCAATTTTC
ATTGAACATTAACATGAGATGTATTTAAAT	CTTGCTATTCGCAAAGTTCCAAGTTGGCCGTGCCAA
ATTGAACATTAACATGAGATGTATTTAAAT	AATTGCAGATATTCTTAAAATAACACGCTCTGCTGT
ATTGAACATTAACATGAGATGTATTTAAAT

>NZ_CP027781|5|5|2622299-2623181|CRISPRCasFinder
ATTGAACATTAACATGAGATGTATTTAAAT	GAAAAATAACTTTTGAAGACACTATAGGATTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCTATTGGTGTAACTTCATCATATTTTGAATCAG
ATTGAACATTAACATGAGATGTATTTAAAT	AGATTCACCCAAGGCAGACAAAGGCATTATTTGGGTT
ATTGAACATTAACATGAGATGTATTTAAAT	TAGCAAAAGAAGTTGAAAGCAATACACCAGTTTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCCTTAGTCTTTACAAGTCTTCCATCTATAGACTTG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATATTCCGGCCACCTATCTTTCCAATTGACAG
ATTGAACATTAACATGAGATGTATTTAAAT	CTTATGAAGGAAATGGAATTTTATAAGAAACAAAAT
ATTGAACATTAACATGAGATGTATTTAAAT	TAATAAGTCAATTACATTAGTTCAATATCAAGCTGGAG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATCTAGCTTATTTAATGATTTAACATAAGCACCT
ATTGAACATTAACATGAGATGTATTTAAAT	TAAAGAACTGCTATTGCTAATGTGCACCAATTTTC
ATTGAACATTAACATGAGATGTATTTAAAT	CTTGCTATTCGCAAAGTTCCAAGTTGGCCGTGCCAA
ATTGAACATTAACATGAGATGTATTTAAAT	AATTGCAGATATTCTTAAAATAACACGCTCTGCTGT
ATTGAACATTAACATGAGATGTATTTAAAT	CTTTTTTAACCTTGCTTAACTTCACCCATACTTG
GTTGAACAATAACAAGGGATGCATTTAAATT

>NZ_CP027781|5|3|2622299-2623180|CRT
ATTGAACATTAACATGAGATGTATTTAAAT	GAAAAATAACTTTTGAAGACACTATAGGATTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCTATTGGTGTAACTTCATCATATTTTGAATCAG
ATTGAACATTAACATGAGATGTATTTAAAT	AGATTCACCCAAGGCAGACAAAGGCATTATTTGGGTT
ATTGAACATTAACATGAGATGTATTTAAAT	TAGCAAAAGAAGTTGAAAGCAATACACCAGTTTTAA
ATTGAACATTAACATGAGATGTATTTAAAT	TCCTTAGTCTTTACAAGTCTTCCATCTATAGACTTG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATATTCCGGCCACCTATCTTTCCAATTGACAG
ATTGAACATTAACATGAGATGTATTTAAAT	CTTATGAAGGAAATGGAATTTTATAAGAAACAAAAT
ATTGAACATTAACATGAGATGTATTTAAAT	TAATAAGTCAATTACATTAGTTCAATATCAAGCTGGAG
ATTGAACATTAACATGAGATGTATTTAAAT	TAATCTAGCTTATTTAATGATTTAACATAAGCACCT
ATTGAACATTAACATGAGATGTATTTAAAT	TAAAGAACTGCTATTGCTAATGTGCACCAATTTTC
ATTGAACATTAACATGAGATGTATTTAAAT	CTTGCTATTCGCAAAGTTCCAAGTTGGCCGTGCCAA
ATTGAACATTAACATGAGATGTATTTAAAT	AATTGCAGATATTCTTAAAATAACACGCTCTGCTGT
ATTGAACATTAACATGAGATGTATTTAAAT	CTTTTTTAACCTTGCTTAACTTCACCCATACTTG
GTTGAACAATAACAAGGGATGCATTTAAAT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900594.1\|2614637_2615537_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	unknown	unknown	gnl\|CDD\|238623
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	unknown	unknown	gnl\|CDD\|270622
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378897
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|213357
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	unknown	unknown	gnl\|CDD\|274468
NZ_CP027781.1\|WP_106900600.1\|2625654_2626029_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900602.1\|2627782_2628970_+\|hypothetical-protein	cmr1gr7	mkCas0086_cmr1gr7_CAS-III-B	unknown
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|369561
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_021106869.1\|2610912_2611686_+\|benzoyl-CoA-reductase-subunit-BadG	unknown	unknown	gnl\|CDD\|224835
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	unknown	unknown	gnl\|CDD\|99750
NZ_CP027781.1\|WP_106900592.1\|2611966_2612182_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	unknown	unknown	gnl\|CDD\|223605
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	unknown	unknown	gnl\|CDD\|378573

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	gnl\|CDD\|238623	cd01298, ATZ_TRZ_like, TRZ/ATZ family contains enzymes from the atrazine degradation pathway and related hydrolases. Atrazine, a chlorinated herbizide, can be catabolized by a variety of different bacteria. The first three steps of the atrazine dehalogenation pathway are catalyzed by atrazine chlorohydrolase (AtzA), hydroxyatrazine ethylaminohydrolase (AtzB), and N-isopropylammelide N-isopropylaminohydrolase (AtzC). All three enzymes belong to the superfamily of metal dependent hydrolases. AtzA and AtzB, beside other related enzymes are represented in this CD.	0
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	gnl\|CDD\|270622	cd00180, PKc, Catalytic domain of Protein Kinases. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.	1.34529e-24
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	gnl\|CDD\|378897	pfam12638, Staygreen, Staygreen protein. This family of proteins have been implicated in chlorophyll degradation. Intriguingly members of this family are also found in non-photosynthetic bacteria.	7.30783e-84
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	gnl\|CDD\|213357	cd12823, Mrs2_Mfm1p-like, Saccharomyces cerevisiae inner mitochondrial membrane Mg2+ transporters Mfm1p and Mrs2p-like family. A eukaryotic subfamily belonging to the Escherichia coli CorA-Salmonella typhimurium ZntB_like family (EcCorA_ZntB-like) family of the MIT superfamily of essential membrane proteins involved in transporting divalent cations (uptake or efflux) across membranes. This functionally diverse subfamily includes the inner mitochondrial membrane Mg2+ transporters Saccharomyces cerevisiae Mfm1p/Lpe10p, Mrs2p, and human MRS2/ MRS2L. It also includes a family of Arabidopsis thaliana proteins (AtMGTs) some of which are localized to distinct tissues, and not all of which can transport Mg2+. Structures of the intracellular domain of two EcCorA_ZntB-like family transporters: Vibrio parahaemolyticus and Salmonella typhimurium ZntB form funnel-shaped homopentamers, the tip of the funnel is formed from two C-terminal transmembrane (TM) helices from each monomer, and the large opening of the funnel from the N-terminal cytoplasmic domains. The GMN signature motif of the MIT superfamily occurs just after TM1, mutation within this motif is known to abolish Mg2+ transport through Salmonella typhimurium CorA, and Mrs2p. Natural variants such as GVN and GIN, as in some ZntB family proteins, may be associated with the transport of different divalent cations, such as zinc and cadmium. The functional diversity of MIT transporters may also be due to minor structural differences regulating gating, substrate selection, and transport.	0.00480426
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	gnl\|CDD\|274468	TIGR03173, pbuX, xanthine permease. All the seed members of this model are observed adjacent to genes for either xanthine phosphoribosyltransferase (for the conversion of xanthine to guanine, GenProp0696) or genes for the conversion of xanthine to urate and its concomitant catabolism (GenProp0640, GenProp0688, GenProp0686 and GenProp0687). A number of sequences scoring higher than trusted to this model are found in different genomic contexts, and the possibility exist that these transport related compounds in addition to or instead of xanthine itself. The outgroup to this family are sequences which are characterized as uracil permeases or are adjacent to established uracil phosphoribosyltransferases.	5.12474e-138
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	gnl\|CDD\|369561	pfam07859, Abhydrolase_3, alpha/beta hydrolase fold. This catalytic domain is found in a very wide range of enzymes.	4.63453e-89
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	9.12195e-20
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	gnl\|CDD\|99750	cd06259, YdcF-like, YdcF-like. YdcF-like is a large family of mainly bacterial proteins, with a few members found in fungi, plants, and archaea. Escherichia coli YdcF has been shown to bind S-adenosyl-L-methionine (AdoMet), but a biochemical function has not been idenitified. The family also includes Escherichia coli sanA and Salmonella typhimurium sfiX, which are involved in vancomycin resistance; sfiX may also be involved in murein synthesis.	1.38244e-41
NZ_CP027781.1\|WP_021106869.1\|2610912_2611686_+\|benzoyl-CoA-reductase-subunit-BadG	gnl\|CDD\|224835	COG1924, COG1924, Activator of 2-hydroxyglutaryl-CoA dehydratase (HSP70-class ATPase domain) [Lipid metabolism].	4.4475e-97
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	gnl\|CDD\|223605	COG0531, PotE, Amino acid transporters [Amino acid transport and metabolism].	4.49897e-27
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	gnl\|CDD\|378573	pfam11155, DUF2935, Domain of unknown function (DUF2935). This family of proteins with unknown function appears to be restricted to Firmicutes. The structure of this protein has been solved and each domain is composed of four alpha helices. A metal cluster composed of iron and magnesium lies between the two domains.	1.91074e-12

>NZ_CP027781.1|WP_106900597.1|2620839_2621292_-|hypothetical-protein
MSKLNPEKLSVEFRDGVTNTEPILGRRYTLTHSDITAELFLTIGLTYAYDKIDVMRDEVLGEWIEKEKNYLFHVYLHVDGNNPIVTGVRNHIFRRELPLALEAIRYGDRKFFISHPKLDNSSIIVHFISSYPSFDRVEKWGTFSDYSLKK
>NZ_CP027781.1|WP_106900596.1|2619604_2620651_+|alpha/beta-hydrolase
MEVNEVKKVIKVVSVILVMLVAVGFFIIKNLTETKDGKLNMYVAANLQLYKILNPKSLNSKSIEETRGALNKQSTRWSNKPIPFSNIKNLDIKMNNEKIPVRIYTPEKGSNFPMIIYSHGAFWIGGNVDTIDGVCRKLSQNTKAIVISVNYRLAPENPFPAGLNDVYNVLQWTYKNAKSINGDEKHIAVVGDSAGGNLSAAVSSMSRDKNGPPITCQVLIYPSTNIFELNSKSWSYFSNSLNVSTEDMEKYISIYVPKKEDRKNPYASPLLSKDFSKLPDTLVVTAEIDPLRDEGEAYANKLKESGVKAEVTRYKGITHGFITMDKITNKADEALNQISLYIQKEFQK
>NZ_CP027781.1|WP_003485222.1|2618940_2619369_-|DUF2935-domain-containing-protein
MYCYTYVNQFACIFNELELWTHISSEHPTFLKTVASLSKINLPKSAVDKLDDIHKRFLGLYNDVVYLKKALRANPMLYYQSIGNIKRIINKFMFYDTQALSFYPELLEFGKENKVWQELVNHIIHEQHFMLELFKNLILQIG
>NZ_CP027781.1|WP_106900595.1|2617524_2618877_+|amidohydrolase
MNQILIKNGYIITMDCSKRIFEKGDILVEDSKIIAIGNVESELIKSNVEIIDANGKIIMPGLVNTHVHLSQQLARGLADDVDLLTWLRKRIWPYESNMDLEDSYISSLACCTELIRSGVTTFCEAGGQEVDGMGKAVEEAGLRGILCRSTMDCGDGLPLKWQETTEESLEKQVELLERWNGKGDGRIKYWFGLRTIFNTTDKLITKTKELADKYKVGIHMHVAEIEEEVRYAEATRGETTVQHLAKLGVLDKNFLAVHTVWLTEQEIDLFKLHNVKVSHNPGAAMKVVLGFAHIPEMLEKGINVSIGTDGAPSNNRMDMFDEMHLTSLIHKGRRLNPKVVPADEVLEMATMNGAKCALWENEIGSLEVGKKADLIIINPKSIGNLPMHDPIGNIVYSMHSSDVESSMCNGKWLMKNKVLLTIDEEDIIREAQEKATALVKKAGIVLPKRF
>NZ_CP027781.1|WP_003493868.1|2615974_2617318_+|purine-permease
MKNTKDTNLIVGIDEKISLRYAFFLGLQHVFAMDLYIVPIILAGILSLDAQNTAYFIQMSFIAAGIATLIQTGLCMRLPIMQGPSYIPIGALAAIGSKLGLQAMVGSLIPGSLFLMILGYPLRFLSKIISKFIPHIVGGTVIVIVGISLMPVAMTNIFTAPGNLKINCILALISSALLVSCMMIGRKSNKFGKAVRLTSVMISLIGGTIAASLLGVVDFTPVTKAAWFSFPKLLPFGKPVFDLKAILTMLFIYAVILVETSGTWFAVSAVTGSELTDEGLNRGAVGEGIGCFVGALFGGTPMTGYSTNAGIIAVTGVGSRMAIIAGGIILVALGMLPKLMNVIACIPSAVVSGVFAVVCVIIAMNGFKSIQHEEFDERNMLLIGLPILLALGTTVLPKDILNSLPSLANYIFSSGITVGALAAVILNILLPKAPVEVSKSQEYEEAV
>NZ_CP027781.1|WP_106900594.1|2614637_2615537_-|hypothetical-protein
MSNKRNLQSIRSFYLCILIFNIVYSSIFHLNNKGFNIKLFGDLTMRSVVLFTFNSILFLCIVIAVEKKINIAEKIKTKVSMRIKPLYLVNMFFITYILVCIFLLKNLDLILSSFVMEIIYIGILILTKKIIALELTDRQLQWQKACGYIDESCEKSSFLWRFKIWYSPHINVPFKNRWKGLSRLLYDLALVYGIFISRGNLFSLLLLILLLPDVLSWIEGLLGLQTSLTGMCTGITEHHSKNSHVVYHKVYVTDYKNKREITFYVDGPLFIHENSNMTVVHGTFSKRVLYVEGLNLDIR
>NZ_CP027781.1|WP_106900593.1|2612974_2614297_-|amino-acid-permease
MLEKKYGLWTTVSMVIGIVIGSGVFFKADNILIASGGNVKTALLAWLVGAISMIFGALVFAECANRFERSNGIVDYAEGMLSEKFAYLIGWFNGIIYYPAIAAVLAWAAGNYTAILFNKDGNFVWIMAAIYMIGIYILNYISPILSGKFQIASTAIKLVPLMLIAILGTFQGLNNGILIENFSKVSTIGDSGSGFAAAVLGAAFAYEGWIIATTINGEIKDAKNTLPKALVFGSLVIVIIYILYFLGIVGMIPTETILKQGDNTVNVAARTVFGNFGASILTIFIIVSCLGTLNGLILGGSRSFYSLAIRGQGIKPEAFSKLDSKTNIPTNSTIANFILICIYLVVWYMNFKGLFPNKMFVDISELPIALIYGIYIIIYIAYMMKMKDLSFIKRFVIPSLALMGALIVVYGGLSKPSVIIDLGISVFVFLSGLLFYNKKK
>NZ_CP027781.1|WP_096043671.1|2612172_2612907_+|protein-kinase-family-protein
MVIKFFKRDTKYLPEQKIHGYTVLKILGEGRFGICYLVQSNNKQYILKQLKTKMLKKIGSKVIYEQEILKNINHNCIPKFIKTLQFEKFFGYVLEYKEGKTFEEIICEDEYVFKREEIYDICIQIIEILKYLHKSGIVHRDIRIPNTIYYKKKVNLVDFGLARWINNKRYTENVDFSYLGDFLLHLYYTSFQCKTFKGKPWYEELDLFSEEMNFLKRLLGIEKKYKNIEEVERDFLLLKSNYNK
>NZ_CP027781.1|WP_106900592.1|2611966_2612182_+|hypothetical-protein
MSILSKIFNLVNSSSNGYHKNKHRGSSYYKKHHRSKSGFLGSMMSVFSSKSRSYSHSYKRHSRRKKYSSWS
>NZ_CP027781.1|WP_021106869.1|2610912_2611686_+|benzoyl-CoA-reductase-subunit-BadG
MYTMGLDIGSTTSKGVIIKDGEEIVASVLVPVGTGTSGPLKLIKELKEKSNLTEKDIEKTVVTGYGRIQYKDADKQISELSCHAKGVAFLIPGARTIIDIGGQDAKAMKLNDKGKLINFIMNDKCAAGTGRFLDVMAGVLETDVSKLGEISEKSTKEVSISSTCTVFAESEVISHLSANAKKEDIVAGIHTSVVRRVSTLAMRVGIEDQVVMVGGVARNKGIVKAMEKELGHDIKVPELAQLTGALGAAIYAFEETK
>NZ_CP027781.1|WP_106900598.1|2623432_2624026_+|YdcF-family-protein
MIVLYIILCSILVCFIVEYTVICSRFKIASYNKGQKQDVIIVLGYHVKKDGDVSPILRERINKAAKLYHEGIAGVIICSGAAVANDYIEADVMANALIELGVPACNIIREKLAKNTYENLVNSKKIMQDRELNTAVIVSSPWHLRKASSYAFRLKMDHTVEKSKFPHEYLIIGVGMIYLYLYTQMFINNLRYHKCKQ
>NZ_CP027781.1|WP_106900599.1|2624945_2625635_+|CRISPR-associated-endoribonuclease-Cas6
MEFWELIATVMLKKDIYFEDCGYIIGKNINKSMLLDKNLKEMHPQKQYKNYVFNSFYPIERDKFYKKDRLYIFNIRGLSKEFIYKIETCLCNLESNDFNVISTSKKEIKQRYIKELYTQTPLIITVDDKPWLQNEGDLDLFKQRLEDNLEKKYKNFFNEDIDVKGKFIKSIEFKNRKPMHYNYKNGIKLLANKVSMLIEDNEEAQKIAFLARATGLGEKNSSIGAGFCK
>NZ_CP027781.1|WP_106900600.1|2625654_2626029_+|hypothetical-protein
MSKTLRFEIVSGVNKGYFHTNSQSESLDLVGGIWQKIAKEEFEKNNIYVSAVIKPSKTVYNQEWGCPENGEETVVLTGVANEEFVDDIEKWKDAVIKLAKELKNQLKQSTLTCEFIETELHYFK
>NZ_CP027781.1|WP_106900601.1|2626063_2627770_+|hypothetical-protein
MTKEIISSHIFVFPFRWDVVKDEACLDTCIDSRLNVEKFIKYLKDINQWEEDINISNIIENKEVENDLDYNTYAYFYDNVRKAIYGKQNLIKKNKNISVDLKNSKYYVGRLFNKKISNTIVRCLNYKNIDANSIYEIHVEKRDDSGTIVFDEHYKLKIKSIKLKVYDTGVATLSYFLDNYEWKNEEDILRINDYGRRIYPQHIPLNTVRNNFLAKKISLKLQNRTIEENFDYGVKEKPTKISKIIMGILGERFISSDKDLEKRKCLNKEEIIFVKPVIDDRMFVICYYNNNFFSRVLTKYDKDEYLKNDFWYQFLFVDNGGATCKDEEMKKELLSKSTYTRWKSYGTLFGISRYSFVILCDESGFSKNVLYNHINTIYYEMILLALVQRASILRFSDETSRIASFERKNIYEQIKKLQEYYIRFVNTIYFREVTAQEQGIELYDKVVELMRIDTEVKRLDEEIDEIQRYINLETNDRTNILLNVITFVGIGVSVISLISSLFSNNKQIGDLTWLVTWQYVPFVMVLLVISVIKKYVNDNKVIKIIMWVITLVAVYIVLDYKFIKLFIK
>NZ_CP027781.1|WP_106900602.1|2627782_2628970_+|hypothetical-protein
MSKVKIELKQHTPLIHFQSEQPGAILRATEVKPKLDKFLKKYAFSGGFEEYKQYLIGYKVGEKDKIWDFGDKQAFDYKLTIYTENPNKIQKIDIKGAMQALYFAGRSNNGNVKGILTNEDIILEFFTFHKGLMEIIKNNIEGFFCINNFGTRQNKGFGSFYLKKPINEVDKLIDRICTHDKTNIYLNIKYNKGDYFQIFEDISVIYPLMKSGLNFPKWPKSYHKSFLFKYMLNKDIGNEKRFIKENFFSPWKRIENDNKEKRYVRAMLGICDGIEFRDSERTGKVKYNSNIERFQSPILFKIINNELFIIPKKIPKEMFYNKFKFSNEFKSGRESKVNKEIIYTPKEDEFNLENFLSGFADYFNNHIKVSNVNNVFENKIRKAKLRRIDIKQVVK
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_6

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_6

2624418-2624709

TypeIII

III-B

Consensus_repeat	Method
GTTGAACATTAACATAAGATGTATTTAAAT	PILER-CR
ATTGAACATTAACATGAGATGTATTTAAAT	CRISPRCasFinder
GTTGAACATTAACATAAGATGTATTTAAAT	CRT

4 spacers

cas6,cmr1gr7,cas10,cmr3gr5,cmr4gr7,cmr5gr11,cmr6gr7

The CRISPR arrays of NZ_CP027781_6

>merge|NZ_CP027781|6|2624418-2624709|PILER-CR,CRISPRCasFinder,CRT
GTTGAACATTAACATAAGATGTATTTAAATATATTTCCATAATCCTTTCTTATTCTGTCTTTGAGTTGAACATTAACATAAGATGTATTTAAATGCAGTAAGAACTCTTTCACCCTTATGAAGTCTTGCTAGTTGAACATTAACATAAGATGTATTTAAATTGGTATTAGCCTTTAGTTCTCTAATTGCTTCCTCGTTGAACATTAACATAAGATGTATTTAAATTAGAGGGAAAAATAAAAGCATGCACAAAACATAAGCAGTTGAACATTAACATGAGGTGTATTTAAAT

>NZ_CP027781|6|3|2624418-2624642|PILER-CR
GTTGAACATTAACATAAGATGTATTTAAAT	ATATTTCCATAATCCTTTCTTATTCTGTCTTTGA
GTTGAACATTAACATAAGATGTATTTAAAT	GCAGTAAGAACTCTTTCACCCTTATGAAGTCTTGCTA
GTTGAACATTAACATAAGATGTATTTAAAT	TGGTATTAGCCTTTAGTTCTCTAATTGCTTCCTC
GTTGAACATTAACATAAGATGTATTTAAAT

>NZ_CP027781|6|6|2624418-2624709|CRISPRCasFinder
GTTGAACATTAACATAAGATGTATTTAAAT	ATATTTCCATAATCCTTTCTTATTCTGTCTTTGA
GTTGAACATTAACATAAGATGTATTTAAAT	GCAGTAAGAACTCTTTCACCCTTATGAAGTCTTGCTA
GTTGAACATTAACATAAGATGTATTTAAAT	TGGTATTAGCCTTTAGTTCTCTAATTGCTTCCTC
GTTGAACATTAACATAAGATGTATTTAAAT	TAGAGGGAAAAATAAAAGCATGCACAAAACATAAGCA
GTTGAACATTAACATGAGGTGTATTTAAAT

>NZ_CP027781|6|4|2624418-2624709|CRT
GTTGAACATTAACATAAGATGTATTTAAAT	ATATTTCCATAATCCTTTCTTATTCTGTCTTTGA
GTTGAACATTAACATAAGATGTATTTAAAT	GCAGTAAGAACTCTTTCACCCTTATGAAGTCTTGCTA
GTTGAACATTAACATAAGATGTATTTAAAT	TGGTATTAGCCTTTAGTTCTCTAATTGCTTCCTC
GTTGAACATTAACATAAGATGTATTTAAAT	TAGAGGGAAAAATAAAAGCATGCACAAAACATAAGCA
GTTGAACATTAACATGAGGTGTATTTAAAT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900594.1\|2614637_2615537_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	unknown	unknown	gnl\|CDD\|238623
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	unknown	unknown	gnl\|CDD\|270622
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378897
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|213357
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	unknown	unknown	gnl\|CDD\|274468
NZ_CP027781.1\|WP_106900600.1\|2625654_2626029_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900602.1\|2627782_2628970_+\|hypothetical-protein	cmr1gr7	mkCas0086_cmr1gr7_CAS-III-B	unknown
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|369561
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	unknown	unknown	gnl\|CDD\|99750
NZ_CP027781.1\|WP_106900592.1\|2611966_2612182_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	unknown	unknown	gnl\|CDD\|223605
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	unknown	unknown	gnl\|CDD\|378573

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900595.1\|2617524_2618877_+\|amidohydrolase	gnl\|CDD\|238623	cd01298, ATZ_TRZ_like, TRZ/ATZ family contains enzymes from the atrazine degradation pathway and related hydrolases. Atrazine, a chlorinated herbizide, can be catabolized by a variety of different bacteria. The first three steps of the atrazine dehalogenation pathway are catalyzed by atrazine chlorohydrolase (AtzA), hydroxyatrazine ethylaminohydrolase (AtzB), and N-isopropylammelide N-isopropylaminohydrolase (AtzC). All three enzymes belong to the superfamily of metal dependent hydrolases. AtzA and AtzB, beside other related enzymes are represented in this CD.	0
NZ_CP027781.1\|WP_106900597.1\|2620839_2621292_-\|hypothetical-protein	gnl\|CDD\|378897	pfam12638, Staygreen, Staygreen protein. This family of proteins have been implicated in chlorophyll degradation. Intriguingly members of this family are also found in non-photosynthetic bacteria.	7.30783e-84
NZ_CP027781.1\|WP_106900601.1\|2626063_2627770_+\|hypothetical-protein	gnl\|CDD\|213357	cd12823, Mrs2_Mfm1p-like, Saccharomyces cerevisiae inner mitochondrial membrane Mg2+ transporters Mfm1p and Mrs2p-like family. A eukaryotic subfamily belonging to the Escherichia coli CorA-Salmonella typhimurium ZntB_like family (EcCorA_ZntB-like) family of the MIT superfamily of essential membrane proteins involved in transporting divalent cations (uptake or efflux) across membranes. This functionally diverse subfamily includes the inner mitochondrial membrane Mg2+ transporters Saccharomyces cerevisiae Mfm1p/Lpe10p, Mrs2p, and human MRS2/ MRS2L. It also includes a family of Arabidopsis thaliana proteins (AtMGTs) some of which are localized to distinct tissues, and not all of which can transport Mg2+. Structures of the intracellular domain of two EcCorA_ZntB-like family transporters: Vibrio parahaemolyticus and Salmonella typhimurium ZntB form funnel-shaped homopentamers, the tip of the funnel is formed from two C-terminal transmembrane (TM) helices from each monomer, and the large opening of the funnel from the N-terminal cytoplasmic domains. The GMN signature motif of the MIT superfamily occurs just after TM1, mutation within this motif is known to abolish Mg2+ transport through Salmonella typhimurium CorA, and Mrs2p. Natural variants such as GVN and GIN, as in some ZntB family proteins, may be associated with the transport of different divalent cations, such as zinc and cadmium. The functional diversity of MIT transporters may also be due to minor structural differences regulating gating, substrate selection, and transport.	0.00480426
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_003493868.1\|2615974_2617318_+\|purine-permease	gnl\|CDD\|274468	TIGR03173, pbuX, xanthine permease. All the seed members of this model are observed adjacent to genes for either xanthine phosphoribosyltransferase (for the conversion of xanthine to guanine, GenProp0696) or genes for the conversion of xanthine to urate and its concomitant catabolism (GenProp0640, GenProp0688, GenProp0686 and GenProp0687). A number of sequences scoring higher than trusted to this model are found in different genomic contexts, and the possibility exist that these transport related compounds in addition to or instead of xanthine itself. The outgroup to this family are sequences which are characterized as uracil permeases or are adjacent to established uracil phosphoribosyltransferases.	5.12474e-138
NZ_CP027781.1\|WP_106900596.1\|2619604_2620651_+\|alpha/beta-hydrolase	gnl\|CDD\|369561	pfam07859, Abhydrolase_3, alpha/beta hydrolase fold. This catalytic domain is found in a very wide range of enzymes.	4.63453e-89
NZ_CP027781.1\|WP_106900599.1\|2624945_2625635_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	9.12195e-20
NZ_CP027781.1\|WP_106900598.1\|2623432_2624026_+\|YdcF-family-protein	gnl\|CDD\|99750	cd06259, YdcF-like, YdcF-like. YdcF-like is a large family of mainly bacterial proteins, with a few members found in fungi, plants, and archaea. Escherichia coli YdcF has been shown to bind S-adenosyl-L-methionine (AdoMet), but a biochemical function has not been idenitified. The family also includes Escherichia coli sanA and Salmonella typhimurium sfiX, which are involved in vancomycin resistance; sfiX may also be involved in murein synthesis.	1.38244e-41
NZ_CP027781.1\|WP_096043671.1\|2612172_2612907_+\|protein-kinase-family-protein	gnl\|CDD\|270622	cd00180, PKc, Catalytic domain of Protein Kinases. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.	1.34529e-24
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900593.1\|2612974_2614297_-\|amino-acid-permease	gnl\|CDD\|223605	COG0531, PotE, Amino acid transporters [Amino acid transport and metabolism].	4.49897e-27
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33
NZ_CP027781.1\|WP_003485222.1\|2618940_2619369_-\|DUF2935-domain-containing-protein	gnl\|CDD\|378573	pfam11155, DUF2935, Domain of unknown function (DUF2935). This family of proteins with unknown function appears to be restricted to Firmicutes. The structure of this protein has been solved and each domain is composed of four alpha helices. A metal cluster composed of iron and magnesium lies between the two domains.	1.91074e-12

>NZ_CP027781.1|WP_106900598.1|2623432_2624026_+|YdcF-family-protein
MIVLYIILCSILVCFIVEYTVICSRFKIASYNKGQKQDVIIVLGYHVKKDGDVSPILRERINKAAKLYHEGIAGVIICSGAAVANDYIEADVMANALIELGVPACNIIREKLAKNTYENLVNSKKIMQDRELNTAVIVSSPWHLRKASSYAFRLKMDHTVEKSKFPHEYLIIGVGMIYLYLYTQMFINNLRYHKCKQ
>NZ_CP027781.1|WP_106900597.1|2620839_2621292_-|hypothetical-protein
MSKLNPEKLSVEFRDGVTNTEPILGRRYTLTHSDITAELFLTIGLTYAYDKIDVMRDEVLGEWIEKEKNYLFHVYLHVDGNNPIVTGVRNHIFRRELPLALEAIRYGDRKFFISHPKLDNSSIIVHFISSYPSFDRVEKWGTFSDYSLKK
>NZ_CP027781.1|WP_106900596.1|2619604_2620651_+|alpha/beta-hydrolase
MEVNEVKKVIKVVSVILVMLVAVGFFIIKNLTETKDGKLNMYVAANLQLYKILNPKSLNSKSIEETRGALNKQSTRWSNKPIPFSNIKNLDIKMNNEKIPVRIYTPEKGSNFPMIIYSHGAFWIGGNVDTIDGVCRKLSQNTKAIVISVNYRLAPENPFPAGLNDVYNVLQWTYKNAKSINGDEKHIAVVGDSAGGNLSAAVSSMSRDKNGPPITCQVLIYPSTNIFELNSKSWSYFSNSLNVSTEDMEKYISIYVPKKEDRKNPYASPLLSKDFSKLPDTLVVTAEIDPLRDEGEAYANKLKESGVKAEVTRYKGITHGFITMDKITNKADEALNQISLYIQKEFQK
>NZ_CP027781.1|WP_003485222.1|2618940_2619369_-|DUF2935-domain-containing-protein
MYCYTYVNQFACIFNELELWTHISSEHPTFLKTVASLSKINLPKSAVDKLDDIHKRFLGLYNDVVYLKKALRANPMLYYQSIGNIKRIINKFMFYDTQALSFYPELLEFGKENKVWQELVNHIIHEQHFMLELFKNLILQIG
>NZ_CP027781.1|WP_106900595.1|2617524_2618877_+|amidohydrolase
MNQILIKNGYIITMDCSKRIFEKGDILVEDSKIIAIGNVESELIKSNVEIIDANGKIIMPGLVNTHVHLSQQLARGLADDVDLLTWLRKRIWPYESNMDLEDSYISSLACCTELIRSGVTTFCEAGGQEVDGMGKAVEEAGLRGILCRSTMDCGDGLPLKWQETTEESLEKQVELLERWNGKGDGRIKYWFGLRTIFNTTDKLITKTKELADKYKVGIHMHVAEIEEEVRYAEATRGETTVQHLAKLGVLDKNFLAVHTVWLTEQEIDLFKLHNVKVSHNPGAAMKVVLGFAHIPEMLEKGINVSIGTDGAPSNNRMDMFDEMHLTSLIHKGRRLNPKVVPADEVLEMATMNGAKCALWENEIGSLEVGKKADLIIINPKSIGNLPMHDPIGNIVYSMHSSDVESSMCNGKWLMKNKVLLTIDEEDIIREAQEKATALVKKAGIVLPKRF
>NZ_CP027781.1|WP_003493868.1|2615974_2617318_+|purine-permease
MKNTKDTNLIVGIDEKISLRYAFFLGLQHVFAMDLYIVPIILAGILSLDAQNTAYFIQMSFIAAGIATLIQTGLCMRLPIMQGPSYIPIGALAAIGSKLGLQAMVGSLIPGSLFLMILGYPLRFLSKIISKFIPHIVGGTVIVIVGISLMPVAMTNIFTAPGNLKINCILALISSALLVSCMMIGRKSNKFGKAVRLTSVMISLIGGTIAASLLGVVDFTPVTKAAWFSFPKLLPFGKPVFDLKAILTMLFIYAVILVETSGTWFAVSAVTGSELTDEGLNRGAVGEGIGCFVGALFGGTPMTGYSTNAGIIAVTGVGSRMAIIAGGIILVALGMLPKLMNVIACIPSAVVSGVFAVVCVIIAMNGFKSIQHEEFDERNMLLIGLPILLALGTTVLPKDILNSLPSLANYIFSSGITVGALAAVILNILLPKAPVEVSKSQEYEEAV
>NZ_CP027781.1|WP_106900594.1|2614637_2615537_-|hypothetical-protein
MSNKRNLQSIRSFYLCILIFNIVYSSIFHLNNKGFNIKLFGDLTMRSVVLFTFNSILFLCIVIAVEKKINIAEKIKTKVSMRIKPLYLVNMFFITYILVCIFLLKNLDLILSSFVMEIIYIGILILTKKIIALELTDRQLQWQKACGYIDESCEKSSFLWRFKIWYSPHINVPFKNRWKGLSRLLYDLALVYGIFISRGNLFSLLLLILLLPDVLSWIEGLLGLQTSLTGMCTGITEHHSKNSHVVYHKVYVTDYKNKREITFYVDGPLFIHENSNMTVVHGTFSKRVLYVEGLNLDIR
>NZ_CP027781.1|WP_106900593.1|2612974_2614297_-|amino-acid-permease
MLEKKYGLWTTVSMVIGIVIGSGVFFKADNILIASGGNVKTALLAWLVGAISMIFGALVFAECANRFERSNGIVDYAEGMLSEKFAYLIGWFNGIIYYPAIAAVLAWAAGNYTAILFNKDGNFVWIMAAIYMIGIYILNYISPILSGKFQIASTAIKLVPLMLIAILGTFQGLNNGILIENFSKVSTIGDSGSGFAAAVLGAAFAYEGWIIATTINGEIKDAKNTLPKALVFGSLVIVIIYILYFLGIVGMIPTETILKQGDNTVNVAARTVFGNFGASILTIFIIVSCLGTLNGLILGGSRSFYSLAIRGQGIKPEAFSKLDSKTNIPTNSTIANFILICIYLVVWYMNFKGLFPNKMFVDISELPIALIYGIYIIIYIAYMMKMKDLSFIKRFVIPSLALMGALIVVYGGLSKPSVIIDLGISVFVFLSGLLFYNKKK
>NZ_CP027781.1|WP_096043671.1|2612172_2612907_+|protein-kinase-family-protein
MVIKFFKRDTKYLPEQKIHGYTVLKILGEGRFGICYLVQSNNKQYILKQLKTKMLKKIGSKVIYEQEILKNINHNCIPKFIKTLQFEKFFGYVLEYKEGKTFEEIICEDEYVFKREEIYDICIQIIEILKYLHKSGIVHRDIRIPNTIYYKKKVNLVDFGLARWINNKRYTENVDFSYLGDFLLHLYYTSFQCKTFKGKPWYEELDLFSEEMNFLKRLLGIEKKYKNIEEVERDFLLLKSNYNK
>NZ_CP027781.1|WP_106900592.1|2611966_2612182_+|hypothetical-protein
MSILSKIFNLVNSSSNGYHKNKHRGSSYYKKHHRSKSGFLGSMMSVFSSKSRSYSHSYKRHSRRKKYSSWS
>NZ_CP027781.1|WP_106900599.1|2624945_2625635_+|CRISPR-associated-endoribonuclease-Cas6
MEFWELIATVMLKKDIYFEDCGYIIGKNINKSMLLDKNLKEMHPQKQYKNYVFNSFYPIERDKFYKKDRLYIFNIRGLSKEFIYKIETCLCNLESNDFNVISTSKKEIKQRYIKELYTQTPLIITVDDKPWLQNEGDLDLFKQRLEDNLEKKYKNFFNEDIDVKGKFIKSIEFKNRKPMHYNYKNGIKLLANKVSMLIEDNEEAQKIAFLARATGLGEKNSSIGAGFCK
>NZ_CP027781.1|WP_106900600.1|2625654_2626029_+|hypothetical-protein
MSKTLRFEIVSGVNKGYFHTNSQSESLDLVGGIWQKIAKEEFEKNNIYVSAVIKPSKTVYNQEWGCPENGEETVVLTGVANEEFVDDIEKWKDAVIKLAKELKNQLKQSTLTCEFIETELHYFK
>NZ_CP027781.1|WP_106900601.1|2626063_2627770_+|hypothetical-protein
MTKEIISSHIFVFPFRWDVVKDEACLDTCIDSRLNVEKFIKYLKDINQWEEDINISNIIENKEVENDLDYNTYAYFYDNVRKAIYGKQNLIKKNKNISVDLKNSKYYVGRLFNKKISNTIVRCLNYKNIDANSIYEIHVEKRDDSGTIVFDEHYKLKIKSIKLKVYDTGVATLSYFLDNYEWKNEEDILRINDYGRRIYPQHIPLNTVRNNFLAKKISLKLQNRTIEENFDYGVKEKPTKISKIIMGILGERFISSDKDLEKRKCLNKEEIIFVKPVIDDRMFVICYYNNNFFSRVLTKYDKDEYLKNDFWYQFLFVDNGGATCKDEEMKKELLSKSTYTRWKSYGTLFGISRYSFVILCDESGFSKNVLYNHINTIYYEMILLALVQRASILRFSDETSRIASFERKNIYEQIKKLQEYYIRFVNTIYFREVTAQEQGIELYDKVVELMRIDTEVKRLDEEIDEIQRYINLETNDRTNILLNVITFVGIGVSVISLISSLFSNNKQIGDLTWLVTWQYVPFVMVLLVISVIKKYVNDNKVIKIIMWVITLVAVYIVLDYKFIKLFIK
>NZ_CP027781.1|WP_106900602.1|2627782_2628970_+|hypothetical-protein
MSKVKIELKQHTPLIHFQSEQPGAILRATEVKPKLDKFLKKYAFSGGFEEYKQYLIGYKVGEKDKIWDFGDKQAFDYKLTIYTENPNKIQKIDIKGAMQALYFAGRSNNGNVKGILTNEDIILEFFTFHKGLMEIIKNNIEGFFCINNFGTRQNKGFGSFYLKKPINEVDKLIDRICTHDKTNIYLNIKYNKGDYFQIFEDISVIYPLMKSGLNFPKWPKSYHKSFLFKYMLNKDIGNEKRFIKENFFSPWKRIENDNKEKRYVRAMLGICDGIEFRDSERTGKVKYNSNIERFQSPILFKIINNELFIIPKKIPKEMFYNKFKFSNEFKSGRESKVNKEIIYTPKEDEFNLENFLSGFADYFNNHIKVSNVNNVFENKIRKAKLRRIDIKQVVK
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_8

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_8

2639250-2639870

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAGTAACATGAGATGTATTTAAAC	PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
GTTGAACAGTAACATGAGATGTATTTAAAC	CRT

9 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_8

>merge|NZ_CP027781|8|2639250-2639870|PILER-CR,CRISPRCasFinder,CRT
GTTGAGCAGTAACATGAGATGTATTTAAACGGTACAGTCCTTAGGTTCTAGTGGGTATAGAAAAGTTGAGCAGTAACATGAGATGTATTTAAACTTATAAAGTCAATTGCATCTCCTGAAGTGTCACAACCGTTGAACAGTAACATGAGATGTATTTAAACGTAAATGCATTCTCCCATACTTCTGTATTTTTAAGTTGAACAGTAACATGAGATGTATTTAAACGCAATAATATCTGGAGTAATGCTATCTCCATTTACGTTGAACAGTAACATGAGATGTATTTAAACTCTAGTTCTTCTATTTTATTTCCAACATTTTTTAATGTTGAACAGTAACATGAGATGTATTTAAACCATACGCACAGTATTCAATATGGCATATTTGAAAGTGTTGAACAGTAACATGAGATGTATTTAAACGCATATTTTCTATAGTCTATTTTTTCCCTTCTATCTGTTGAACAGTAACATGAGATGTATTTAAACATTATATGATGGTAAAACAGAAGGACAAAAGCAAGGGTTGAACAGTAACATGAGATGTATTTAAATATTAAATACTCGCTTTTTACCATATCTGTCATGCTAGTTGAACATTAACATAGGATGTATTTAAGCA

>NZ_CP027781|8|5|2639250-2639737|PILER-CR
GTTGAGCAGTAACATGAGATGTATTTAAAC	GGTACAGTCCTTAGGTTCTAGTGGGTATAGAAAA
GTTGAGCAGTAACATGAGATGTATTTAAAC	TTATAAAGTCAATTGCATCTCCTGAAGTGTCACAACC
GTTGAACAGTAACATGAGATGTATTTAAAC	GTAAATGCATTCTCCCATACTTCTGTATTTTTAA
GTTGAACAGTAACATGAGATGTATTTAAAC	GCAATAATATCTGGAGTAATGCTATCTCCATTTAC
GTTGAACAGTAACATGAGATGTATTTAAAC	TCTAGTTCTTCTATTTTATTTCCAACATTTTTTAAT
GTTGAACAGTAACATGAGATGTATTTAAAC	CATACGCACAGTATTCAATATGGCATATTTGAAAGT
GTTGAACAGTAACATGAGATGTATTTAAAC	GCATATTTTCTATAGTCTATTTTTTCCCTTCTATCT
GTTGAACAGTAACATGAGATGTATTTAAAC

>NZ_CP027781|8|8|2639250-2639870|CRISPRCasFinder
GTTGAGCAGTAACATGAGATGTATTTAAAC	GGTACAGTCCTTAGGTTCTAGTGGGTATAGAAAA
GTTGAGCAGTAACATGAGATGTATTTAAAC	TTATAAAGTCAATTGCATCTCCTGAAGTGTCACAACC
GTTGAACAGTAACATGAGATGTATTTAAAC	GTAAATGCATTCTCCCATACTTCTGTATTTTTAA
GTTGAACAGTAACATGAGATGTATTTAAAC	GCAATAATATCTGGAGTAATGCTATCTCCATTTAC
GTTGAACAGTAACATGAGATGTATTTAAAC	TCTAGTTCTTCTATTTTATTTCCAACATTTTTTAAT
GTTGAACAGTAACATGAGATGTATTTAAAC	CATACGCACAGTATTCAATATGGCATATTTGAAAGT
GTTGAACAGTAACATGAGATGTATTTAAAC	GCATATTTTCTATAGTCTATTTTTTCCCTTCTATCT
GTTGAACAGTAACATGAGATGTATTTAAAC	ATTATATGATGGTAAAACAGAAGGACAAAAGCAAGG
GTTGAACAGTAACATGAGATGTATTTAAAT	ATTAAATACTCGCTTTTTACCATATCTGTCATGCTA
GTTGAACATTAACATAGGATGTATTTAAGCA

>NZ_CP027781|8|6|2639250-2639869|CRT
GTTGAGCAGTAACATGAGATGTATTTAAAC	GGTACAGTCCTTAGGTTCTAGTGGGTATAGAAAA
GTTGAGCAGTAACATGAGATGTATTTAAAC	TTATAAAGTCAATTGCATCTCCTGAAGTGTCACAACC
GTTGAACAGTAACATGAGATGTATTTAAAC	GTAAATGCATTCTCCCATACTTCTGTATTTTTAA
GTTGAACAGTAACATGAGATGTATTTAAAC	GCAATAATATCTGGAGTAATGCTATCTCCATTTAC
GTTGAACAGTAACATGAGATGTATTTAAAC	TCTAGTTCTTCTATTTTATTTCCAACATTTTTTAAT
GTTGAACAGTAACATGAGATGTATTTAAAC	CATACGCACAGTATTCAATATGGCATATTTGAAAGT
GTTGAACAGTAACATGAGATGTATTTAAAC	GCATATTTTCTATAGTCTATTTTTTCCCTTCTATCT
GTTGAACAGTAACATGAGATGTATTTAAAC	ATTATATGATGGTAAAACAGAAGGACAAAAGCAAGG
GTTGAACAGTAACATGAGATGTATTTAAAT	ATTAAATACTCGCTTTTTACCATATCTGTCATGCTA
GTTGAACATTAACATAGGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_7

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_7

2638180-2638999

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAGTAACATAGGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
GTTGAACAGTAACATAGGATGTATTTAAAT	CRT

12 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_7

>merge|NZ_CP027781|7|2638180-2638999|PILER-CR,CRISPRCasFinder,CRT
GTTGAACAGTAACATAGGATGTATTTAAATTTAGTACATTCCAAACCACAGTTATGAGGTAGACGTTGAACAGTAACATAGGATGTATTTAAATGACATATTTGGATTAACTGAAAGAAGAGTAAGACAGGTTGAACAGTAACATAGGATGTATTTAAATTTATCATATAACCTTCTTTCCTTCTCCATCATATGTGTTGAACAGTAACATAGGATGTATTTAAATAATAAAATATCACCTTTACATAAATATATAGCTTGTTGAACAGTAACATAGGATGTATTTAAATGTTGATAACAATAAAGATATGGCTATACAAATGTTAGTGTTGAACAGTAACATAGGATGTATTTAAATCTTTTATATCTCCATAATGCATATGTCTAACTTTAGTTGAACAGTAACATAGGATGTATTTAAATTAACAACCATTTCTTAAAACTAGATCTTCTTTTATTGTTGAACAGTAACATAGGATGTATTTAAATCATTATAAATATTAAGCAAGAGTACCAGGAAGCATTGGTTGAACAGTAACATAGGATGTATTTAAATTTGCATAACTCTCACTTATGTTTAACTTTCTGGCTAGTTGAACAGTAACATAGGATGTATTTAAATTATTCTATTTTTATGCCTCTATCGCCTATGTATAATATTGAACATTAACATAAGATGTATTTAAATAGCAAATCAAATAAATTACTTTGCTGAAACATATAAGTTGAACATTAACATAAAATGTATTTAAATGTATTAGAACATAGAGCAAATAACCCTTCATGGGCGTTGAACAATAACATAAGATGTATTTAATCA

>NZ_CP027781|7|4|2638180-2638801|PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	TTAGTACATTCCAAACCACAGTTATGAGGTAGAC
GTTGAACAGTAACATAGGATGTATTTAAAT	GACATATTTGGATTAACTGAAAGAAGAGTAAGACAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTATCATATAACCTTCTTTCCTTCTCCATCATATGT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATAAAATATCACCTTTACATAAATATATAGCTT
GTTGAACAGTAACATAGGATGTATTTAAAT	GTTGATAACAATAAAGATATGGCTATACAAATGTTAGT
GTTGAACAGTAACATAGGATGTATTTAAAT	CTTTTATATCTCCATAATGCATATGTCTAACTTTA
GTTGAACAGTAACATAGGATGTATTTAAAT	TAACAACCATTTCTTAAAACTAGATCTTCTTTTATT
GTTGAACAGTAACATAGGATGTATTTAAAT	CATTATAAATATTAAGCAAGAGTACCAGGAAGCATTG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTGCATAACTCTCACTTATGTTTAACTTTCTGGCTA
GTTGAACAGTAACATAGGATGTATTTAAAT

>NZ_CP027781|7|7|2638180-2638999|CRISPRCasFinder
GTTGAACAGTAACATAGGATGTATTTAAAT	TTAGTACATTCCAAACCACAGTTATGAGGTAGAC
GTTGAACAGTAACATAGGATGTATTTAAAT	GACATATTTGGATTAACTGAAAGAAGAGTAAGACAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTATCATATAACCTTCTTTCCTTCTCCATCATATGT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATAAAATATCACCTTTACATAAATATATAGCTT
GTTGAACAGTAACATAGGATGTATTTAAAT	GTTGATAACAATAAAGATATGGCTATACAAATGTTAGT
GTTGAACAGTAACATAGGATGTATTTAAAT	CTTTTATATCTCCATAATGCATATGTCTAACTTTA
GTTGAACAGTAACATAGGATGTATTTAAAT	TAACAACCATTTCTTAAAACTAGATCTTCTTTTATT
GTTGAACAGTAACATAGGATGTATTTAAAT	CATTATAAATATTAAGCAAGAGTACCAGGAAGCATTG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTGCATAACTCTCACTTATGTTTAACTTTCTGGCTA
GTTGAACAGTAACATAGGATGTATTTAAAT	TATTCTATTTTTATGCCTCTATCGCCTATGTATAAT
ATTGAACATTAACATAAGATGTATTTAAAT	AGCAAATCAAATAAATTACTTTGCTGAAACATATAA
GTTGAACATTAACATAAAATGTATTTAAAT	GTATTAGAACATAGAGCAAATAACCCTTCATGGGC
GTTGAACAATAACATAAGATGTATTTAATCA

>NZ_CP027781|7|5|2638180-2638998|CRT
GTTGAACAGTAACATAGGATGTATTTAAAT	TTAGTACATTCCAAACCACAGTTATGAGGTAGAC
GTTGAACAGTAACATAGGATGTATTTAAAT	GACATATTTGGATTAACTGAAAGAAGAGTAAGACAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTATCATATAACCTTCTTTCCTTCTCCATCATATGT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATAAAATATCACCTTTACATAAATATATAGCTT
GTTGAACAGTAACATAGGATGTATTTAAAT	GTTGATAACAATAAAGATATGGCTATACAAATGTTAGT
GTTGAACAGTAACATAGGATGTATTTAAAT	CTTTTATATCTCCATAATGCATATGTCTAACTTTA
GTTGAACAGTAACATAGGATGTATTTAAAT	TAACAACCATTTCTTAAAACTAGATCTTCTTTTATT
GTTGAACAGTAACATAGGATGTATTTAAAT	CATTATAAATATTAAGCAAGAGTACCAGGAAGCATTG
GTTGAACAGTAACATAGGATGTATTTAAAT	TTGCATAACTCTCACTTATGTTTAACTTTCTGGCTA
GTTGAACAGTAACATAGGATGTATTTAAAT	TATTCTATTTTTATGCCTCTATCGCCTATGTATAAT
ATTGAACATTAACATAAGATGTATTTAAAT	AGCAAATCAAATAAATTACTTTGCTGAAACATATAA
GTTGAACATTAACATAAAATGTATTTAAAT	GTATTAGAACATAGAGCAAATAACCCTTCATGGGC
GTTGAACAATAACATAAGATGTATTTAATC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_11

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_11

2641937-2642420

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAATAACATAAGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
GTTGAACAATAACATAAGATGTATTTAAAT	CRT

7 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_11

>merge|NZ_CP027781|11|2641937-2642420|PILER-CR,CRISPRCasFinder,CRT
GTTGAACAATAACATAAGATGTATTTAAATGAGTTTAATATTTCAAAGAACTCATTAACAGTTAGTGTTGAACAATAACATAAGATGTATTTAAATTTATATAATATGGTATTAACGATGGTTCTATACCGTTGAACAATAACATAAGATGTATTTAAATATTATTTCAAATTTAAAATTAGATTCTTTTTTACGTTGAACAATAACATAAGATGTATTTAAATCATTCATCTTCTGCATAAGGTTCTATTATATCCTCGTTGAACAATAACATAAGATGTATTTAAATACAGATTGATGAGGTAAGAACTAAAACTATAGAAGTTGAACAATAACATAAGATGTATTTAAATCGAGTTAACACATCCTTTCCATTAGTCTTAAACTTGTTGAACAATAACATAAGATGTATTTAAATTTGCTAGGCAGTATTTACTATTATCAAGTAAATCTGTTGAACAATAACATAAGATGTATTTAAGCA

>NZ_CP027781|11|8|2641937-2642354|PILER-CR
GTTGAACAATAACATAAGATGTATTTAAAT	GAGTTTAATATTTCAAAGAACTCATTAACAGTTAGT
GTTGAACAATAACATAAGATGTATTTAAAT	TTATATAATATGGTATTAACGATGGTTCTATACC
GTTGAACAATAACATAAGATGTATTTAAAT	ATTATTTCAAATTTAAAATTAGATTCTTTTTTAC
GTTGAACAATAACATAAGATGTATTTAAAT	CATTCATCTTCTGCATAAGGTTCTATTATATCCTC
GTTGAACAATAACATAAGATGTATTTAAAT	ACAGATTGATGAGGTAAGAACTAAAACTATAGAA
GTTGAACAATAACATAAGATGTATTTAAAT	CGAGTTAACACATCCTTTCCATTAGTCTTAAACTT
GTTGAACAATAACATAAGATGTATTTAAAT

>NZ_CP027781|11|11|2641937-2642420|CRISPRCasFinder
GTTGAACAATAACATAAGATGTATTTAAAT	GAGTTTAATATTTCAAAGAACTCATTAACAGTTAGT
GTTGAACAATAACATAAGATGTATTTAAAT	TTATATAATATGGTATTAACGATGGTTCTATACC
GTTGAACAATAACATAAGATGTATTTAAAT	ATTATTTCAAATTTAAAATTAGATTCTTTTTTAC
GTTGAACAATAACATAAGATGTATTTAAAT	CATTCATCTTCTGCATAAGGTTCTATTATATCCTC
GTTGAACAATAACATAAGATGTATTTAAAT	ACAGATTGATGAGGTAAGAACTAAAACTATAGAA
GTTGAACAATAACATAAGATGTATTTAAAT	CGAGTTAACACATCCTTTCCATTAGTCTTAAACTT
GTTGAACAATAACATAAGATGTATTTAAAT	TTGCTAGGCAGTATTTACTATTATCAAGTAAATCT
GTTGAACAATAACATAAGATGTATTTAAGCA

>NZ_CP027781|11|9|2641937-2642419|CRT
GTTGAACAATAACATAAGATGTATTTAAAT	GAGTTTAATATTTCAAAGAACTCATTAACAGTTAGT
GTTGAACAATAACATAAGATGTATTTAAAT	TTATATAATATGGTATTAACGATGGTTCTATACC
GTTGAACAATAACATAAGATGTATTTAAAT	ATTATTTCAAATTTAAAATTAGATTCTTTTTTAC
GTTGAACAATAACATAAGATGTATTTAAAT	CATTCATCTTCTGCATAAGGTTCTATTATATCCTC
GTTGAACAATAACATAAGATGTATTTAAAT	ACAGATTGATGAGGTAAGAACTAAAACTATAGAA
GTTGAACAATAACATAAGATGTATTTAAAT	CGAGTTAACACATCCTTTCCATTAGTCTTAAACTT
GTTGAACAATAACATAAGATGTATTTAAAT	TTGCTAGGCAGTATTTACTATTATCAAGTAAATCT
GTTGAACAATAACATAAGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_10

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_10

2641062-2641685

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAGTAACATAGGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
GTTGAACAGTAACATAGGATGTATTTAAAT	CRT

9 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_10

>merge|NZ_CP027781|10|2641062-2641685|PILER-CR,CRISPRCasFinder,CRT
GTTGAACAGTAACATAGGATGTATTTAAATAAGATTAGTGCTAAAGCATCAGCACATTTTGCAGTGCTGTTGAACAGTAACATAGGATGTATTTAAATATGACTTTTTCAGTTTCTCCCCCATCAGGGTCTTCGTTGAACAGTAACATAGGATGTATTTAAATGAAGAACAAATAAAAGAATATAAAGAAAAAGTTAAGGTTGAACAGTAACATAGGATGTATTTAAATTCTATACAACATTATAAAGAAAAATATGGAGTTTGTTGAACAGTAACATAGGATGTATTTAAATAATTTTAATATTATTTCTTTATTATCCATTTTATGTTGAACAGTAACATAGGATGTATTTAAATTTTGTAACATTAAAACAATCTTTTGGTAGATATAAGTTGAACAGTAACATAGGATGTATTTAAATTCATAAGGAATAGCATTTTGTTTAAATATTATTTTCGTTGAACAGTAACATAGGATGTATTTAAATTTCGTACAATCTTTAGTAACTTCTTTAGTTTTATCTAGTTGAACAATAACATGAGATGTATTTAAATTCAAATTGTTTTTGGAGTCCCTTAATCATTTGTTTGAAGTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|10|7|2641062-2641549|PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	AAGATTAGTGCTAAAGCATCAGCACATTTTGCAGTGCT
GTTGAACAGTAACATAGGATGTATTTAAAT	ATGACTTTTTCAGTTTCTCCCCCATCAGGGTCTTC
GTTGAACAGTAACATAGGATGTATTTAAAT	GAAGAACAAATAAAAGAATATAAAGAAAAAGTTAAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TCTATACAACATTATAAAGAAAAATATGGAGTTT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATTTTAATATTATTTCTTTATTATCCATTTTAT
GTTGAACAGTAACATAGGATGTATTTAAAT	TTTGTAACATTAAAACAATCTTTTGGTAGATATAA
GTTGAACAGTAACATAGGATGTATTTAAAT	TCATAAGGAATAGCATTTTGTTTAAATATTATTTTC
GTTGAACAGTAACATAGGATGTATTTAAAT

>NZ_CP027781|10|10|2641062-2641685|CRISPRCasFinder
GTTGAACAGTAACATAGGATGTATTTAAAT	AAGATTAGTGCTAAAGCATCAGCACATTTTGCAGTGCT
GTTGAACAGTAACATAGGATGTATTTAAAT	ATGACTTTTTCAGTTTCTCCCCCATCAGGGTCTTC
GTTGAACAGTAACATAGGATGTATTTAAAT	GAAGAACAAATAAAAGAATATAAAGAAAAAGTTAAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TCTATACAACATTATAAAGAAAAATATGGAGTTT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATTTTAATATTATTTCTTTATTATCCATTTTAT
GTTGAACAGTAACATAGGATGTATTTAAAT	TTTGTAACATTAAAACAATCTTTTGGTAGATATAA
GTTGAACAGTAACATAGGATGTATTTAAAT	TCATAAGGAATAGCATTTTGTTTAAATATTATTTTC
GTTGAACAGTAACATAGGATGTATTTAAAT	TTCGTACAATCTTTAGTAACTTCTTTAGTTTTATCTA
GTTGAACAATAACATGAGATGTATTTAAAT	TCAAATTGTTTTTGGAGTCCCTTAATCATTTGTTTGAA
GTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|10|8|2641062-2641684|CRT
GTTGAACAGTAACATAGGATGTATTTAAAT	AAGATTAGTGCTAAAGCATCAGCACATTTTGCAGTGCT
GTTGAACAGTAACATAGGATGTATTTAAAT	ATGACTTTTTCAGTTTCTCCCCCATCAGGGTCTTC
GTTGAACAGTAACATAGGATGTATTTAAAT	GAAGAACAAATAAAAGAATATAAAGAAAAAGTTAAG
GTTGAACAGTAACATAGGATGTATTTAAAT	TCTATACAACATTATAAAGAAAAATATGGAGTTT
GTTGAACAGTAACATAGGATGTATTTAAAT	AATTTTAATATTATTTCTTTATTATCCATTTTAT
GTTGAACAGTAACATAGGATGTATTTAAAT	TTTGTAACATTAAAACAATCTTTTGGTAGATATAA
GTTGAACAGTAACATAGGATGTATTTAAAT	TCATAAGGAATAGCATTTTGTTTAAATATTATTTTC
GTTGAACAGTAACATAGGATGTATTTAAAT	TTCGTACAATCTTTAGTAACTTCTTTAGTTTTATCTA
GTTGAACAATAACATGAGATGTATTTAAAT	TCAAATTGTTTTTGGAGTCCCTTAATCATTTGTTTGAA
GTTGAACAATAACATGAGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_9

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_9

2640121-2640810

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAATAACATGAGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
GTTGAACAATAACATGAGATGTATTTAAAT	CRT

10 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_9

>merge|NZ_CP027781|9|2640121-2640810|PILER-CR,CRISPRCasFinder,CRT
GTTGAACAATAACATGAGATGTATTTAAATTTGCATTATTTAATTGTATAGCCATTTCTGTTATTGTGTTGAACAATAACATGAGATGTATTTAAATTAATCTGTTAAATCACTCCATACATATTTATTATGTTGAACAATAACATGAGATGTATTTAAATTTTAATCTAGGAGATATAATTACAGGAAATATAGAAGTTGAACAATAACATGAGATGTATTTAAATTTCAAAACTTGTATAAAGCCTTTACTTGTTAGTACCCGTTGAACAATAACATGAGATGTATTTAAATTAATATGTATATAATACTTAATTCAATATGTTTTCGTTGAACAATAACATGAGATGTATTTAAATAGGTAAGAGAGAGGTTAGTTGTGGATATGAGTGTGAGTTGAACAATAACATGAGATGTATTTAAATATATTTAAGTTTAATAGAGTAATAAGCTTACTTATTGTTGAACAATAACATGAGATGTATTTAAATGATTTCCTATTGGTAGTTGATGCAGGATCTACACATGTTGAACAATAACATGAGATGTATTTAAATTTTTTTATCATATCTTCTTCTAGCCCAGTACCGTTTGTTGAACAATAACATGAGATGTATTTAAATCCAAAATTTGATTCTTTCATATCATTTATATTGATAGTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|9|6|2640121-2640809|PILER-CR
GTTGAACAATAACATGAGATGTATTTAAAT	TTGCATTATTTAATTGTATAGCCATTTCTGTTATTGT
GTTGAACAATAACATGAGATGTATTTAAAT	TAATCTGTTAAATCACTCCATACATATTTATTAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTAATCTAGGAGATATAATTACAGGAAATATAGAA
GTTGAACAATAACATGAGATGTATTTAAAT	TTCAAAACTTGTATAAAGCCTTTACTTGTTAGTACCC
GTTGAACAATAACATGAGATGTATTTAAAT	TAATATGTATATAATACTTAATTCAATATGTTTTC
GTTGAACAATAACATGAGATGTATTTAAAT	AGGTAAGAGAGAGGTTAGTTGTGGATATGAGTGTGA
GTTGAACAATAACATGAGATGTATTTAAAT	ATATTTAAGTTTAATAGAGTAATAAGCTTACTTATT
GTTGAACAATAACATGAGATGTATTTAAAT	GATTTCCTATTGGTAGTTGATGCAGGATCTACACAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTTTTATCATATCTTCTTCTAGCCCAGTACCGTTT
GTTGAACAATAACATGAGATGTATTTAAAT	CCAAAATTTGATTCTTTCATATCATTTATATTGATA
GTTGAACAATAACATGAGATGTATTTAAGC

>NZ_CP027781|9|9|2640121-2640810|CRISPRCasFinder
GTTGAACAATAACATGAGATGTATTTAAAT	TTGCATTATTTAATTGTATAGCCATTTCTGTTATTGT
GTTGAACAATAACATGAGATGTATTTAAAT	TAATCTGTTAAATCACTCCATACATATTTATTAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTAATCTAGGAGATATAATTACAGGAAATATAGAA
GTTGAACAATAACATGAGATGTATTTAAAT	TTCAAAACTTGTATAAAGCCTTTACTTGTTAGTACCC
GTTGAACAATAACATGAGATGTATTTAAAT	TAATATGTATATAATACTTAATTCAATATGTTTTC
GTTGAACAATAACATGAGATGTATTTAAAT	AGGTAAGAGAGAGGTTAGTTGTGGATATGAGTGTGA
GTTGAACAATAACATGAGATGTATTTAAAT	ATATTTAAGTTTAATAGAGTAATAAGCTTACTTATT
GTTGAACAATAACATGAGATGTATTTAAAT	GATTTCCTATTGGTAGTTGATGCAGGATCTACACAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTTTTATCATATCTTCTTCTAGCCCAGTACCGTTT
GTTGAACAATAACATGAGATGTATTTAAAT	CCAAAATTTGATTCTTTCATATCATTTATATTGATA
GTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|9|7|2640121-2640809|CRT
GTTGAACAATAACATGAGATGTATTTAAAT	TTGCATTATTTAATTGTATAGCCATTTCTGTTATTGT
GTTGAACAATAACATGAGATGTATTTAAAT	TAATCTGTTAAATCACTCCATACATATTTATTAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTAATCTAGGAGATATAATTACAGGAAATATAGAA
GTTGAACAATAACATGAGATGTATTTAAAT	TTCAAAACTTGTATAAAGCCTTTACTTGTTAGTACCC
GTTGAACAATAACATGAGATGTATTTAAAT	TAATATGTATATAATACTTAATTCAATATGTTTTC
GTTGAACAATAACATGAGATGTATTTAAAT	AGGTAAGAGAGAGGTTAGTTGTGGATATGAGTGTGA
GTTGAACAATAACATGAGATGTATTTAAAT	ATATTTAAGTTTAATAGAGTAATAAGCTTACTTATT
GTTGAACAATAACATGAGATGTATTTAAAT	GATTTCCTATTGGTAGTTGATGCAGGATCTACACAT
GTTGAACAATAACATGAGATGTATTTAAAT	TTTTTTATCATATCTTCTTCTAGCCCAGTACCGTTT
GTTGAACAATAACATGAGATGTATTTAAAT	CCAAAATTTGATTCTTTCATATCATTTATATTGATA
GTTGAACAATAACATGAGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_12

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_12

2642701-2642957

TypeIII

III-B

Consensus_repeat	Method
GTTGAACAGTAACATAGGATGTATTTAAAT	CRISPRCasFinder
TAACATGAGATGTATTTAAATTTA	CRT

3 spacers

cmr6gr7,cmr5gr11,cmr4gr7,cmr3gr5,cas10,cas6

The CRISPR arrays of NZ_CP027781_12

>merge|NZ_CP027781|12|2642701-2642957|CRISPRCasFinder,CRT
GTTGAACATTAACATGAGATGTATTTAAATTTAGCATTGCTATCCCAGACTATTTTTTTTATTATAGTTGAACATTAACATGAGATGTATTTAAATCTATTTTATTTAAAAAGCCCACTTATTCATCTCCTCGTTGAACAATAACATGAGATGTATTTAAATTTATTTTTAGAACTATTGAAGGAATATATGAATGAAGTTGAACAATAACATGAGGAATATAAGCCGTTGAACAGTAACATGAGATGGATTTAAAT

>NZ_CP027781|12|12|2642701-2642957|CRISPRCasFinder
GTTGAACATTAACATGAGATGTATTTAAAT	TTAGCATTGCTATCCCAGACTATTTTTTTTATTATA
GTTGAACATTAACATGAGATGTATTTAAAT	CTATTTTATTTAAAAAGCCCACTTATTCATCTCCTC
GTTGAACAATAACATGAGATGTATTTAAAT	TTATTTTTAGAACTATTGAAGGAATATATGAATGAAGTTGAACAATAACATGAGGAATATAAGCC
GTTGAACAGTAACATGAGATGGATTTAAAT

>NZ_CP027781|12|10|2642710-2642931|CRT
TAACATGAGATGTATTTAAATTTA	GCATTGCTATCCCAGACTATTTTTTTTATTATAGTTGAACAT
TAACATGAGATGTATTTAAATCTA	TTTTATTTAAAAAGCCCACTTATTCATCTCCTCGTTGAACAA
TAACATGAGATGTATTTAAATTTA	TTTTTAGAACTATTGAAGGAATATATGAATGAAGTTGAACAA
TAACATGAGGAATATAAGCCGTTG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|133378
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	cmr5gr11	mkCas0098_cmr5gr11_CAS-III-B	gnl\|CDD\|187880
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	cmr6gr7	cd09661_cmr6gr7_CAS-III-B	gnl\|CDD\|187792
NZ_CP027781.1\|WP_106900608.1\|2634498_2634639_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900607.1\|2634122_2634461_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	cmr4gr7	cd09682_cmr4gr7_CAS-III-B	gnl\|CDD\|274210
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	cmr3gr5	pfam09700_cmr3gr5_CAS-III-B	gnl\|CDD\|273855
NZ_CP027781.1\|WP_106900609.1\|2634652_2634946_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	cas10	cd09679_cas10_CAS-III	gnl\|CDD\|187810
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900610.1\|2634994_2635792_+\|MerR-family-transcriptional-regulator	gnl\|CDD\|133378	cd00592, HTH_MerR-like, Helix-Turn-Helix DNA binding domain of MerR-like transcription regulators. Helix-turn-helix (HTH) MerR-like transcription regulator, N-terminal domain. The MerR family transcription regulators have been shown to mediate responses to stress including exposure to heavy metals, drugs, or oxygen radicals in eubacterial and some archaeal species. They regulate transcription of multidrug/metal ion transporter genes and oxidative stress regulons by reconfiguring the spacer between the -35 and -10 promoter elements. A typical MerR regulator is comprised of two distinct domains that harbor the regulatory (effector-binding) site and the active (DNA-binding) site. Their N-terminal domains are homologous and contain a DNA-binding winged HTH motif, while the C-terminal domains are often dissimilar and bind specific coactivator molecules such as metal ions, drugs, and organic substrates.	4.37823e-15
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_033065792.1\|2632777_2633212_+\|hypothetical-protein	gnl\|CDD\|187880	cd09749, Cmr5_III-B, CRISPR/Cas system-associated protein Cmr5. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Small alpha-helical protein; signature gene for subtype III-B.	1.40499e-07
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900606.1\|2633223_2634111_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr6	gnl\|CDD\|187792	cd09661, Cmr6_III-B, CRISPR/Cas system-associated RAMP superfamily protein Cmr6. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; RAMP superfamily protein; This protein is a subunit of Cmr complex.	4.10891e-28
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900605.1\|2631910_2632750_+\|type-III-B-CRISPR-module-RAMP-protein-Cmr4	gnl\|CDD\|274210	TIGR02580, putative_CRISPR-associated_protein, CRISPR type III-B/RAMP module RAMP protein Cmr4. This model represents a CRISPR-associated protein from the family that includes TM1792 of Thermotoga maritima. This family is part of the broad RAMP superfamily (pfam03787) collection of CRISPR-associated proteins. It is the fourth of a recurring set of six proteins, four of are in the RAMP superfamily, that we designate the CRISPR RAMP module.	4.08554e-48
NZ_CP027781.1\|WP_106900604.1\|2630699_2631899_+\|CRISPR-associated-protein-Cmr3	gnl\|CDD\|273855	TIGR01888, Hypothetical_protein_SSO1730, CRISPR type III-B/RAMP module-associated protein Cmr3. CRISPR is a term for Clustered Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR associated) proteins. This highly divergent family is found in at least ten different archaeal and bacterial species as part of the CRISPR RAMP modulue but is not a member of the RAMP superfamily itself. A typical example is TM1793 from Thermotoga maritima.	2.16008e-11
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900603.1\|2628970_2630683_+\|type-III-B-CRISPR-associated-protein-Cas10/Cmr2	gnl\|CDD\|187810	cd09679, Cas10_III, CRISPR/Cas system-associated protein Cas10. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Multidomain protein with permuted HD nuclease domain, palm domain and Zn-ribbon; MTH326-like has inactivated polymerase catalytic domain; alr1562 and slr7011 - predicted only on the basis of size, presence of HD domain, and location with RAMPs in one operon; signature gene for type III; also known as Crm2 family.	5.39784e-33

>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900610.1|2634994_2635792_+|MerR-family-transcriptional-regulator
MRYSITDLAEILGCTTSAIHYFEKEHLIEVEKGKNGHRYYNVVDVFRLLSYTKYRSMEIPMKTIIAQFGGEENNYKLIEEREAMYQLEALKRAQYYMNLADAIGEHLVSIRRIEELLNKYEFAKSPEVTIMCDDECGWLSKKRSSQRMIHEWVKAMPTVQLGVFDSRMGISNFGYLVKTKKREELELPLGLHTKQLKSTSCIHTIVMADEDFTQHPQKVFKKASEFVIKKGLEIGEIAWGKILLVEVEKGAKLHPYIELWISIKI
>NZ_CP027781.1|WP_106900609.1|2634652_2634946_+|hypothetical-protein
MNFFTLNILIGAMAFIINKINNMSQDIDPFGAFNDIEENLEEIDNEKVTNFVNGLINASMSNPSIGYFFMFLGYMTPILNLLLLIKGIVNYFNRAAG
>NZ_CP027781.1|WP_106900608.1|2634498_2634639_+|hypothetical-protein
MLRIGFCHVFTRIKVFRDFYLICYKVHILYNHLDGFRYIINIKGYT
>NZ_CP027781.1|WP_106900607.1|2634122_2634461_+|hypothetical-protein
MDINSITNSLFIGMKIEKPKKETEIIKITDDGFWYRIGEKNKKKVTYDEIEEAIKEIKEKGMLTRQWYKEKFPQISKNNPCNFTTIGGVLVKFKLAEYTMGKYLYKNEIIYK
>NZ_CP027781.1|WP_106900606.1|2633223_2634111_+|type-III-B-CRISPR-module-RAMP-protein-Cmr6
MIGNIGYLYYKEYFKDEYINECKIQSKKYDEKNNPLIKINQKILDNSNIDILKNNKFIKEIQDKLYKKRIYFKTTYPGLIVGTGYSHILKEQEEFKLSLEFDYTTGLPVINGSSIKGMLRSVFYNKKDDEKLIEEKEKYIRDILKELIKKENPKFNGEFNFEELTNNIFEGKCKSKDKNGIHMSISERDIFLGATIDIEATIEEMKRTKQEKNNLLGEDYVTPHGEGKDELKNPNPIKFLKVMPNVVWCFGFDLKDFNKDISADIKKKLFKQILLDLGIGAKTNVGYGRLEFISY
>NZ_CP027781.1|WP_033065792.1|2632777_2633212_+|hypothetical-protein
MNKREIEKQIPIAIDLIDEFMKKKKFLKKDDKEDDKKLKGIPKEYKGYISNFGASIIQSGLLSTVAFFEANDSKSKSDKQVLMELILKVVDIYNEKQLEWKNNSPFLHYILENNNKQTEEEVINAAIAVKLAMRVFKFTENSES
>NZ_CP027781.1|WP_106900605.1|2631910_2632750_+|type-III-B-CRISPR-module-RAMP-protein-Cmr4
MDNFKIYTIRCLTNMHVGSGDASYTLIDNQVQRDVITGFPTINSSSLKGSLRSFLDPKKEKSKAIKYIFGDKEDGMGNYKIFPGMLLSMPVRSNVKPFFRATCPRIIKDFLGFIENFQPQTSDIKNIKTLEEDLKNIEKVADKNKNTIFILKNFNRDIDVKFDNNQKIEGIKITSEREISLKGEERIKEIFGESLILIDDNSFNDIVDRLPVIARNKLDNGESENLWYEEVVPRETRFYFGTILGKEHQSEFGKIEGKQPVQIGGNATIGYGYCDIKSI
>NZ_CP027781.1|WP_106900604.1|2630699_2631899_+|CRISPR-associated-protein-Cmr3
MSKYLVKLKPVDSFFFGGEKVFDFYDGKKPLKNNIVKSREFPQQTSILGMIRKEILVLNSCIREKWDYSKDQQKENNKLIGERSFNITDKNEDFGIINSISPVFIIEETKVSDKFLIKIPKDHNVNDGLNKYNPFKFNNDKGNCLKVKTNLVKEVYLPIDFEAKKGLSEDFIDIKTGDIVSKNKVFIRDCSIGIKLDENHKTKDNSLFRLEKYKFEYDNRYERADKCFAFILDVEEEKGKITFENYKNIITLGGEGSHFFISFEKVNFDIKEKIDFINKEKNSFTIKERVRVSTNKEEIKETKLIYKIILLSDTYISKDIYEKNCNYSISTKIDFRNLCSDNYCKNIDEYHYKRLKKSDSKYSLLEKGSVLFASKENYDRLIKNINNSKFQKIGYNIFI
>NZ_CP027781.1|WP_106900603.1|2628970_2630683_+|type-III-B-CRISPR-associated-protein-Cas10/Cmr2
MTKNKKSYIGLTIGPIVETIGNAKQTGELWASSYLFSYIMKNIIKTLIVKDREVNKDREQNEKLENRFILPCIDDILNKLSKNEMEQKSIQKIENNTDKAEQEVGLFHDRFIFQSENGEFDLVKESINEVIDGIVTGIENHDVCKDKSREEIKSDIEDFLKIYYLEIDIDLNQEEKENKLSSENNIIFKVNRALDALELREKILGNNGVENNYILQTLNNKQLKEQDFKKHFLSKDAYGENGKDGDYPSLFKIALDETYNNEFPNEDEKIKEELKQMGERKRLKANEYVAIIQADGDSMGRVIEKFKIHNDRENIYVDYKDFSSKLLEYDKNSHEKIKKYGGFTIYAGGDDLLFIAPVITKNKNNIFQLIDVLSGLFDNEFKHEEEKPTTSFGIAIVHHKFPLYYALDEARDLLFNKAKNYKFNGEEKNAIAFKVIKSSGQSFETVVGKKSESYKQFKELFGNVSNSLNGKDRKIKNYLKAIHFKLKRDKVILNKIGKNEELLENYFKNNFDEKFHENGDIKKYINYLIKFIYLIYGEIKTDEDKNKCIEQIYTYLRFIKFMDEDINLDN
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_13

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_13

2652296-2653031

TypeI-B

III-B

Consensus_repeat	Method
GTTGAACATTAACATGAGATGTATTTAAAT	CRISPRCasFinder
GTTGAACATTAACATGAGATGTATTTAAAT	CRT

11 spacers

cas6,cas8b1,cas7b,cas5,cas3,cas4,cas1,cas2

The CRISPR arrays of NZ_CP027781_13

>merge|NZ_CP027781|13|2652296-2653031|CRISPRCasFinder,CRT
GTTGAACATTAACATGAGATGTATTTAAATAAGTCTATTAAATAATCATCAATAGTCCTTAACTGGGTTGAACATTAACATGAGATGTATTTAAATAAGAACAAAGGTTGTTCCAGAAATAGACGCAATTAGGTTGAACATTAACATGAGATGTATTTAAATACTTGCTGAAGAACTTGAAATAAGTAAAGGAAGTGTTGAACATTAACATGAGATGTATTTAAATGCTTTACATTCTCCATATTTAAAAGGGCCTTTAGTTGAACATTAACATGAGATGTATTTAAATGCAACCACCCGAAAAAACTTTTCAATATAGATATTGTTGAACATTAACATGAGATGTATTTAAATTTGAATATGGTTGGTACGGTCCTCTACCTCTTTTAGATGTTGAACATTAACATGAGATGTATTTAAATAAAAGAAGGGAAACCAGTTATAGACAAGATATTGAGTTGAACATTAACATGAGATGTATTTAAATAGTAATACCAAATCTTAAACATGATATGGATAGTAGTTGAACATTAACATGAGATGTATTTAAATATATTAGCTAACGTGCTTTCACTCAACCATAATTTAGTTGAACATTAACATGAGATGTATTTAAATCACAAAAATATTTGACATTCACTGGGAAAGGTGATATGTTAAATATTAACATGAGATGTATTTAAAGATTATTACGTTTATTATTAAATTTGAACCTTAACATAAGATGTAAATACTG

>NZ_CP027781|13|13|2652296-2653031|CRISPRCasFinder
GTTGAACATTAACATGAGATGTATTTAAAT	AAGTCTATTAAATAATCATCAATAGTCCTTAACTGG
GTTGAACATTAACATGAGATGTATTTAAAT	AAGAACAAAGGTTGTTCCAGAAATAGACGCAATTAG
GTTGAACATTAACATGAGATGTATTTAAAT	ACTTGCTGAAGAACTTGAAATAAGTAAAGGAAGT
GTTGAACATTAACATGAGATGTATTTAAAT	GCTTTACATTCTCCATATTTAAAAGGGCCTTTA
GTTGAACATTAACATGAGATGTATTTAAAT	GCAACCACCCGAAAAAACTTTTCAATATAGATATT
GTTGAACATTAACATGAGATGTATTTAAAT	TTGAATATGGTTGGTACGGTCCTCTACCTCTTTTAGAT
GTTGAACATTAACATGAGATGTATTTAAAT	AAAAGAAGGGAAACCAGTTATAGACAAGATATTGA
GTTGAACATTAACATGAGATGTATTTAAAT	AGTAATACCAAATCTTAAACATGATATGGATAGTA
GTTGAACATTAACATGAGATGTATTTAAAT	ATATTAGCTAACGTGCTTTCACTCAACCATAATTTA
GTTGAACATTAACATGAGATGTATTTAAAT	CACAAAAATATTTGACATTCACTGGGAAAGGTGATAT
GTTAAATATTAACATGAGATGTATTTAAAG	ATTATTACGTTTATTATTAAA
TTTGAACCTTAACATAAGATGTAAATACTG

>NZ_CP027781|13|11|2652296-2653031|CRT
GTTGAACATTAACATGAGATGTATTTAAAT	AAGTCTATTAAATAATCATCAATAGTCCTTAACTGG
GTTGAACATTAACATGAGATGTATTTAAAT	AAGAACAAAGGTTGTTCCAGAAATAGACGCAATTAG
GTTGAACATTAACATGAGATGTATTTAAAT	ACTTGCTGAAGAACTTGAAATAAGTAAAGGAAGT
GTTGAACATTAACATGAGATGTATTTAAAT	GCTTTACATTCTCCATATTTAAAAGGGCCTTTA
GTTGAACATTAACATGAGATGTATTTAAAT	GCAACCACCCGAAAAAACTTTTCAATATAGATATT
GTTGAACATTAACATGAGATGTATTTAAAT	TTGAATATGGTTGGTACGGTCCTCTACCTCTTTTAGAT
GTTGAACATTAACATGAGATGTATTTAAAT	AAAAGAAGGGAAACCAGTTATAGACAAGATATTGA
GTTGAACATTAACATGAGATGTATTTAAAT	AGTAATACCAAATCTTAAACATGATATGGATAGTA
GTTGAACATTAACATGAGATGTATTTAAAT	ATATTAGCTAACGTGCTTTCACTCAACCATAATTTA
GTTGAACATTAACATGAGATGTATTTAAAT	CACAAAAATATTTGACATTCACTGGGAAAGGTGATAT
GTTAAATATTAACATGAGATGTATTTAAAG	ATTATTACGTTTATTATTAAA
TTTGAACCTTAACATAAGATGTAAATACTG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225117
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	cas1	cd09722_cas1_CAS-I-B	gnl\|CDD\|187853
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	unknown	unknown	gnl\|CDD\|172889
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	unknown	unknown	gnl\|CDD\|379767
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	cas2	cd09725_cas2_CAS-I:CAS-II:CAS-III:CAS-V	gnl\|CDD\|187856
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	unknown	unknown	gnl\|CDD\|227595
NZ_CP027781.1\|WP_106900612.1\|2643454_2643700_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	cas4	pfam01930_cas4_CAS-I	gnl\|CDD\|366863
NZ_CP027781.1\|WP_045886184.1\|2644589_2644823_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|379312
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	cas3	cd09639_cas3_CAS-I	gnl\|CDD\|187770
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|340904
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	cas7b	pfam05107_cas7b_CAS-I-B:CAS-I-C	gnl\|CDD\|377458
NZ_CP027781.1\|WP_106900613.1\|2643902_2644586_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	cas5	cls001430_cas5_CAS-I-B	gnl\|CDD\|131641
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	unknown	unknown	gnl\|CDD\|239241
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	cas8b1	mkCas0106_cas8b1_CAS-I-B	gnl\|CDD\|188234

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900615.1\|2646717_2647608_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|225117	COG2207, AraC, AraC-type DNA-binding domain-containing proteins [Transcription].	1.14231e-28
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|187853	cd09722, Cas1_I-B, CRISPR/Cas system-associated protein Cas1. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas1 is the most universal CRISPR system protein thought to be involved in spacer integration; Cas1 is metal-dependent deoxyribonuclease, also binds RNA; Shown to possess a unique fold consisting of a N-terminal beta-strand domain and a C-terminal alpha-helical domain.	1.80703e-158
NZ_CP027781.1\|WP_106900614.1\|2645895_2646417_-\|DUF4825-domain-containing-protein	gnl\|CDD\|379767	pfam16107, DUF4825, Domain of unknown function (DUF4825). This domain forms the N-terminal, extracellular domain of some homologs of Staph BlaR1 proteases, where it replaces the penicillin-binding domain of BlaR1. It is also found in many uncharacterized proteins in a broad range of bacteria. Its association with BlaR1 homologs suggests it may be involved in substrate-, possibly antibiotic-binding, but this prediction has not been verified experimentally.	5.61855e-26
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|187856	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas2 is present in majority of CRISPR/Cas systems along with Cas1; RNAse specific to U-rich regions; Possesses an RRM/ferredoxin fold.	4.43432e-25
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	gnl\|CDD\|227595	COG5270, COG5270, PUA domain (predicted RNA-binding domain) [Translation, ribosomal structure and biogenesis].	0.00376455
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	gnl\|CDD\|366863	pfam01930, Cas_Cas4, Domain of unknown function DUF83. This domain has no known function. The domain contains three conserved cysteines at its C-terminus.	6.70868e-57
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	gnl\|CDD\|172889	PRK14413, PRK14413, glycerol-3-phosphate acyltransferase.	1.14663e-93
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	gnl\|CDD\|131641	TIGR02592, hypothetical_protein_CTC_01466, CRISPR-associated protein Cas5, subtype I-B/HMARI. This is a CRISPR-associated protein unique to the hmari subtype of cas genes and CRISPR repeat, which is the only subtype present in Haloarcula marismortui ATCC 43049. The hmari type, though uncommon, is also found in the Aquificae, Thermotogae, Firmicutes, and Dictyoglomi.	9.42806e-61
NZ_CP027781.1\|WP_106900616.1\|2647614_2648355_+\|SAM-dependent-methyltransferase	gnl\|CDD\|379312	pfam13649, Methyltransf_25, Methyltransferase domain. This family appears to be a methyltransferase domain.	6.25558e-12
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	gnl\|CDD\|187770	cd09639, Cas3_I, CRISPR/Cas system-associated protein Cas3. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; DEAD/DEAH box helicase DNA helicase cas3'; Often but not always is fused to HD nuclease domain; signature gene for Type I.	1.30528e-27
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900617.1\|2648458_2649865_-\|MFS-transporter	gnl\|CDD\|340904	cd17346, MFS_DtpA_like, Dipeptide and tripeptide permease A (DtpA)-like subfamily of the Major Facilitator Superfamily of transporters. The DtpA-like subfamily includes four Escherichia coli proteins: dipeptide and tripeptide permeases A (DtpA, TppB or YdgR), B (DtpB or YhiP), C (DtpC or YjdL), and D (DtpD or YbgH). They are proton-dependent permeases that transport di- and tripeptides. DtpA and DtpB display a preference for di- and tripeptides composed of L-amino acids. DtpC shows higher specificity for dipeptides compared to tripeptides, and prefers dipeptides containing a C-terminal lysine residue. The DtpA-like subfamily belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	7.19844e-120
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	gnl\|CDD\|377458	pfam05107, Cas_Cas7, CRISPR-associated protein Cas7. CRISPR-associated protein Cas7 is one of the components of the type I-B cascade-like antiviral defense complex. In Haloferax volcanii, Cas5, Cas6 and Cas7 form a small complex that aids the stability of CRISPR-derived RNA.	1.14927e-46
NZ_CP027781.1\|WP_106900611.1\|2635888_2637886_+\|2-enoate-reductase	gnl\|CDD\|239241	cd02931, ER_like_FMN, Enoate reductase (ER)-like FMN-binding domain. Enoate reductase catalyzes the NADH-dependent reduction of carbon-carbon double bonds of several molecules, including nonactivated 2-enoates, alpha,beta-unsaturated aldehydes, cyclic ketones, and methylketones. ERs are similar to 2,4-dienoyl-CoA reductase from E. coli and to the old yellow enzyme from Saccharomyces cerevisiae.	0
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	gnl\|CDD\|188234	TIGR02591, cas_Csh1, CRISPR-associated protein Cas8b/Csh1, subtype I-B/HMARI. This domain is found in the C-terminal 2/3 of a family of CRISPR associated proteins of the Hmari subtype. Except for the two sequences from halophilic archaea this domain contains a pair of CXXC motifs.	3.80423e-36

>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900617.1|2648458_2649865_-|MFS-transporter
MSEKKQKHPIGLWLVNISIALQSYAAYAVVSILILFLTADVSKNGLGLSVPKAAAIIGLYQGINYMGSLVGGYITDKWLGIQKSLILGCFLTACGYLALFFAKPNIGSVWLGLIILIVAGAFFKAQISSLVGELYGKNELSKKDAAYSIFYMFINIGAFFGPIIAGLISDKWFAKVAADGEIAAYGYKYIFLMCTLIMIFIGIFIWIVSPKWLGEIGKYPVSKDKKTSTESVSTKSTEKANSQPLTQLEKNRIKAMIVMFVFVIIFWSAWDQTATSFSLLANKLVNRTIGGFTMPVPWLTSINAIFCVVLSPIIANIWLKLGNSKKGDLSVPTKMGLGMILTGIAFLTLILGISTLGGVLDGSKQMNILFIIVAYFLLTVGELCLSPIGMAMFNKLAPAKYGSLAMGAWYLSFFFSSIISGKLAGFTDTLGYTQIFGLISGIVIVFGVILILLRNGLLKLMSLDELDK
>NZ_CP027781.1|WP_106900616.1|2647614_2648355_+|SAM-dependent-methyltransferase
MINYYGSLCTTMYELLHPHAPEDELRFYLQYARKEMKILEPLCGSGRFLVPFLERGFNITGFDMSEEMLKELYKKAPKAKVFESSIEKFSPKEKYDYIFITSGSFSLFLDEDIAFNVLVKMKEALAPKGKFVFAAETTANIIPDREEYLENCHVKTKEGYDIIFKSKSFYDKHKKILSTPSLYELYDGDKLLGKEEMDFRIKLYDSGELDKLILKAGFKGSYVFSDFKKSKPVDRNSETFLYECYI
>NZ_CP027781.1|WP_106900615.1|2646717_2647608_+|AraC-family-transcriptional-regulator
MNYRKDIENCIDYIEEHIKEPLTLKEITQEIGYSSYHFCRVFSFLKGMPLMEYVRKRKLSLSTIDLLEGEKIIDVALKWGFETPSSFARAFRKEFGCSPTQYIKKMKSYYKSENNLILGKFMNDPYIVKKHGFKVAGYGIKTNVADSKYTKDVASFWSNYNGENLESKLYKILSPLKHGEVGLCIPCSDSGDITYLLGVIVEDFSKVTSDMITVEVPKAQYAVFTTNPVNTVDSKDQREFAKIIKESWKYIFDEWFKNNDYEYDEEKLDFEFYDERCHLRPDTVMDIYVPIKKLER
>NZ_CP027781.1|WP_106900614.1|2645895_2646417_-|DUF4825-domain-containing-protein
MKNKFKVLVPLVLILSLNLVGCRINSEKKSKGNIKNSSKVETYDLIKYKGTYVGDNSSVGSIIKNLPANKYSAGFSLQTSKEPYEITVNYKANENLGEENYNKFWSDKKANKLLEKNAVVLLSLIPNAEIIKFNVDNIGEESYKYDRKNLEQKYGNLKNLFKDNDSLNKFLNN
>NZ_CP027781.1|WP_045886184.1|2644589_2644823_+|hypothetical-protein
MGGTMKKLVLSKWVLLYPDSLSCIFDESKKKVVFLTREYDEIHLVVEVVSEKLVFQPRWNVVITELDKFKYEIKTNS
>NZ_CP027781.1|WP_106900613.1|2643902_2644586_+|hypothetical-protein
MKNKLKITAVTLALVMGLSIVTPGVTVFASELKQESQTSLWDIEEETNTNYDEKEVQAVIQITDTDLIINGKVYNSDKLESLLETAQEVDQASNGGRQKRFAAAAGVYFIPGVGQVALAATGAIVLGGVTIGASHWAYKTIKNWLNNPQNSVSRAYGIPKSLLDKNGNVKLGNFNQKVGGRSAWKDPKTGYIKEKDTAGHAGKKWKIKDKKGARKASTDGNGKIISK
>NZ_CP027781.1|WP_106900612.1|2643454_2643700_+|hypothetical-protein
MVDKSNKILKELSIKLDRVYKDHIERIRKEIEKKIKSLNELQKWVQNRCESYYNRKTIIDYLIYINLAVTPILFFIRFRFQ
>NZ_CP027781.1|WP_106900611.1|2635888_2637886_+|2-enoate-reductase
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNERGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGAKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPGEEFEEKGRDIPEGIEAAKMLVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKNAVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVAAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALVKWYEGILKDLGVEIKLNVGASKENIKEFEADEVLIATGSNPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIGGGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLIDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSQKDLYNEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM
>NZ_CP027781.1|WP_106900621.1|2654367_2656116_+|type-I-B-CRISPR-associated-protein-Cas8b/Csh1
MLKDAIDTFKSIYEKKGESFITDSYIPADGDYVIVESYENTFRELDIVKIKQDKKTKEIDRSSEYFKFICNADYLSKLIDMNKPIDGKKIIHSNNYLSFFVKKENVNNGKLNDEVIDSYYEILKTPEIKYSKEKLRLYKEIEDKHGKVNEDLIENIKMWIKDNIKNYANEDSKDKSYLKIFFKYDIEEYKKENEKYLIPNIFNSVEFNVKIGEETYGLPNDNMGLNSKKPYLENKSRKTKVPYLISLEEVLLQKKFFDYLLNQVSIGKTNIYIDKKGIYTKSDKESMDNDFSGIYFRIKKGKEVEIHDFDTINHYKANINPIKLKNVINIDLNKSDLTYNINITKISTIKDLINKVFFSKFLSSNYFTESKDMNINDNNLKRNILLSRRTLFNWFYKGNEFTVWKVFGHSSLSLIKGSIENGYIFKAGEQFNLRCALKEYFVGGESMADVLLGVKASLRDKISQKDTASIDNDKEYYFAVGQVASYLISLSKAAKKTHSLANPIINAKSDDRIKAELKKLFKKYNYTMDRRISRRFDNLMYMVSAYIPDLEEKVNDDLIIAGYLHSSLIYEKSSKEENKNEQ
>NZ_CP027781.1|WP_106900622.1|2656105_2657065_+|CRISPR-associated-protein
MNSRVYGVLGIVSRMSNWNADFTGYPKTTSTGDTFGSDKAFKYPIKKMWSDQGEKVIYIKSMKLQEGKKGEIEFIPRSLKERYEYLFKGEDLKKDKDSKKVLTNLFSAIDVKNFGATFAEEGNNISITGAVQIGQGFNKYSDSFPEEQQILSPFRDPNNKKNNKKEEEEKEAKSSTLGTKIVSNEAHYFYPVTINPKSYDGFKELGVTEGYTEEDYKKFKKASMIAATSFSTNAKIGCENEFAMFVETDEDLYLPDLSQYVLFEKCDDKGKIKIECNNLFKDLESRIKSIEIYYNPYTTNIDKNIDNAKYFNIFTKEEI
>NZ_CP027781.1|WP_106900623.1|2657067_2657811_+|type-I-B-CRISPR-associated-protein-Cas5
MDVLKFNLKGRTAFFKKPDVNTYFYFTYGNIHKVALLGILGSILGLKGYNDQNENDKYPEFYEKLKGLRIGIVPMNKEGYIPKKIQTFNNSVGYASKEQGGNLIIKEQWLEDPKWDIYILLQGDIEDQLKDNILDRNFKFIPYLGKNDHIATIENIEIIKDSKKTDNVKKIDSLYAKDYFSFRNSKYDFDEEDDLEDTWKYEEMLPMSLEENTNKYNLKSFVYTNSLVDSSSYESIYECNNKNIFFF
>NZ_CP027781.1|WP_106900624.1|2658010_2660599_+|CRISPR-associated-helicase/endonuclease-Cas3
MYFIDVEKFPIDKFVKNHSNIYAHKSEDNSRFEILKEHLELSEEYLYKVIKAKNLDNVLMNFQNYLFEENCSKGIKIFKEMIFNIIYMHDMGKINCCFQYKKMDNELFKEQDGITFNYSNHSMLSSLIYINYYFKRIKELKNVTSDIKDKLRFFMMINSYIISRHHSHLDSFNEYKNKFLEEDGEGKRLYFEQLCIFKSSYDDDIVFEKKPKLMKKLFELTEDYLNNELISSKKKIYLYIYERFFASLLLGCDYYSTSQFMNNCKLNYFGEITDINKFYDGLKKTEIYNKIRDYEKERYLKYDNFNDVKDINILRNEMFLDAEKMLEENIESNIYYLEAPTGSGKSTVALNLSFKLIEQDKNLNKIFNVYPFNTLVEQNIASLNKIFDYDKELLDEIAVINSLVPIKEVKKKEIEDEENEEVNYDKSLLNRQFLNYPIVLNTHVSMFNYLFGTAKDDLFPLIQLANSVIVLDEIQSYKNNIWKEIIMFLNCYAEILNIRIIIMSATLPNLNKLIDYDDFNTINLIKNRDKYFKNPLFKDRVSIDFSLLGKGDNTYEALKEHVLNTSKNTEDNILIEFINKKRALEFHNDLVMELSDKKKVLLITGDDNSIERNDIIKRVKDENNIVLVATQVIEAGVDIDMDIGYKDISMLDSDEQFLGRINRSCKKPKSTVYFFDLDSASSIYRGDYRKEKNVTLKSNNIRDILIKKDFQKYYDLILKRINDESSSHNENNTEDFINERIGELDFLEVEKKMRLIDDDKDEITVFLCRNIALENGQDLEGKKVWEDYKELLKDGELKYAKKRVKLSKAASNLNYFIYKVKSRDFPYNDRLGEIYCIYEGENYFTNGKFDRKNFTTGACNFI
>NZ_CP027781.1|WP_106900625.1|2660752_2661244_+|CRISPR-associated-protein-Cas4
MKVNGTLINYYFHCKRQCWLHGNRINLEDNSKDVKIGKAIHEVKSEKSKQTEISIDNIKIDKLTKDYLTEIKKSDADIEAAKWQVLLYLKVLKDKGIERKGKLQFIEKNKSKNTIIIELDKENLEELNKIIKNIKNLLLEENPPEIINEPKCKKCAYFEYCYI
>NZ_CP027781.1|WP_106900626.1|2661253_2662252_+|type-I-B-CRISPR-associated-endonuclease-Cas1
MGSTRYITSIGELKRKDNSLCFRKNNKNVYIPVENTKEIYCMSEVSINSKLLDFLSQNNIVMHFFNYYEGYSGTFYPKKHYNSGKLIVKQVEAYKDKRLMVAKSIVSAIGENIYELLYHYYRHDRTEVKGTLEWIKNDMKINLEKANNIKEIMQVEGETWYRFYGEFKNILPEDFVMNKRVKRPPDNPINALISFGNTLLYGKTITAIYNTHLDQRISFLHEPSEGRFSLSLDISEAFKPVIVFKTIFDLVNNKKIQVSKHFDKKLNYCLLNEEGRKIFITAFEEKLESVFIHKKLKRRVTYKNAIKLDCYKMIKFILEDKEFKPFSLKEKM
>NZ_CP027781.1|WP_106900627.1|2662252_2662543_+|CRISPR-associated-endonuclease-Cas2
MGKGFNYNYAFVFYDVNEKRVNRVFKVCKKYLSHFQKSVFRGEITPANLILLKKDLNREIDECEDFVCIIKLMNNNVYGEEILGNKGITTGEDLIL
>NZ_CP027781.1|WP_106900628.1|2666563_2667052_-|50S-ribosomal-protein-L7ae
MISKKIIAFIAMTIMMISLLIGCSNNTMDKVYNDNSKIASVYDTFGLDKSDEIIESGIYKGKLKLSGSGTIWTYESSSDFDLKVPYILSVKSGKAKIVLISPDNTVVNLVENTDKATMKGTTSLTLPIKKGNNRIKLVGYKKADIDIELHIEKGTFKKIGFN
>NZ_CP027781.1|WP_106900629.1|2667879_2668473_+|glycerol-3-phosphate-acyltransferase
MIIIITSVISFLLGSIPTGYFITKKTCGIDIRTKGSGNIGSTNVKRIVGTKISIITQTIDVLKGIIPVVLGIYLSKIIKLPVSIDTYLSIIAIAGILGHDYTPFLKFKGGKGVNTTLGVFIFIAPIPTLTGLAVYFILGLFTSIVSIRSIAIGITIPIMCIITKLPIQIIISTTIAGILMVFRHKDNLVRIMRKEEK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_14

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_14

2662736-2662832

TypeI-B

III-B

Consensus_repeat	Method
GTTGAACAGTAACATAAGATGTATTTAAAT	CRISPRCasFinder

1 spacers

cas2,cas1,cas4,cas3,cas5,cas7b,cas8b1,cas6

The CRISPR arrays of NZ_CP027781_14

>merge|NZ_CP027781|14|2662736-2662832|CRISPRCasFinder
ATTGAACATTAACATGAGATGTATTTAAATAATCATGTATTCAACACGATTAGAGGTTGGCGATAAATTGAACATTAACATGAGATGTATTTAAGCA

>NZ_CP027781|14|14|2662736-2662832|CRISPRCasFinder
ATTGAACATTAACATGAGATGTATTTAAAT	AATCATGTATTCAACACGATTAGAGGTTGGCGATAA
ATTGAACATTAACATGAGATGTATTTAAGCA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	cas1	cd09722_cas1_CAS-I-B	gnl\|CDD\|187853
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|238045
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	unknown	unknown	gnl\|CDD\|227595
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	cas2	cd09725_cas2_CAS-I:CAS-II:CAS-III:CAS-V	gnl\|CDD\|187856
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	unknown	unknown	gnl\|CDD\|172889
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	cas4	pfam01930_cas4_CAS-I	gnl\|CDD\|366863
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	unknown	unknown	gnl\|CDD\|236502
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|238129
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	cas3	cd09639_cas3_CAS-I	gnl\|CDD\|187770
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|99905
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	cas5	cls001430_cas5_CAS-I-B	gnl\|CDD\|131641
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	unknown	unknown	gnl\|CDD\|379915
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	cas7b	pfam05107_cas7b_CAS-I-B:CAS-I-C	gnl\|CDD\|377458
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	unknown	unknown	gnl\|CDD\|183481
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	unknown	unknown	gnl\|CDD\|226234
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	unknown	unknown	gnl\|CDD\|274303
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	cas8b1	mkCas0106_cas8b1_CAS-I-B	gnl\|CDD\|188234
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|187853	cd09722, Cas1_I-B, CRISPR/Cas system-associated protein Cas1. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas1 is the most universal CRISPR system protein thought to be involved in spacer integration; Cas1 is metal-dependent deoxyribonuclease, also binds RNA; Shown to possess a unique fold consisting of a N-terminal beta-strand domain and a C-terminal alpha-helical domain.	1.80703e-158
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	gnl\|CDD\|238045	cd00093, HTH_XRE, Helix-turn-helix XRE-family like proteins. Prokaryotic DNA binding proteins belonging to the xenobiotic response element family of transcriptional regulators.	1.31225e-08
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	gnl\|CDD\|183481	PRK12376, PRK12376, putative translaldolase; Provisional.	5.89019e-156
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	gnl\|CDD\|227595	COG5270, COG5270, PUA domain (predicted RNA-binding domain) [Translation, ribosomal structure and biogenesis].	0.00376455
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|187856	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas2 is present in majority of CRISPR/Cas systems along with Cas1; RNAse specific to U-rich regions; Possesses an RRM/ferredoxin fold.	4.43432e-25
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	gnl\|CDD\|172889	PRK14413, PRK14413, glycerol-3-phosphate acyltransferase.	1.14663e-93
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	gnl\|CDD\|366863	pfam01930, Cas_Cas4, Domain of unknown function DUF83. This domain has no known function. The domain contains three conserved cysteines at its C-terminus.	6.70868e-57
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	gnl\|CDD\|236502	PRK09410, ulaA, PTS system ascorbate-specific transporter subunit IIC; Reviewed.	0
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|238129	cd00211, PTS_IIA_fru, PTS_IIA, PTS system, fructose/mannitol specific IIA subunit. The bacterial phosphoenolpyruvate: sugar phosphotransferase system (PTS) is a multi-protein system involved in the regulation of a variety of metabolic and transcriptional processes. This family is one of four structurally and functionally distinct group IIA PTS system cytoplasmic enzymes, necessary for the uptake of carbohydrates across the cytoplasmic membrane and their phosphorylation.	4.79769e-38
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	gnl\|CDD\|187770	cd09639, Cas3_I, CRISPR/Cas system-associated protein Cas3. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; DEAD/DEAH box helicase DNA helicase cas3'; Often but not always is fused to HD nuclease domain; signature gene for Type I.	1.30528e-27
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	gnl\|CDD\|131641	TIGR02592, hypothetical_protein_CTC_01466, CRISPR-associated protein Cas5, subtype I-B/HMARI. This is a CRISPR-associated protein unique to the hmari subtype of cas genes and CRISPR repeat, which is the only subtype present in Haloarcula marismortui ATCC 43049. The hmari type, though uncommon, is also found in the Aquificae, Thermotogae, Firmicutes, and Dictyoglomi.	9.42806e-61
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	gnl\|CDD\|379915	pfam17032, zinc_ribbon_15, zinc-ribbon family. This zinc-ribbon region is found on a set of largely microsporidia-specific proteins.	0.000168002
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	gnl\|CDD\|377458	pfam05107, Cas_Cas7, CRISPR-associated protein Cas7. CRISPR-associated protein Cas7 is one of the components of the type I-B cascade-like antiviral defense complex. In Haloferax volcanii, Cas5, Cas6 and Cas7 form a small complex that aids the stability of CRISPR-derived RNA.	1.14927e-46
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|99905	cd05563, PTS_IIB_ascorbate, PTS_IIB_ascorbate: subunit IIB of enzyme II (EII) of the L-ascorbate-specific phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS). In this system, EII is an L-ascorbate-specific permease with two cytoplasmic subunits (IIA and IIB) and a transmembrane channel IIC subunit. Subunits IIA, IIB, and IIC are encoded by the sgaA, sgaB, and sgaT genes of the E. coli sgaTBA operon. In some bacteria, the IIB (SgaB) domain is fused C-terminal to the IIA (SgaT) domain. The IIB domain fold includes a central four-stranded parallel open twisted beta-sheet flanked by alpha-helices on both sides. The seven major PTS systems with this IIB fold include ascorbate, chitobiose/lichenan, lactose, galactitol, mannitol, fructose, and a sensory system with similarity to the bacterial bgl system.	2.52704e-28
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	gnl\|CDD\|226234	COG3711, BglG, Transcriptional antiterminator [Transcription].	2.31547e-58
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	gnl\|CDD\|274303	TIGR02794, Protein_TolA, TolA protein. TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB. [Transport and binding proteins, Other, Cellular processes, Pathogenesis].	8.40551e-07
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	gnl\|CDD\|188234	TIGR02591, cas_Csh1, CRISPR-associated protein Cas8b/Csh1, subtype I-B/HMARI. This domain is found in the C-terminal 2/3 of a family of CRISPR associated proteins of the Hmari subtype. Except for the two sequences from halophilic archaea this domain contains a pair of CXXC motifs.	3.80423e-36
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98

>NZ_CP027781.1|WP_106900627.1|2662252_2662543_+|CRISPR-associated-endonuclease-Cas2
MGKGFNYNYAFVFYDVNEKRVNRVFKVCKKYLSHFQKSVFRGEITPANLILLKKDLNREIDECEDFVCIIKLMNNNVYGEEILGNKGITTGEDLIL
>NZ_CP027781.1|WP_106900626.1|2661253_2662252_+|type-I-B-CRISPR-associated-endonuclease-Cas1
MGSTRYITSIGELKRKDNSLCFRKNNKNVYIPVENTKEIYCMSEVSINSKLLDFLSQNNIVMHFFNYYEGYSGTFYPKKHYNSGKLIVKQVEAYKDKRLMVAKSIVSAIGENIYELLYHYYRHDRTEVKGTLEWIKNDMKINLEKANNIKEIMQVEGETWYRFYGEFKNILPEDFVMNKRVKRPPDNPINALISFGNTLLYGKTITAIYNTHLDQRISFLHEPSEGRFSLSLDISEAFKPVIVFKTIFDLVNNKKIQVSKHFDKKLNYCLLNEEGRKIFITAFEEKLESVFIHKKLKRRVTYKNAIKLDCYKMIKFILEDKEFKPFSLKEKM
>NZ_CP027781.1|WP_106900625.1|2660752_2661244_+|CRISPR-associated-protein-Cas4
MKVNGTLINYYFHCKRQCWLHGNRINLEDNSKDVKIGKAIHEVKSEKSKQTEISIDNIKIDKLTKDYLTEIKKSDADIEAAKWQVLLYLKVLKDKGIERKGKLQFIEKNKSKNTIIIELDKENLEELNKIIKNIKNLLLEENPPEIINEPKCKKCAYFEYCYI
>NZ_CP027781.1|WP_106900624.1|2658010_2660599_+|CRISPR-associated-helicase/endonuclease-Cas3
MYFIDVEKFPIDKFVKNHSNIYAHKSEDNSRFEILKEHLELSEEYLYKVIKAKNLDNVLMNFQNYLFEENCSKGIKIFKEMIFNIIYMHDMGKINCCFQYKKMDNELFKEQDGITFNYSNHSMLSSLIYINYYFKRIKELKNVTSDIKDKLRFFMMINSYIISRHHSHLDSFNEYKNKFLEEDGEGKRLYFEQLCIFKSSYDDDIVFEKKPKLMKKLFELTEDYLNNELISSKKKIYLYIYERFFASLLLGCDYYSTSQFMNNCKLNYFGEITDINKFYDGLKKTEIYNKIRDYEKERYLKYDNFNDVKDINILRNEMFLDAEKMLEENIESNIYYLEAPTGSGKSTVALNLSFKLIEQDKNLNKIFNVYPFNTLVEQNIASLNKIFDYDKELLDEIAVINSLVPIKEVKKKEIEDEENEEVNYDKSLLNRQFLNYPIVLNTHVSMFNYLFGTAKDDLFPLIQLANSVIVLDEIQSYKNNIWKEIIMFLNCYAEILNIRIIIMSATLPNLNKLIDYDDFNTINLIKNRDKYFKNPLFKDRVSIDFSLLGKGDNTYEALKEHVLNTSKNTEDNILIEFINKKRALEFHNDLVMELSDKKKVLLITGDDNSIERNDIIKRVKDENNIVLVATQVIEAGVDIDMDIGYKDISMLDSDEQFLGRINRSCKKPKSTVYFFDLDSASSIYRGDYRKEKNVTLKSNNIRDILIKKDFQKYYDLILKRINDESSSHNENNTEDFINERIGELDFLEVEKKMRLIDDDKDEITVFLCRNIALENGQDLEGKKVWEDYKELLKDGELKYAKKRVKLSKAASNLNYFIYKVKSRDFPYNDRLGEIYCIYEGENYFTNGKFDRKNFTTGACNFI
>NZ_CP027781.1|WP_106900623.1|2657067_2657811_+|type-I-B-CRISPR-associated-protein-Cas5
MDVLKFNLKGRTAFFKKPDVNTYFYFTYGNIHKVALLGILGSILGLKGYNDQNENDKYPEFYEKLKGLRIGIVPMNKEGYIPKKIQTFNNSVGYASKEQGGNLIIKEQWLEDPKWDIYILLQGDIEDQLKDNILDRNFKFIPYLGKNDHIATIENIEIIKDSKKTDNVKKIDSLYAKDYFSFRNSKYDFDEEDDLEDTWKYEEMLPMSLEENTNKYNLKSFVYTNSLVDSSSYESIYECNNKNIFFF
>NZ_CP027781.1|WP_106900622.1|2656105_2657065_+|CRISPR-associated-protein
MNSRVYGVLGIVSRMSNWNADFTGYPKTTSTGDTFGSDKAFKYPIKKMWSDQGEKVIYIKSMKLQEGKKGEIEFIPRSLKERYEYLFKGEDLKKDKDSKKVLTNLFSAIDVKNFGATFAEEGNNISITGAVQIGQGFNKYSDSFPEEQQILSPFRDPNNKKNNKKEEEEKEAKSSTLGTKIVSNEAHYFYPVTINPKSYDGFKELGVTEGYTEEDYKKFKKASMIAATSFSTNAKIGCENEFAMFVETDEDLYLPDLSQYVLFEKCDDKGKIKIECNNLFKDLESRIKSIEIYYNPYTTNIDKNIDNAKYFNIFTKEEI
>NZ_CP027781.1|WP_106900621.1|2654367_2656116_+|type-I-B-CRISPR-associated-protein-Cas8b/Csh1
MLKDAIDTFKSIYEKKGESFITDSYIPADGDYVIVESYENTFRELDIVKIKQDKKTKEIDRSSEYFKFICNADYLSKLIDMNKPIDGKKIIHSNNYLSFFVKKENVNNGKLNDEVIDSYYEILKTPEIKYSKEKLRLYKEIEDKHGKVNEDLIENIKMWIKDNIKNYANEDSKDKSYLKIFFKYDIEEYKKENEKYLIPNIFNSVEFNVKIGEETYGLPNDNMGLNSKKPYLENKSRKTKVPYLISLEEVLLQKKFFDYLLNQVSIGKTNIYIDKKGIYTKSDKESMDNDFSGIYFRIKKGKEVEIHDFDTINHYKANINPIKLKNVINIDLNKSDLTYNINITKISTIKDLINKVFFSKFLSSNYFTESKDMNINDNNLKRNILLSRRTLFNWFYKGNEFTVWKVFGHSSLSLIKGSIENGYIFKAGEQFNLRCALKEYFVGGESMADVLLGVKASLRDKISQKDTASIDNDKEYYFAVGQVASYLISLSKAAKKTHSLANPIINAKSDDRIKAELKKLFKKYNYTMDRRISRRFDNLMYMVSAYIPDLEEKVNDDLIIAGYLHSSLIYEKSSKEENKNEQ
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900628.1|2666563_2667052_-|50S-ribosomal-protein-L7ae
MISKKIIAFIAMTIMMISLLIGCSNNTMDKVYNDNSKIASVYDTFGLDKSDEIIESGIYKGKLKLSGSGTIWTYESSSDFDLKVPYILSVKSGKAKIVLISPDNTVVNLVENTDKATMKGTTSLTLPIKKGNNRIKLVGYKKADIDIELHIEKGTFKKIGFN
>NZ_CP027781.1|WP_106900629.1|2667879_2668473_+|glycerol-3-phosphate-acyltransferase
MIIIITSVISFLLGSIPTGYFITKKTCGIDIRTKGSGNIGSTNVKRIVGTKISIITQTIDVLKGIIPVVLGIYLSKIIKLPVSIDTYLSIIAIAGILGHDYTPFLKFKGGKGVNTTLGVFIFIAPIPTLTGLAVYFILGLFTSIVSIRSIAIGITIPIMCIITKLPIQIIISTTIAGILMVFRHKDNLVRIMRKEEK
>NZ_CP027781.1|WP_106900630.1|2668814_2669468_+|transpeptidase-transglycosylase
MDKFRNMKKSHIALLVIMYMVLMGSFPRFTGWVTIFSAIAVGGYFLKNKKDLKELTRKKKNFIFAGIIILAIIGSFNVAVGNNIQNEKLLAEKSKQEQQIKKEQEEKKLAEEQKRIQEEVKKKAEEEKRKQEEENKVKAENEQAQAAFAQSTGKGNSNDQSNESENADDNQNYTVYKTRTGSKYHSSGCRYLKKSCYETTVSQARNEGLTPCSVCNP
>NZ_CP027781.1|WP_106900631.1|2669738_2670455_+|transaldolase
MKYNDLKIKIFADGADLNGMLDAYNKGIVKGFTTNPSLMKKAGITDYKEFAKEVLAKIKDMPVSFEVFSDDLETMEKEAEVLGNLSENVYIKIPVTNTKGESTAPLIKKLSEKGYHLNVTAIFTIDQVKEVVEALKSGVDSIVSVFAGRIADTGEDPVSIMKEASKICKTKEGVELLWASCREFYSIVEADKCGCEIITVTNDILKKMPNMGKDLKEYSIETVRGFYKDASSLGFSIL
>NZ_CP027781.1|WP_003485280.1|2670478_2670916_+|PTS-maltose-transporter-subunit-IIBC
MLKNYINDQVVEVNVEVKNWEEAVRLGGKLLEEDGAVEHSYIDAMVDTVKNMGPYIVIAPGIAMPHARPEAGAKNIRIGLLKLKNPVNFGNEEHDPVDIVIFLCAVDNKAHIEVLGELVQLIEDDDFLKIVRNASTKKEILDYIK
>NZ_CP027781.1|WP_003361919.1|2670944_2671229_+|PTS-maltose-transporter-subunit-IIBC
MNILTVCGNGIGSSLMLAMKIEEICKENGIAANVESTDFNSAQGKKADLIVTVKELAEQFEGRDVAVVRSYINKKKITEDVLEIIKQKDEELKK
>NZ_CP027781.1|WP_025776024.1|2671241_2672606_+|PTS-ascorbate-transporter-subunit-IIC
MLGLLQFLRDVLKQPALLMGIMALVGLVALKKPGHKVLTGTLKPILGYLMLGAGADFIVANLEPLGGMIQTGFNITGVVPNNEAIVAVAQKVLGVETMSILVVGLLINLVIARFTKYKYVFLTGHHSFFMACLLSAVLGTSGMKGTELILFGGFLLGAWSAISPAIGQKYTLKVTDGDEIAMGHFGSLAYYVSAWVGSKVGKPEESTENIEIPEKWGFLRDTTISTAITMMVFYIVAAVAAGPEYVSKLSDGMSPILFAIMSSLKFAVGVTIVYNGVRMILGDLIPAFQGIATKIIPDAIPAVDCAVFFPYAPTAVIIGFVSSFIGGIIGMVLLGVAGGVLIIPGLVPHFFCGSTAGIFGNATGGKKGAVIGSFVNGLLITFAPALLLPVLSTLGFKNTTFGDFDFGVLGIIIGKTSNLAGKTGIIIIAMLMLLALIVPNFIKTKSKALNNIEE
>NZ_CP027781.1|WP_106900632.1|2672817_2674911_+|sugar-transporter
MLNKRCSNILQMIVNNEKPITIKEISKKVNKSPRTVRYDLDKIDDYLTEIEFPKLERKSNLGISLDLKDEEIKKLFKIIGKINNYDYVLSQKERVFYIIYELLNKSEFVTINMLSDRMMVSRSTIINDLIEVKKWLSENKITLESSKGQGIKILGRERDLRRAAVKLFFQSMDSINFFNVTTLKLFNDIDIDFIRNTIKIAEEQMETSFSDDAFNNLVIHIAIAIKRIELSKDIIMDSEELKNLRKTAEYAIASGIAKMLEDRFKISIPEDEIGYITIHILGSNTSTLENIVKDDWIYLHLIVFKLIENVENITGVNFSKDNKLFDSLAQHIRPAIYRLKHDIKVKNPLIEEIKEKYFYIFESIEEGVKFIEEDIGDSVNQEEIGYLTLHFMASIERSKNKKHRKPNVLIVCATGIGTSKFISNKLKSIFDINIIDTISSHTMEKVLKYNKNIDLIVTTIPLKVKGIKCIEVNTFLTEKNISELGLYFAKFIRDNSEECNSSCKYEERDKVQEILNIIKENCTIHDYYKLRNKLALYLNIKDPTLTEDHKPSLKELLKPDFIKLNEEAKDWEDAVRKSGEILMNNGCVKESYIDAMVNTVKNMGPYIVIAPGIAMPHAAPEDGVLKTGISMLTLKNPISFGNAEHDPVSIIISICSIDKVNHMNALKELMSIMDQEDFLSKVKSMKTPSEIDSILYS
>NZ_CP027781.1|WP_003358205.1|2675235_2675589_+|zinc-ribbon-domain-containing-protein
MIIWGWGKVTKKIIGAVFERTCNYCNTDEVWNLCVVRTWFTLFFIPIIPYKKQYCIACPKCWSYIELTQEEFEKIKIDITSSSNNINEKVVTDNIKYAGKTETQINYLKQMEEYANK
>NZ_CP027781.1|WP_106900633.1|2675809_2676373_-|XRE-family-transcriptional-regulator
MGLSKKELGKLVKNARKLKSEKVGKRYTQQMLAQDINKSQSYIGDIEAGRTYPSFIVLNSIASACGISLSYFQDENKINKDIDKFINLQLHNMDKENVHNIREEIKKDPDAKLNYIYDSLTKDNNLLKESTTHSLDNLDGIIDFLINNTDLMTCLALDINKMSNKEICDFSKDLLHQLDLVSYKYKK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_15

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_15

2663085-2665282

TypeI-B

II-B:III-B

Consensus_repeat	Method
ATTGAACAACAACATGAGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAAGATGTATTTAAAT	CRISPRCasFinder
TTGAACANNAACATNAGATGTATTTAAAT	CRT
GTTGAACAGTAACATAAGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAAGATGTATTTAAATG	PILER-CR

33 spacers

cas2,cas1,cas4,cas3,cas5,cas7b,cas8b1,cas6

The CRISPR arrays of NZ_CP027781_15

>merge|NZ_CP027781|15|2663085-2665282|PILER-CR,CRISPRCasFinder,CRT,PILER-CR,PILER-CR
ATTGAACAACAACATGAGATGTATTTAAATTGCACTGTAATATCAACTCCTTTTAATTTGATTAATCATTGAACAACAACATGAGATGTATTTAAATTAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCCATTGAACAACAACATGAGATGTATTTAAATTAAAATTATCTCTCCTTTTTACTTCAGAATATCTTATTGAACAACAACATGAGATGTATTTAAATTCTATCTTTACAGCTACTACACTAATAAAATCCAATTGAACAACAACATGAGATGTATTTAAATTTGTTTGTTTGTGTAGACCCACAAGCAACTAATCCATTGAACAACAACATGAGATGTATTTAAATAAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAATATTGAACAACAACATGAGATGTATTTAAATGATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTGATTGAACAACAACATGAGATGTATTTAAATGAATGTAGAGCATTAATTAAATGCAAAAAGAATTTAATTGAACAACAACATGAGATGTATTTAAATTAGTAATCCATGACATTACCCCTATATTTTTTACCAATTGAACAACAACATGAGATGTATTTAAATTCATAAGCATAAGTTATTACCTCTTCTGTGTCATCAATTGAACAACAACATGAGATGTATTTAAATAAGTGTTACTGGGTATGAATGGGCGTCTGAATTTAATTGAACAACAACATGAGATGTATTTAAATAAGTTTAAATCATAATCTCCAATTGAATCTATATATTGAACAACAACATGAGATGTATTTAAATAAATTAGAATTTATTATTTTTATAGTACTTATATCATTGAACAACAACATGAGATGTATTTAAATAATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAAATTGAACAACAACATGAGATGTATTTAAATCAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTAATTGAACAACAACATGAGATGTATTTAAATCTTAGTTGTAACCCTTTTCTGATATCAAATTTATCTATTGAACAGTAACATAAGATGTATTTAAATTATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGTGTTGAACAGTAACATAAGATGTATTTAAATGAATCAGTACTATAGTCTTCATATATATATCCTATGTTGAACAGTAACATAAGATGTATTTAAATAGCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAAGTTGAACAGTAACATAAGATGTATTTAAATGTATATTACCTCCCAACAAATATATTTAATTTAATTAGTTGAACAGTAACATAAGATGTATTTAAATAGGTTTTAAGTATAACTACAGAATGAGAAAGTTTAGTTGAACAGTAACATAAGATGTATTTAAATGAATCTTTCCCAAACGCTTGAATGCCAGAACTGGCGTTGAACAGTAACATAAGATGTATTTAAATAAAGTACACATAACCATTATCATTTTTAAAGCACCTGTTGAACAGTAACATAAGATGTATTTAAATTAATATAGATTATTTGTTAGGGAGACCTTCAATAAAGTTGAACAGTAACATAAGATGTATTTAAATAAAGAAAATGAAATTACAGAAGAAGAGTTACCTTTAGTTGAACAGTAACATAAGATGTATTTAAATAAGCAATATGTTTCGTAGGATGTTTTTAAATCAACAGTTGAACAGTAACATAAGATGTATTTAAATGTAGATGGTTTGCTTGGTGTTACATTTGAAGATGGTTGAACAGTAACATAAGATGTATTTAAATGCCATTAAAGAAGCTTTACTAATACTTTTCTTTAATGTTGAACAGTAACATAAGATGTATTTAAATTAAATAACTATATAATAGGTATAAAATAAAGCTTAGGTTGAACAGTAACATAAGATGTATTTAAATGTTAAAGATTTTTTTAATTTATCCCTAACTTTTAGTTGAACAGTAACATAAGATGTATTTAAATGAAATTGAAAATCGTAAACAAGAATGTATAGCTCGGTTGAACAGTAACATAAGATGTATTTAAATTGTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTACGTTGAACAGTAACATAAGATGTATTTAAATGAAGAAATGAAACGAGCGGTCATAAGTGCTTTAGGTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|15|9|2663085-2664097|PILER-CR
ATTGAACAACAACATGAGATGTATTTAAAT	TGCACTGTAATATCAACTCCTTTTAATTTGATTAATC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAATTATCTCTCCTTTTTACTTCAGAATATCTT
ATTGAACAACAACATGAGATGTATTTAAAT	TCTATCTTTACAGCTACTACACTAATAAAATCCA
ATTGAACAACAACATGAGATGTATTTAAAT	TTGTTTGTTTGTGTAGACCCACAAGCAACTAATCC
ATTGAACAACAACATGAGATGTATTTAAAT	AAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAAT
ATTGAACAACAACATGAGATGTATTTAAAT	GATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTG
ATTGAACAACAACATGAGATGTATTTAAAT	GAATGTAGAGCATTAATTAAATGCAAAAAGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	TAGTAATCCATGACATTACCCCTATATTTTTTACCA
ATTGAACAACAACATGAGATGTATTTAAAT	TCATAAGCATAAGTTATTACCTCTTCTGTGTCATCA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTGTTACTGGGTATGAATGGGCGTCTGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTTTAAATCATAATCTCCAATTGAATCTATAT
ATTGAACAACAACATGAGATGTATTTAAAT	AAATTAGAATTTATTATTTTTATAGTACTTATATC
ATTGAACAACAACATGAGATGTATTTAAAT	AATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAA
ATTGAACAACAACATGAGATGTATTTAAAT	CAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTA
ATTGAACAACAACATGAGATGTATTTAAATCTTAGTTGTAACCCTTTTCTGATATCAAATTTATCTATTGAACAGTAACATAAGATGTATTTAAATT	ATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGTG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCAGTACTATAGTCTTCATATATATATCCTATG
TTGAACAGTAACATAAGATGTATTTAAATA	GCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAAG
TTGAACAGTAACATAAGATGTATTTAAATG	TATATTACCTCCCAACAAATATATTTAATTTAATTAG
TTGAACAGTAACATAAGATGTATTTAAATA	GGTTTTAAGTATAACTACAGAATGAGAAAGTTTAG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCTTTCCCAAACGCTTGAATGCCAGAACTGGCG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGTACACATAACCATTATCATTTTTAAAGCACCTG
TTGAACAGTAACATAAGATGTATTTAAATT	AATATAGATTATTTGTTAGGGAGACCTTCAATAAAG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGAAAATGAAATTACAGAAGAAGAGTTACCTTTAG
TTGAACAGTAACATAAGATGTATTTAAATA	AGCAATATGTTTCGTAGGATGTTTTTAAATCAACAG
TTGAACAGTAACATAAGATGTATTTAAATG	TAGATGGTTTGCTTGGTGTTACATTTGAAGATGG
TTGAACAGTAACATAAGATGTATTTAAATGCCATTAAAGAAGCTTTACTAATACTTTTCTTTAATGTTGAACAGTAACATAAGATGTATTTAAATTAAATAACTATATAATAGGTATAAAATAAAGCTTAGGTTGAACAGTAACATAAGATGTATTTAAATG	TTAAAGATTTTTTTAATTTATCCCTAACTTTTA
GTTGAACAGTAACATAAGATGTATTTAAATG	AAATTGAAAATCGTAAACAAGAATGTATAGCTCG
GTTGAACAGTAACATAAGATGTATTTAAATT	GTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTAC


>NZ_CP027781|15|15|2663085-2665282|CRISPRCasFinder
ATTGAACAACAACATGAGATGTATTTAAAT	TGCACTGTAATATCAACTCCTTTTAATTTGATTAATC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAATTATCTCTCCTTTTTACTTCAGAATATCTT
ATTGAACAACAACATGAGATGTATTTAAAT	TCTATCTTTACAGCTACTACACTAATAAAATCCA
ATTGAACAACAACATGAGATGTATTTAAAT	TTGTTTGTTTGTGTAGACCCACAAGCAACTAATCC
ATTGAACAACAACATGAGATGTATTTAAAT	AAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAAT
ATTGAACAACAACATGAGATGTATTTAAAT	GATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTG
ATTGAACAACAACATGAGATGTATTTAAAT	GAATGTAGAGCATTAATTAAATGCAAAAAGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	TAGTAATCCATGACATTACCCCTATATTTTTTACCA
ATTGAACAACAACATGAGATGTATTTAAAT	TCATAAGCATAAGTTATTACCTCTTCTGTGTCATCA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTGTTACTGGGTATGAATGGGCGTCTGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTTTAAATCATAATCTCCAATTGAATCTATAT
ATTGAACAACAACATGAGATGTATTTAAAT	AAATTAGAATTTATTATTTTTATAGTACTTATATC
ATTGAACAACAACATGAGATGTATTTAAAT	AATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAA
ATTGAACAACAACATGAGATGTATTTAAAT	CAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTA
ATTGAACAACAACATGAGATGTATTTAAAT	CTTAGTTGTAACCCTTTTCTGATATCAAATTTATCT
ATTGAACAGTAACATAAGATGTATTTAAAT	TATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGT
GTTGAACAGTAACATAAGATGTATTTAAAT	GAATCAGTACTATAGTCTTCATATATATATCCTAT
GTTGAACAGTAACATAAGATGTATTTAAAT	AGCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAA
GTTGAACAGTAACATAAGATGTATTTAAAT	GTATATTACCTCCCAACAAATATATTTAATTTAATTA
GTTGAACAGTAACATAAGATGTATTTAAAT	AGGTTTTAAGTATAACTACAGAATGAGAAAGTTTA
GTTGAACAGTAACATAAGATGTATTTAAAT	GAATCTTTCCCAAACGCTTGAATGCCAGAACTGGC
GTTGAACAGTAACATAAGATGTATTTAAAT	AAAGTACACATAACCATTATCATTTTTAAAGCACCT
GTTGAACAGTAACATAAGATGTATTTAAAT	TAATATAGATTATTTGTTAGGGAGACCTTCAATAAA
GTTGAACAGTAACATAAGATGTATTTAAAT	AAAGAAAATGAAATTACAGAAGAAGAGTTACCTTTA
GTTGAACAGTAACATAAGATGTATTTAAAT	AAGCAATATGTTTCGTAGGATGTTTTTAAATCAACA
GTTGAACAGTAACATAAGATGTATTTAAAT	GTAGATGGTTTGCTTGGTGTTACATTTGAAGATG
GTTGAACAGTAACATAAGATGTATTTAAAT	GCCATTAAAGAAGCTTTACTAATACTTTTCTTTAAT
GTTGAACAGTAACATAAGATGTATTTAAAT	TAAATAACTATATAATAGGTATAAAATAAAGCTTAG
GTTGAACAGTAACATAAGATGTATTTAAAT	GTTAAAGATTTTTTTAATTTATCCCTAACTTTTA
GTTGAACAGTAACATAAGATGTATTTAAAT	GAAATTGAAAATCGTAAACAAGAATGTATAGCTCG
GTTGAACAGTAACATAAGATGTATTTAAAT	TGTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTAC
GTTGAACAGTAACATAAGATGTATTTAAAT	GAAGAAATGAAACGAGCGGTCATAAGTGCTTTAG
GTTGAACAATAACATGAGATGTATTTAAGCA

>NZ_CP027781|15|12|2663086-2665281|CRT
TTGAACAACAACATGAGATGTATTTAAAT	TGCACTGTAATATCAACTCCTTTTAATTTGATTAATCA
TTGAACAACAACATGAGATGTATTTAAAT	TAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCCA
TTGAACAACAACATGAGATGTATTTAAAT	TAAAATTATCTCTCCTTTTTACTTCAGAATATCTTA
TTGAACAACAACATGAGATGTATTTAAAT	TCTATCTTTACAGCTACTACACTAATAAAATCCAA
TTGAACAACAACATGAGATGTATTTAAAT	TTGTTTGTTTGTGTAGACCCACAAGCAACTAATCCA
TTGAACAACAACATGAGATGTATTTAAAT	AAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAATA
TTGAACAACAACATGAGATGTATTTAAAT	GATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTGA
TTGAACAACAACATGAGATGTATTTAAAT	GAATGTAGAGCATTAATTAAATGCAAAAAGAATTTAA
TTGAACAACAACATGAGATGTATTTAAAT	TAGTAATCCATGACATTACCCCTATATTTTTTACCAA
TTGAACAACAACATGAGATGTATTTAAAT	TCATAAGCATAAGTTATTACCTCTTCTGTGTCATCAA
TTGAACAACAACATGAGATGTATTTAAAT	AAGTGTTACTGGGTATGAATGGGCGTCTGAATTTAA
TTGAACAACAACATGAGATGTATTTAAAT	AAGTTTAAATCATAATCTCCAATTGAATCTATATA
TTGAACAACAACATGAGATGTATTTAAAT	AAATTAGAATTTATTATTTTTATAGTACTTATATCA
TTGAACAACAACATGAGATGTATTTAAAT	AATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAAA
TTGAACAACAACATGAGATGTATTTAAAT	CAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTAA
TTGAACAACAACATGAGATGTATTTAAAT	CTTAGTTGTAACCCTTTTCTGATATCAAATTTATCTA
TTGAACAGTAACATAAGATGTATTTAAAT	TATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGTG
TTGAACAGTAACATAAGATGTATTTAAAT	GAATCAGTACTATAGTCTTCATATATATATCCTATG
TTGAACAGTAACATAAGATGTATTTAAAT	AGCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAAG
TTGAACAGTAACATAAGATGTATTTAAAT	GTATATTACCTCCCAACAAATATATTTAATTTAATTAG
TTGAACAGTAACATAAGATGTATTTAAAT	AGGTTTTAAGTATAACTACAGAATGAGAAAGTTTAG
TTGAACAGTAACATAAGATGTATTTAAAT	GAATCTTTCCCAAACGCTTGAATGCCAGAACTGGCG
TTGAACAGTAACATAAGATGTATTTAAAT	AAAGTACACATAACCATTATCATTTTTAAAGCACCTG
TTGAACAGTAACATAAGATGTATTTAAAT	TAATATAGATTATTTGTTAGGGAGACCTTCAATAAAG
TTGAACAGTAACATAAGATGTATTTAAAT	AAAGAAAATGAAATTACAGAAGAAGAGTTACCTTTAG
TTGAACAGTAACATAAGATGTATTTAAAT	AAGCAATATGTTTCGTAGGATGTTTTTAAATCAACAG
TTGAACAGTAACATAAGATGTATTTAAAT	GTAGATGGTTTGCTTGGTGTTACATTTGAAGATGG
TTGAACAGTAACATAAGATGTATTTAAAT	GCCATTAAAGAAGCTTTACTAATACTTTTCTTTAATG
TTGAACAGTAACATAAGATGTATTTAAAT	TAAATAACTATATAATAGGTATAAAATAAAGCTTAGG
TTGAACAGTAACATAAGATGTATTTAAAT	GTTAAAGATTTTTTTAATTTATCCCTAACTTTTAG
TTGAACAGTAACATAAGATGTATTTAAAT	GAAATTGAAAATCGTAAACAAGAATGTATAGCTCGG
TTGAACAGTAACATAAGATGTATTTAAAT	TGTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTACG
TTGAACAGTAACATAAGATGTATTTAAAT	GAAGAAATGAAACGAGCGGTCATAAGTGCTTTAGG
TTGAACAATAACATGAGATGTATTTAAGC

>NZ_CP027781|15|10|2664135-2664888|PILER-CR
	TGCACTGTAATATCAACTCCTTTTAATTTGATTAATC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAATTATCTCTCCTTTTTACTTCAGAATATCTT
ATTGAACAACAACATGAGATGTATTTAAAT	TCTATCTTTACAGCTACTACACTAATAAAATCCA
ATTGAACAACAACATGAGATGTATTTAAAT	TTGTTTGTTTGTGTAGACCCACAAGCAACTAATCC
ATTGAACAACAACATGAGATGTATTTAAAT	AAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAAT
ATTGAACAACAACATGAGATGTATTTAAAT	GATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTG
ATTGAACAACAACATGAGATGTATTTAAAT	GAATGTAGAGCATTAATTAAATGCAAAAAGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	TAGTAATCCATGACATTACCCCTATATTTTTTACCA
ATTGAACAACAACATGAGATGTATTTAAAT	TCATAAGCATAAGTTATTACCTCTTCTGTGTCATCA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTGTTACTGGGTATGAATGGGCGTCTGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTTTAAATCATAATCTCCAATTGAATCTATAT
ATTGAACAACAACATGAGATGTATTTAAAT	AAATTAGAATTTATTATTTTTATAGTACTTATATC
ATTGAACAACAACATGAGATGTATTTAAAT	AATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAA
ATTGAACAACAACATGAGATGTATTTAAAT	CAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTA
ATTGAACAACAACATGAGATGTATTTAAATCTTAGTTGTAACCCTTTTCTGATATCAAATTTATCTATTGAACAGTAACATAAGATGTATTTAAATT	ATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGTG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCAGTACTATAGTCTTCATATATATATCCTATG
TTGAACAGTAACATAAGATGTATTTAAATA	GCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAAG
TTGAACAGTAACATAAGATGTATTTAAATG	TATATTACCTCCCAACAAATATATTTAATTTAATTAG
TTGAACAGTAACATAAGATGTATTTAAATA	GGTTTTAAGTATAACTACAGAATGAGAAAGTTTAG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCTTTCCCAAACGCTTGAATGCCAGAACTGGCG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGTACACATAACCATTATCATTTTTAAAGCACCTG
TTGAACAGTAACATAAGATGTATTTAAATT	AATATAGATTATTTGTTAGGGAGACCTTCAATAAAG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGAAAATGAAATTACAGAAGAAGAGTTACCTTTAG
TTGAACAGTAACATAAGATGTATTTAAATA	AGCAATATGTTTCGTAGGATGTTTTTAAATCAACAG
TTGAACAGTAACATAAGATGTATTTAAATG	TAGATGGTTTGCTTGGTGTTACATTTGAAGATGG
TTGAACAGTAACATAAGATGTATTTAAATGCCATTAAAGAAGCTTTACTAATACTTTTCTTTAATGTTGAACAGTAACATAAGATGTATTTAAATTAAATAACTATATAATAGGTATAAAATAAAGCTTAGGTTGAACAGTAACATAAGATGTATTTAAATG	TTAAAGATTTTTTTAATTTATCCCTAACTTTTA
GTTGAACAGTAACATAAGATGTATTTAAATG	AAATTGAAAATCGTAAACAAGAATGTATAGCTCG
GTTGAACAGTAACATAAGATGTATTTAAATT	GTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTAC


>NZ_CP027781|15|11|2664991-2665218|PILER-CR
	TGCACTGTAATATCAACTCCTTTTAATTTGATTAATC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAAGAAGCTCTATTTTCCCAGTAGGGTATAGCC
ATTGAACAACAACATGAGATGTATTTAAAT	TAAAATTATCTCTCCTTTTTACTTCAGAATATCTT
ATTGAACAACAACATGAGATGTATTTAAAT	TCTATCTTTACAGCTACTACACTAATAAAATCCA
ATTGAACAACAACATGAGATGTATTTAAAT	TTGTTTGTTTGTGTAGACCCACAAGCAACTAATCC
ATTGAACAACAACATGAGATGTATTTAAAT	AAACTTAGGAAAAATAAAGGATTAACTTTAGAAGAAT
ATTGAACAACAACATGAGATGTATTTAAAT	GATAGCGAGCTCTATGACTAACGGAGAGTGGCAGTG
ATTGAACAACAACATGAGATGTATTTAAAT	GAATGTAGAGCATTAATTAAATGCAAAAAGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	TAGTAATCCATGACATTACCCCTATATTTTTTACCA
ATTGAACAACAACATGAGATGTATTTAAAT	TCATAAGCATAAGTTATTACCTCTTCTGTGTCATCA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTGTTACTGGGTATGAATGGGCGTCTGAATTTA
ATTGAACAACAACATGAGATGTATTTAAAT	AAGTTTAAATCATAATCTCCAATTGAATCTATAT
ATTGAACAACAACATGAGATGTATTTAAAT	AAATTAGAATTTATTATTTTTATAGTACTTATATC
ATTGAACAACAACATGAGATGTATTTAAAT	AATTAAAACTTGGAACAGTAAAGCTGAGGGTGAAAA
ATTGAACAACAACATGAGATGTATTTAAAT	CAATATCCTGGTTTAGGGTATTTCTTACCTAAGTTA
ATTGAACAACAACATGAGATGTATTTAAATCTTAGTTGTAACCCTTTTCTGATATCAAATTTATCTATTGAACAGTAACATAAGATGTATTTAAATT	ATGTCTTAGTAACTTGACGTATATTAGTCTGAGTAGTG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCAGTACTATAGTCTTCATATATATATCCTATG
TTGAACAGTAACATAAGATGTATTTAAATA	GCAATAAAAACAAGGCTTTTACTTTTAAAAGGTGAAG
TTGAACAGTAACATAAGATGTATTTAAATG	TATATTACCTCCCAACAAATATATTTAATTTAATTAG
TTGAACAGTAACATAAGATGTATTTAAATA	GGTTTTAAGTATAACTACAGAATGAGAAAGTTTAG
TTGAACAGTAACATAAGATGTATTTAAATG	AATCTTTCCCAAACGCTTGAATGCCAGAACTGGCG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGTACACATAACCATTATCATTTTTAAAGCACCTG
TTGAACAGTAACATAAGATGTATTTAAATT	AATATAGATTATTTGTTAGGGAGACCTTCAATAAAG
TTGAACAGTAACATAAGATGTATTTAAATA	AAGAAAATGAAATTACAGAAGAAGAGTTACCTTTAG
TTGAACAGTAACATAAGATGTATTTAAATA	AGCAATATGTTTCGTAGGATGTTTTTAAATCAACAG
TTGAACAGTAACATAAGATGTATTTAAATG	TAGATGGTTTGCTTGGTGTTACATTTGAAGATGG
TTGAACAGTAACATAAGATGTATTTAAATGCCATTAAAGAAGCTTTACTAATACTTTTCTTTAATGTTGAACAGTAACATAAGATGTATTTAAATTAAATAACTATATAATAGGTATAAAATAAAGCTTAGGTTGAACAGTAACATAAGATGTATTTAAATG	TTAAAGATTTTTTTAATTTATCCCTAACTTTTA
GTTGAACAGTAACATAAGATGTATTTAAATG	AAATTGAAAATCGTAAACAAGAATGTATAGCTCG
GTTGAACAGTAACATAAGATGTATTTAAATT	GTAATAAGTTAAAGGCATTAGTGGGTGAAAAACTTAC
GTTGAACAGTAACATAAGATGTATTTAAATG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	cas1	cd09722_cas1_CAS-I-B	gnl\|CDD\|187853
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|238045
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	unknown	unknown	gnl\|CDD\|227595
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	cas2	cd09725_cas2_CAS-I:CAS-II:CAS-III:CAS-V	gnl\|CDD\|187856
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	unknown	unknown	gnl\|CDD\|172889
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	cas4	pfam01930_cas4_CAS-I	gnl\|CDD\|366863
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	unknown	unknown	gnl\|CDD\|236502
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|238129
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	cas3	cd09639_cas3_CAS-I	gnl\|CDD\|187770
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|99905
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	cas5	cls001430_cas5_CAS-I-B	gnl\|CDD\|131641
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	unknown	unknown	gnl\|CDD\|379915
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	cas7b	pfam05107_cas7b_CAS-I-B:CAS-I-C	gnl\|CDD\|377458
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	unknown	unknown	gnl\|CDD\|183481
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	unknown	unknown	gnl\|CDD\|226234
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	unknown	unknown	gnl\|CDD\|274303
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	cas8b1	mkCas0106_cas8b1_CAS-I-B	gnl\|CDD\|188234
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|187853	cd09722, Cas1_I-B, CRISPR/Cas system-associated protein Cas1. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas1 is the most universal CRISPR system protein thought to be involved in spacer integration; Cas1 is metal-dependent deoxyribonuclease, also binds RNA; Shown to possess a unique fold consisting of a N-terminal beta-strand domain and a C-terminal alpha-helical domain.	1.80703e-158
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	gnl\|CDD\|238045	cd00093, HTH_XRE, Helix-turn-helix XRE-family like proteins. Prokaryotic DNA binding proteins belonging to the xenobiotic response element family of transcriptional regulators.	1.31225e-08
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	gnl\|CDD\|183481	PRK12376, PRK12376, putative translaldolase; Provisional.	5.89019e-156
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	gnl\|CDD\|227595	COG5270, COG5270, PUA domain (predicted RNA-binding domain) [Translation, ribosomal structure and biogenesis].	0.00376455
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|187856	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas2 is present in majority of CRISPR/Cas systems along with Cas1; RNAse specific to U-rich regions; Possesses an RRM/ferredoxin fold.	4.43432e-25
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	gnl\|CDD\|172889	PRK14413, PRK14413, glycerol-3-phosphate acyltransferase.	1.14663e-93
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	gnl\|CDD\|366863	pfam01930, Cas_Cas4, Domain of unknown function DUF83. This domain has no known function. The domain contains three conserved cysteines at its C-terminus.	6.70868e-57
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	gnl\|CDD\|236502	PRK09410, ulaA, PTS system ascorbate-specific transporter subunit IIC; Reviewed.	0
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|238129	cd00211, PTS_IIA_fru, PTS_IIA, PTS system, fructose/mannitol specific IIA subunit. The bacterial phosphoenolpyruvate: sugar phosphotransferase system (PTS) is a multi-protein system involved in the regulation of a variety of metabolic and transcriptional processes. This family is one of four structurally and functionally distinct group IIA PTS system cytoplasmic enzymes, necessary for the uptake of carbohydrates across the cytoplasmic membrane and their phosphorylation.	4.79769e-38
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	gnl\|CDD\|187770	cd09639, Cas3_I, CRISPR/Cas system-associated protein Cas3. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; DEAD/DEAH box helicase DNA helicase cas3'; Often but not always is fused to HD nuclease domain; signature gene for Type I.	1.30528e-27
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	gnl\|CDD\|131641	TIGR02592, hypothetical_protein_CTC_01466, CRISPR-associated protein Cas5, subtype I-B/HMARI. This is a CRISPR-associated protein unique to the hmari subtype of cas genes and CRISPR repeat, which is the only subtype present in Haloarcula marismortui ATCC 43049. The hmari type, though uncommon, is also found in the Aquificae, Thermotogae, Firmicutes, and Dictyoglomi.	9.42806e-61
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	gnl\|CDD\|379915	pfam17032, zinc_ribbon_15, zinc-ribbon family. This zinc-ribbon region is found on a set of largely microsporidia-specific proteins.	0.000168002
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	gnl\|CDD\|377458	pfam05107, Cas_Cas7, CRISPR-associated protein Cas7. CRISPR-associated protein Cas7 is one of the components of the type I-B cascade-like antiviral defense complex. In Haloferax volcanii, Cas5, Cas6 and Cas7 form a small complex that aids the stability of CRISPR-derived RNA.	1.14927e-46
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|99905	cd05563, PTS_IIB_ascorbate, PTS_IIB_ascorbate: subunit IIB of enzyme II (EII) of the L-ascorbate-specific phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS). In this system, EII is an L-ascorbate-specific permease with two cytoplasmic subunits (IIA and IIB) and a transmembrane channel IIC subunit. Subunits IIA, IIB, and IIC are encoded by the sgaA, sgaB, and sgaT genes of the E. coli sgaTBA operon. In some bacteria, the IIB (SgaB) domain is fused C-terminal to the IIA (SgaT) domain. The IIB domain fold includes a central four-stranded parallel open twisted beta-sheet flanked by alpha-helices on both sides. The seven major PTS systems with this IIB fold include ascorbate, chitobiose/lichenan, lactose, galactitol, mannitol, fructose, and a sensory system with similarity to the bacterial bgl system.	2.52704e-28
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	gnl\|CDD\|226234	COG3711, BglG, Transcriptional antiterminator [Transcription].	2.31547e-58
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	gnl\|CDD\|274303	TIGR02794, Protein_TolA, TolA protein. TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB. [Transport and binding proteins, Other, Cellular processes, Pathogenesis].	8.40551e-07
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	gnl\|CDD\|188234	TIGR02591, cas_Csh1, CRISPR-associated protein Cas8b/Csh1, subtype I-B/HMARI. This domain is found in the C-terminal 2/3 of a family of CRISPR associated proteins of the Hmari subtype. Except for the two sequences from halophilic archaea this domain contains a pair of CXXC motifs.	3.80423e-36
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98

>NZ_CP027781.1|WP_106900627.1|2662252_2662543_+|CRISPR-associated-endonuclease-Cas2
MGKGFNYNYAFVFYDVNEKRVNRVFKVCKKYLSHFQKSVFRGEITPANLILLKKDLNREIDECEDFVCIIKLMNNNVYGEEILGNKGITTGEDLIL
>NZ_CP027781.1|WP_106900626.1|2661253_2662252_+|type-I-B-CRISPR-associated-endonuclease-Cas1
MGSTRYITSIGELKRKDNSLCFRKNNKNVYIPVENTKEIYCMSEVSINSKLLDFLSQNNIVMHFFNYYEGYSGTFYPKKHYNSGKLIVKQVEAYKDKRLMVAKSIVSAIGENIYELLYHYYRHDRTEVKGTLEWIKNDMKINLEKANNIKEIMQVEGETWYRFYGEFKNILPEDFVMNKRVKRPPDNPINALISFGNTLLYGKTITAIYNTHLDQRISFLHEPSEGRFSLSLDISEAFKPVIVFKTIFDLVNNKKIQVSKHFDKKLNYCLLNEEGRKIFITAFEEKLESVFIHKKLKRRVTYKNAIKLDCYKMIKFILEDKEFKPFSLKEKM
>NZ_CP027781.1|WP_106900625.1|2660752_2661244_+|CRISPR-associated-protein-Cas4
MKVNGTLINYYFHCKRQCWLHGNRINLEDNSKDVKIGKAIHEVKSEKSKQTEISIDNIKIDKLTKDYLTEIKKSDADIEAAKWQVLLYLKVLKDKGIERKGKLQFIEKNKSKNTIIIELDKENLEELNKIIKNIKNLLLEENPPEIINEPKCKKCAYFEYCYI
>NZ_CP027781.1|WP_106900624.1|2658010_2660599_+|CRISPR-associated-helicase/endonuclease-Cas3
MYFIDVEKFPIDKFVKNHSNIYAHKSEDNSRFEILKEHLELSEEYLYKVIKAKNLDNVLMNFQNYLFEENCSKGIKIFKEMIFNIIYMHDMGKINCCFQYKKMDNELFKEQDGITFNYSNHSMLSSLIYINYYFKRIKELKNVTSDIKDKLRFFMMINSYIISRHHSHLDSFNEYKNKFLEEDGEGKRLYFEQLCIFKSSYDDDIVFEKKPKLMKKLFELTEDYLNNELISSKKKIYLYIYERFFASLLLGCDYYSTSQFMNNCKLNYFGEITDINKFYDGLKKTEIYNKIRDYEKERYLKYDNFNDVKDINILRNEMFLDAEKMLEENIESNIYYLEAPTGSGKSTVALNLSFKLIEQDKNLNKIFNVYPFNTLVEQNIASLNKIFDYDKELLDEIAVINSLVPIKEVKKKEIEDEENEEVNYDKSLLNRQFLNYPIVLNTHVSMFNYLFGTAKDDLFPLIQLANSVIVLDEIQSYKNNIWKEIIMFLNCYAEILNIRIIIMSATLPNLNKLIDYDDFNTINLIKNRDKYFKNPLFKDRVSIDFSLLGKGDNTYEALKEHVLNTSKNTEDNILIEFINKKRALEFHNDLVMELSDKKKVLLITGDDNSIERNDIIKRVKDENNIVLVATQVIEAGVDIDMDIGYKDISMLDSDEQFLGRINRSCKKPKSTVYFFDLDSASSIYRGDYRKEKNVTLKSNNIRDILIKKDFQKYYDLILKRINDESSSHNENNTEDFINERIGELDFLEVEKKMRLIDDDKDEITVFLCRNIALENGQDLEGKKVWEDYKELLKDGELKYAKKRVKLSKAASNLNYFIYKVKSRDFPYNDRLGEIYCIYEGENYFTNGKFDRKNFTTGACNFI
>NZ_CP027781.1|WP_106900623.1|2657067_2657811_+|type-I-B-CRISPR-associated-protein-Cas5
MDVLKFNLKGRTAFFKKPDVNTYFYFTYGNIHKVALLGILGSILGLKGYNDQNENDKYPEFYEKLKGLRIGIVPMNKEGYIPKKIQTFNNSVGYASKEQGGNLIIKEQWLEDPKWDIYILLQGDIEDQLKDNILDRNFKFIPYLGKNDHIATIENIEIIKDSKKTDNVKKIDSLYAKDYFSFRNSKYDFDEEDDLEDTWKYEEMLPMSLEENTNKYNLKSFVYTNSLVDSSSYESIYECNNKNIFFF
>NZ_CP027781.1|WP_106900622.1|2656105_2657065_+|CRISPR-associated-protein
MNSRVYGVLGIVSRMSNWNADFTGYPKTTSTGDTFGSDKAFKYPIKKMWSDQGEKVIYIKSMKLQEGKKGEIEFIPRSLKERYEYLFKGEDLKKDKDSKKVLTNLFSAIDVKNFGATFAEEGNNISITGAVQIGQGFNKYSDSFPEEQQILSPFRDPNNKKNNKKEEEEKEAKSSTLGTKIVSNEAHYFYPVTINPKSYDGFKELGVTEGYTEEDYKKFKKASMIAATSFSTNAKIGCENEFAMFVETDEDLYLPDLSQYVLFEKCDDKGKIKIECNNLFKDLESRIKSIEIYYNPYTTNIDKNIDNAKYFNIFTKEEI
>NZ_CP027781.1|WP_106900621.1|2654367_2656116_+|type-I-B-CRISPR-associated-protein-Cas8b/Csh1
MLKDAIDTFKSIYEKKGESFITDSYIPADGDYVIVESYENTFRELDIVKIKQDKKTKEIDRSSEYFKFICNADYLSKLIDMNKPIDGKKIIHSNNYLSFFVKKENVNNGKLNDEVIDSYYEILKTPEIKYSKEKLRLYKEIEDKHGKVNEDLIENIKMWIKDNIKNYANEDSKDKSYLKIFFKYDIEEYKKENEKYLIPNIFNSVEFNVKIGEETYGLPNDNMGLNSKKPYLENKSRKTKVPYLISLEEVLLQKKFFDYLLNQVSIGKTNIYIDKKGIYTKSDKESMDNDFSGIYFRIKKGKEVEIHDFDTINHYKANINPIKLKNVINIDLNKSDLTYNINITKISTIKDLINKVFFSKFLSSNYFTESKDMNINDNNLKRNILLSRRTLFNWFYKGNEFTVWKVFGHSSLSLIKGSIENGYIFKAGEQFNLRCALKEYFVGGESMADVLLGVKASLRDKISQKDTASIDNDKEYYFAVGQVASYLISLSKAAKKTHSLANPIINAKSDDRIKAELKKLFKKYNYTMDRRISRRFDNLMYMVSAYIPDLEEKVNDDLIIAGYLHSSLIYEKSSKEENKNEQ
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900628.1|2666563_2667052_-|50S-ribosomal-protein-L7ae
MISKKIIAFIAMTIMMISLLIGCSNNTMDKVYNDNSKIASVYDTFGLDKSDEIIESGIYKGKLKLSGSGTIWTYESSSDFDLKVPYILSVKSGKAKIVLISPDNTVVNLVENTDKATMKGTTSLTLPIKKGNNRIKLVGYKKADIDIELHIEKGTFKKIGFN
>NZ_CP027781.1|WP_106900629.1|2667879_2668473_+|glycerol-3-phosphate-acyltransferase
MIIIITSVISFLLGSIPTGYFITKKTCGIDIRTKGSGNIGSTNVKRIVGTKISIITQTIDVLKGIIPVVLGIYLSKIIKLPVSIDTYLSIIAIAGILGHDYTPFLKFKGGKGVNTTLGVFIFIAPIPTLTGLAVYFILGLFTSIVSIRSIAIGITIPIMCIITKLPIQIIISTTIAGILMVFRHKDNLVRIMRKEEK
>NZ_CP027781.1|WP_106900630.1|2668814_2669468_+|transpeptidase-transglycosylase
MDKFRNMKKSHIALLVIMYMVLMGSFPRFTGWVTIFSAIAVGGYFLKNKKDLKELTRKKKNFIFAGIIILAIIGSFNVAVGNNIQNEKLLAEKSKQEQQIKKEQEEKKLAEEQKRIQEEVKKKAEEEKRKQEEENKVKAENEQAQAAFAQSTGKGNSNDQSNESENADDNQNYTVYKTRTGSKYHSSGCRYLKKSCYETTVSQARNEGLTPCSVCNP
>NZ_CP027781.1|WP_106900631.1|2669738_2670455_+|transaldolase
MKYNDLKIKIFADGADLNGMLDAYNKGIVKGFTTNPSLMKKAGITDYKEFAKEVLAKIKDMPVSFEVFSDDLETMEKEAEVLGNLSENVYIKIPVTNTKGESTAPLIKKLSEKGYHLNVTAIFTIDQVKEVVEALKSGVDSIVSVFAGRIADTGEDPVSIMKEASKICKTKEGVELLWASCREFYSIVEADKCGCEIITVTNDILKKMPNMGKDLKEYSIETVRGFYKDASSLGFSIL
>NZ_CP027781.1|WP_003485280.1|2670478_2670916_+|PTS-maltose-transporter-subunit-IIBC
MLKNYINDQVVEVNVEVKNWEEAVRLGGKLLEEDGAVEHSYIDAMVDTVKNMGPYIVIAPGIAMPHARPEAGAKNIRIGLLKLKNPVNFGNEEHDPVDIVIFLCAVDNKAHIEVLGELVQLIEDDDFLKIVRNASTKKEILDYIK
>NZ_CP027781.1|WP_003361919.1|2670944_2671229_+|PTS-maltose-transporter-subunit-IIBC
MNILTVCGNGIGSSLMLAMKIEEICKENGIAANVESTDFNSAQGKKADLIVTVKELAEQFEGRDVAVVRSYINKKKITEDVLEIIKQKDEELKK
>NZ_CP027781.1|WP_025776024.1|2671241_2672606_+|PTS-ascorbate-transporter-subunit-IIC
MLGLLQFLRDVLKQPALLMGIMALVGLVALKKPGHKVLTGTLKPILGYLMLGAGADFIVANLEPLGGMIQTGFNITGVVPNNEAIVAVAQKVLGVETMSILVVGLLINLVIARFTKYKYVFLTGHHSFFMACLLSAVLGTSGMKGTELILFGGFLLGAWSAISPAIGQKYTLKVTDGDEIAMGHFGSLAYYVSAWVGSKVGKPEESTENIEIPEKWGFLRDTTISTAITMMVFYIVAAVAAGPEYVSKLSDGMSPILFAIMSSLKFAVGVTIVYNGVRMILGDLIPAFQGIATKIIPDAIPAVDCAVFFPYAPTAVIIGFVSSFIGGIIGMVLLGVAGGVLIIPGLVPHFFCGSTAGIFGNATGGKKGAVIGSFVNGLLITFAPALLLPVLSTLGFKNTTFGDFDFGVLGIIIGKTSNLAGKTGIIIIAMLMLLALIVPNFIKTKSKALNNIEE
>NZ_CP027781.1|WP_106900632.1|2672817_2674911_+|sugar-transporter
MLNKRCSNILQMIVNNEKPITIKEISKKVNKSPRTVRYDLDKIDDYLTEIEFPKLERKSNLGISLDLKDEEIKKLFKIIGKINNYDYVLSQKERVFYIIYELLNKSEFVTINMLSDRMMVSRSTIINDLIEVKKWLSENKITLESSKGQGIKILGRERDLRRAAVKLFFQSMDSINFFNVTTLKLFNDIDIDFIRNTIKIAEEQMETSFSDDAFNNLVIHIAIAIKRIELSKDIIMDSEELKNLRKTAEYAIASGIAKMLEDRFKISIPEDEIGYITIHILGSNTSTLENIVKDDWIYLHLIVFKLIENVENITGVNFSKDNKLFDSLAQHIRPAIYRLKHDIKVKNPLIEEIKEKYFYIFESIEEGVKFIEEDIGDSVNQEEIGYLTLHFMASIERSKNKKHRKPNVLIVCATGIGTSKFISNKLKSIFDINIIDTISSHTMEKVLKYNKNIDLIVTTIPLKVKGIKCIEVNTFLTEKNISELGLYFAKFIRDNSEECNSSCKYEERDKVQEILNIIKENCTIHDYYKLRNKLALYLNIKDPTLTEDHKPSLKELLKPDFIKLNEEAKDWEDAVRKSGEILMNNGCVKESYIDAMVNTVKNMGPYIVIAPGIAMPHAAPEDGVLKTGISMLTLKNPISFGNAEHDPVSIIISICSIDKVNHMNALKELMSIMDQEDFLSKVKSMKTPSEIDSILYS
>NZ_CP027781.1|WP_003358205.1|2675235_2675589_+|zinc-ribbon-domain-containing-protein
MIIWGWGKVTKKIIGAVFERTCNYCNTDEVWNLCVVRTWFTLFFIPIIPYKKQYCIACPKCWSYIELTQEEFEKIKIDITSSSNNINEKVVTDNIKYAGKTETQINYLKQMEEYANK
>NZ_CP027781.1|WP_106900633.1|2675809_2676373_-|XRE-family-transcriptional-regulator
MGLSKKELGKLVKNARKLKSEKVGKRYTQQMLAQDINKSQSYIGDIEAGRTYPSFIVLNSIASACGISLSYFQDENKINKDIDKFINLQLHNMDKENVHNIREEIKKDPDAKLNYIYDSLTKDNNLLKESTTHSLDNLDGIIDFLINNTDLMTCLALDINKMSNKEICDFSKDLLHQLDLVSYKYKK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_16

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_16

2665535-2666286

TypeI-B

III-B

Consensus_repeat	Method
GTTGAACCTTAACATAGGATGTATTTAAAT	PILER-CR
GTTGAACAGTAACATAAGATGTATTTAAAT	CRISPRCasFinder
GTTGAACCTTAACATAGGATGTATTTAAAT	CRT

11 spacers

cas2,cas1,cas4,cas3,cas5,cas7b,cas8b1,cas6

The CRISPR arrays of NZ_CP027781_16

>merge|NZ_CP027781|16|2665535-2666286|PILER-CR,CRISPRCasFinder,CRT
GTTGAACCTTAACATAGGATGTATTTAAATCTAAGTTAAAACCTGTAGTTAGTGGAGCAGCAGTTGCGTTGAACCTTAACATAGGATGTATTTAAATGAGGGATTTATATCCAAGAAATAACACCAACGGCTGGTTGAACCTTAACATAGGATGTATTTAAATATGTGTCTTAATATTTAAAAATATATCTTTTTATTTGTTGAACCTTAACATAGGATGTATTTAAATATAGTTACAGCATGGACTAATGTATGGAGCGTGATGTTGAACCTTAACATAGGATGTATTTAAATAAAACTTGTTGAAATAAGAAAAGAGGTTATTAATGTTGAACCTTAACATAGGATGTATTTAAATAAAGTTATCTCCTAAATTAGAAGGACCATTAGAAGAGTTGAACCTTAACATAGGATGTATTTAAATAACAATTTTAAATAGGTTGGAAGAAAGATGGGATAGTTGAACCTTAACATAGGATGTATTTAAATACTTATAGAATTAAATATGATAGAAGATGAAGATTTTGTTGAACCTTAACATAGGATGTATTTAAATACATGTTATCCATACTAATAAGCAGTTAGAAGAAAGTTGAACCTTAACATAGGATGTATTTAAATCAAGGTCCTTATAGCTGGCAATATGAAATTAATGCGTTGAACCTTAACATAGGATGTATTTAAATCCAACTAACCAAAACAGATACTTATCTATAGTGGTAGTTGAACCTTAACATAGGATGTATTTAAGC

>NZ_CP027781|16|12|2665535-2666220|PILER-CR
GTTGAACCTTAACATAGGATGTATTTAAAT	CTAAGTTAAAACCTGTAGTTAGTGGAGCAGCAGTTGC
GTTGAACCTTAACATAGGATGTATTTAAAT	GAGGGATTTATATCCAAGAAATAACACCAACGGCTG
GTTGAACCTTAACATAGGATGTATTTAAAT	ATGTGTCTTAATATTTAAAAATATATCTTTTTATTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ATAGTTACAGCATGGACTAATGTATGGAGCGTGAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAACTTGTTGAAATAAGAAAAGAGGTTATTAAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAGTTATCTCCTAAATTAGAAGGACCATTAGAAGA
GTTGAACCTTAACATAGGATGTATTTAAAT	AACAATTTTAAATAGGTTGGAAGAAAGATGGGATA
GTTGAACCTTAACATAGGATGTATTTAAAT	ACTTATAGAATTAAATATGATAGAAGATGAAGATTTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ACATGTTATCCATACTAATAAGCAGTTAGAAGAAA
GTTGAACCTTAACATAGGATGTATTTAAAT	CAAGGTCCTTATAGCTGGCAATATGAAATTAATGC
GTTGAACCTTAACATAGGATGTATTTAAAT

>NZ_CP027781|16|16|2665535-2666286|CRISPRCasFinder
GTTGAACCTTAACATAGGATGTATTTAAAT	CTAAGTTAAAACCTGTAGTTAGTGGAGCAGCAGTTGC
GTTGAACCTTAACATAGGATGTATTTAAAT	GAGGGATTTATATCCAAGAAATAACACCAACGGCTG
GTTGAACCTTAACATAGGATGTATTTAAAT	ATGTGTCTTAATATTTAAAAATATATCTTTTTATTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ATAGTTACAGCATGGACTAATGTATGGAGCGTGAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAACTTGTTGAAATAAGAAAAGAGGTTATTAAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAGTTATCTCCTAAATTAGAAGGACCATTAGAAGA
GTTGAACCTTAACATAGGATGTATTTAAAT	AACAATTTTAAATAGGTTGGAAGAAAGATGGGATA
GTTGAACCTTAACATAGGATGTATTTAAAT	ACTTATAGAATTAAATATGATAGAAGATGAAGATTTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ACATGTTATCCATACTAATAAGCAGTTAGAAGAAA
GTTGAACCTTAACATAGGATGTATTTAAAT	CAAGGTCCTTATAGCTGGCAATATGAAATTAATGC
GTTGAACCTTAACATAGGATGTATTTAAAT	CCAACTAACCAAAACAGATACTTATCTATAGTGGTA
GTTGAACCTTAACATAGGATGTATTTAAGC

>NZ_CP027781|16|13|2665535-2666286|CRT
GTTGAACCTTAACATAGGATGTATTTAAAT	CTAAGTTAAAACCTGTAGTTAGTGGAGCAGCAGTTGC
GTTGAACCTTAACATAGGATGTATTTAAAT	GAGGGATTTATATCCAAGAAATAACACCAACGGCTG
GTTGAACCTTAACATAGGATGTATTTAAAT	ATGTGTCTTAATATTTAAAAATATATCTTTTTATTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ATAGTTACAGCATGGACTAATGTATGGAGCGTGAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAACTTGTTGAAATAAGAAAAGAGGTTATTAAT
GTTGAACCTTAACATAGGATGTATTTAAAT	AAAGTTATCTCCTAAATTAGAAGGACCATTAGAAGA
GTTGAACCTTAACATAGGATGTATTTAAAT	AACAATTTTAAATAGGTTGGAAGAAAGATGGGATA
GTTGAACCTTAACATAGGATGTATTTAAAT	ACTTATAGAATTAAATATGATAGAAGATGAAGATTTT
GTTGAACCTTAACATAGGATGTATTTAAAT	ACATGTTATCCATACTAATAAGCAGTTAGAAGAAA
GTTGAACCTTAACATAGGATGTATTTAAAT	CAAGGTCCTTATAGCTGGCAATATGAAATTAATGC
GTTGAACCTTAACATAGGATGTATTTAAAT	CCAACTAACCAAAACAGATACTTATCTATAGTGGTA
GTTGAACCTTAACATAGGATGTATTTAAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	cas1	cd09722_cas1_CAS-I-B	gnl\|CDD\|187853
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|238045
NZ_CP027781.1\|WP_106900619.1\|2651511_2652006_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	unknown	unknown	gnl\|CDD\|227595
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	cas2	cd09725_cas2_CAS-I:CAS-II:CAS-III:CAS-V	gnl\|CDD\|187856
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	unknown	unknown	gnl\|CDD\|172889
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	cas4	pfam01930_cas4_CAS-I	gnl\|CDD\|366863
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	unknown	unknown	gnl\|CDD\|236502
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|238129
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	cas3	cd09639_cas3_CAS-I	gnl\|CDD\|187770
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	cas6	cd09652_cas6_CAS-I:CAS-III	gnl\|CDD\|273848
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	unknown	unknown	gnl\|CDD\|99905
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	cas5	cls001430_cas5_CAS-I-B	gnl\|CDD\|131641
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	unknown	unknown	gnl\|CDD\|379915
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	cas7b	pfam05107_cas7b_CAS-I-B:CAS-I-C	gnl\|CDD\|377458
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	unknown	unknown	gnl\|CDD\|183481
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	unknown	unknown	gnl\|CDD\|226234
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	unknown	unknown	gnl\|CDD\|274303
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	cas8b1	mkCas0106_cas8b1_CAS-I-B	gnl\|CDD\|188234
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	unknown	unknown	gnl\|CDD\|100047

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106900626.1\|2661253_2662252_+\|type-I-B-CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|187853	cd09722, Cas1_I-B, CRISPR/Cas system-associated protein Cas1. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas1 is the most universal CRISPR system protein thought to be involved in spacer integration; Cas1 is metal-dependent deoxyribonuclease, also binds RNA; Shown to possess a unique fold consisting of a N-terminal beta-strand domain and a C-terminal alpha-helical domain.	1.80703e-158
NZ_CP027781.1\|WP_106900633.1\|2675809_2676373_-\|XRE-family-transcriptional-regulator	gnl\|CDD\|238045	cd00093, HTH_XRE, Helix-turn-helix XRE-family like proteins. Prokaryotic DNA binding proteins belonging to the xenobiotic response element family of transcriptional regulators.	1.31225e-08
NZ_CP027781.1\|WP_106900631.1\|2669738_2670455_+\|transaldolase	gnl\|CDD\|183481	PRK12376, PRK12376, putative translaldolase; Provisional.	5.89019e-156
NZ_CP027781.1\|WP_106900628.1\|2666563_2667052_-\|50S-ribosomal-protein-L7ae	gnl\|CDD\|227595	COG5270, COG5270, PUA domain (predicted RNA-binding domain) [Translation, ribosomal structure and biogenesis].	0.00376455
NZ_CP027781.1\|WP_106900627.1\|2662252_2662543_+\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|187856	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas2 is present in majority of CRISPR/Cas systems along with Cas1; RNAse specific to U-rich regions; Possesses an RRM/ferredoxin fold.	4.43432e-25
NZ_CP027781.1\|WP_106900629.1\|2667879_2668473_+\|glycerol-3-phosphate-acyltransferase	gnl\|CDD\|172889	PRK14413, PRK14413, glycerol-3-phosphate acyltransferase.	1.14663e-93
NZ_CP027781.1\|WP_106900625.1\|2660752_2661244_+\|CRISPR-associated-protein-Cas4	gnl\|CDD\|366863	pfam01930, Cas_Cas4, Domain of unknown function DUF83. This domain has no known function. The domain contains three conserved cysteines at its C-terminus.	6.70868e-57
NZ_CP027781.1\|WP_025776024.1\|2671241_2672606_+\|PTS-ascorbate-transporter-subunit-IIC	gnl\|CDD\|236502	PRK09410, ulaA, PTS system ascorbate-specific transporter subunit IIC; Reviewed.	0
NZ_CP027781.1\|WP_003485280.1\|2670478_2670916_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|238129	cd00211, PTS_IIA_fru, PTS_IIA, PTS system, fructose/mannitol specific IIA subunit. The bacterial phosphoenolpyruvate: sugar phosphotransferase system (PTS) is a multi-protein system involved in the regulation of a variety of metabolic and transcriptional processes. This family is one of four structurally and functionally distinct group IIA PTS system cytoplasmic enzymes, necessary for the uptake of carbohydrates across the cytoplasmic membrane and their phosphorylation.	4.79769e-38
NZ_CP027781.1\|WP_106900624.1\|2658010_2660599_+\|CRISPR-associated-helicase/endonuclease-Cas3	gnl\|CDD\|187770	cd09639, Cas3_I, CRISPR/Cas system-associated protein Cas3. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; DEAD/DEAH box helicase DNA helicase cas3'; Often but not always is fused to HD nuclease domain; signature gene for Type I.	1.30528e-27
NZ_CP027781.1\|WP_106900620.1\|2653659_2654352_+\|CRISPR-associated-endoribonuclease-Cas6	gnl\|CDD\|273848	TIGR01877, CRISPR-associated_endoribonuclease_Cas6_1, CRISPR-associated endoribonuclease Cas6. CRISPR is a term for Clustered, Regularly Interspaced Short Palidromic Repeats. A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This broadly distributed, highly divergent Cas family is now characterized as an endoribonuclease that generates guide RNAs for host defense against phage and other invaders. The family contains a C-terminal motif GXGXXXXXGXG, where the each X between two Gly is hydrophobic and the spacer XXXXX contains (usually) one Arg or Lys. The seed alignment for the current version of this model has gappy columns removed. Members of this protein family are found associated with several different CRISPR/cas system subtypes, and consequently we designate this family Cas6.	1.00788e-15
NZ_CP027781.1\|WP_106900623.1\|2657067_2657811_+\|type-I-B-CRISPR-associated-protein-Cas5	gnl\|CDD\|131641	TIGR02592, hypothetical_protein_CTC_01466, CRISPR-associated protein Cas5, subtype I-B/HMARI. This is a CRISPR-associated protein unique to the hmari subtype of cas genes and CRISPR repeat, which is the only subtype present in Haloarcula marismortui ATCC 43049. The hmari type, though uncommon, is also found in the Aquificae, Thermotogae, Firmicutes, and Dictyoglomi.	9.42806e-61
NZ_CP027781.1\|WP_003358205.1\|2675235_2675589_+\|zinc-ribbon-domain-containing-protein	gnl\|CDD\|379915	pfam17032, zinc_ribbon_15, zinc-ribbon family. This zinc-ribbon region is found on a set of largely microsporidia-specific proteins.	0.000168002
NZ_CP027781.1\|WP_106900622.1\|2656105_2657065_+\|CRISPR-associated-protein	gnl\|CDD\|377458	pfam05107, Cas_Cas7, CRISPR-associated protein Cas7. CRISPR-associated protein Cas7 is one of the components of the type I-B cascade-like antiviral defense complex. In Haloferax volcanii, Cas5, Cas6 and Cas7 form a small complex that aids the stability of CRISPR-derived RNA.	1.14927e-46
NZ_CP027781.1\|WP_003361919.1\|2670944_2671229_+\|PTS-maltose-transporter-subunit-IIBC	gnl\|CDD\|99905	cd05563, PTS_IIB_ascorbate, PTS_IIB_ascorbate: subunit IIB of enzyme II (EII) of the L-ascorbate-specific phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS). In this system, EII is an L-ascorbate-specific permease with two cytoplasmic subunits (IIA and IIB) and a transmembrane channel IIC subunit. Subunits IIA, IIB, and IIC are encoded by the sgaA, sgaB, and sgaT genes of the E. coli sgaTBA operon. In some bacteria, the IIB (SgaB) domain is fused C-terminal to the IIA (SgaT) domain. The IIB domain fold includes a central four-stranded parallel open twisted beta-sheet flanked by alpha-helices on both sides. The seven major PTS systems with this IIB fold include ascorbate, chitobiose/lichenan, lactose, galactitol, mannitol, fructose, and a sensory system with similarity to the bacterial bgl system.	2.52704e-28
NZ_CP027781.1\|WP_106900632.1\|2672817_2674911_+\|sugar-transporter	gnl\|CDD\|226234	COG3711, BglG, Transcriptional antiterminator [Transcription].	2.31547e-58
NZ_CP027781.1\|WP_106900630.1\|2668814_2669468_+\|transpeptidase-transglycosylase	gnl\|CDD\|274303	TIGR02794, Protein_TolA, TolA protein. TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB. [Transport and binding proteins, Other, Cellular processes, Pathogenesis].	8.40551e-07
NZ_CP027781.1\|WP_106900621.1\|2654367_2656116_+\|type-I-B-CRISPR-associated-protein-Cas8b/Csh1	gnl\|CDD\|188234	TIGR02591, cas_Csh1, CRISPR-associated protein Cas8b/Csh1, subtype I-B/HMARI. This domain is found in the C-terminal 2/3 of a family of CRISPR associated proteins of the Hmari subtype. Except for the two sequences from halophilic archaea this domain contains a pair of CXXC motifs.	3.80423e-36
NZ_CP027781.1\|WP_106900618.1\|2650854_2651469_+\|sugar-O-acetyltransferase	gnl\|CDD\|100047	cd03357, LbH_MAT_GAT, Maltose O-acetyltransferase (MAT) and Galactoside O-acetyltransferase (GAT): MAT and GAT catalyze the CoA-dependent acetylation of the 6-hydroxyl group of their respective sugar substrates. MAT acetylates maltose and glucose exclusively at the C6 position of the nonreducing end glucosyl moiety. GAT specifically acetylates galactopyranosides. Furthermore, MAT shows higher affinity toward artificial substrates containing an alkyl or hydrophobic chain as well as a glucosyl unit. Active MAT and GAT are homotrimers, with each subunit consisting of an N-terminal alpha-helical region and a C-terminal left-handed parallel alpha-helix (LbH) subdomain with 6 turns, each containing three imperfect tandem repeats of a hexapeptide repeat motif (X-[STAV]-X-[LIV]-[GAED]-X).	1.08351e-98

>NZ_CP027781.1|WP_106900627.1|2662252_2662543_+|CRISPR-associated-endonuclease-Cas2
MGKGFNYNYAFVFYDVNEKRVNRVFKVCKKYLSHFQKSVFRGEITPANLILLKKDLNREIDECEDFVCIIKLMNNNVYGEEILGNKGITTGEDLIL
>NZ_CP027781.1|WP_106900626.1|2661253_2662252_+|type-I-B-CRISPR-associated-endonuclease-Cas1
MGSTRYITSIGELKRKDNSLCFRKNNKNVYIPVENTKEIYCMSEVSINSKLLDFLSQNNIVMHFFNYYEGYSGTFYPKKHYNSGKLIVKQVEAYKDKRLMVAKSIVSAIGENIYELLYHYYRHDRTEVKGTLEWIKNDMKINLEKANNIKEIMQVEGETWYRFYGEFKNILPEDFVMNKRVKRPPDNPINALISFGNTLLYGKTITAIYNTHLDQRISFLHEPSEGRFSLSLDISEAFKPVIVFKTIFDLVNNKKIQVSKHFDKKLNYCLLNEEGRKIFITAFEEKLESVFIHKKLKRRVTYKNAIKLDCYKMIKFILEDKEFKPFSLKEKM
>NZ_CP027781.1|WP_106900625.1|2660752_2661244_+|CRISPR-associated-protein-Cas4
MKVNGTLINYYFHCKRQCWLHGNRINLEDNSKDVKIGKAIHEVKSEKSKQTEISIDNIKIDKLTKDYLTEIKKSDADIEAAKWQVLLYLKVLKDKGIERKGKLQFIEKNKSKNTIIIELDKENLEELNKIIKNIKNLLLEENPPEIINEPKCKKCAYFEYCYI
>NZ_CP027781.1|WP_106900624.1|2658010_2660599_+|CRISPR-associated-helicase/endonuclease-Cas3
MYFIDVEKFPIDKFVKNHSNIYAHKSEDNSRFEILKEHLELSEEYLYKVIKAKNLDNVLMNFQNYLFEENCSKGIKIFKEMIFNIIYMHDMGKINCCFQYKKMDNELFKEQDGITFNYSNHSMLSSLIYINYYFKRIKELKNVTSDIKDKLRFFMMINSYIISRHHSHLDSFNEYKNKFLEEDGEGKRLYFEQLCIFKSSYDDDIVFEKKPKLMKKLFELTEDYLNNELISSKKKIYLYIYERFFASLLLGCDYYSTSQFMNNCKLNYFGEITDINKFYDGLKKTEIYNKIRDYEKERYLKYDNFNDVKDINILRNEMFLDAEKMLEENIESNIYYLEAPTGSGKSTVALNLSFKLIEQDKNLNKIFNVYPFNTLVEQNIASLNKIFDYDKELLDEIAVINSLVPIKEVKKKEIEDEENEEVNYDKSLLNRQFLNYPIVLNTHVSMFNYLFGTAKDDLFPLIQLANSVIVLDEIQSYKNNIWKEIIMFLNCYAEILNIRIIIMSATLPNLNKLIDYDDFNTINLIKNRDKYFKNPLFKDRVSIDFSLLGKGDNTYEALKEHVLNTSKNTEDNILIEFINKKRALEFHNDLVMELSDKKKVLLITGDDNSIERNDIIKRVKDENNIVLVATQVIEAGVDIDMDIGYKDISMLDSDEQFLGRINRSCKKPKSTVYFFDLDSASSIYRGDYRKEKNVTLKSNNIRDILIKKDFQKYYDLILKRINDESSSHNENNTEDFINERIGELDFLEVEKKMRLIDDDKDEITVFLCRNIALENGQDLEGKKVWEDYKELLKDGELKYAKKRVKLSKAASNLNYFIYKVKSRDFPYNDRLGEIYCIYEGENYFTNGKFDRKNFTTGACNFI
>NZ_CP027781.1|WP_106900623.1|2657067_2657811_+|type-I-B-CRISPR-associated-protein-Cas5
MDVLKFNLKGRTAFFKKPDVNTYFYFTYGNIHKVALLGILGSILGLKGYNDQNENDKYPEFYEKLKGLRIGIVPMNKEGYIPKKIQTFNNSVGYASKEQGGNLIIKEQWLEDPKWDIYILLQGDIEDQLKDNILDRNFKFIPYLGKNDHIATIENIEIIKDSKKTDNVKKIDSLYAKDYFSFRNSKYDFDEEDDLEDTWKYEEMLPMSLEENTNKYNLKSFVYTNSLVDSSSYESIYECNNKNIFFF
>NZ_CP027781.1|WP_106900622.1|2656105_2657065_+|CRISPR-associated-protein
MNSRVYGVLGIVSRMSNWNADFTGYPKTTSTGDTFGSDKAFKYPIKKMWSDQGEKVIYIKSMKLQEGKKGEIEFIPRSLKERYEYLFKGEDLKKDKDSKKVLTNLFSAIDVKNFGATFAEEGNNISITGAVQIGQGFNKYSDSFPEEQQILSPFRDPNNKKNNKKEEEEKEAKSSTLGTKIVSNEAHYFYPVTINPKSYDGFKELGVTEGYTEEDYKKFKKASMIAATSFSTNAKIGCENEFAMFVETDEDLYLPDLSQYVLFEKCDDKGKIKIECNNLFKDLESRIKSIEIYYNPYTTNIDKNIDNAKYFNIFTKEEI
>NZ_CP027781.1|WP_106900621.1|2654367_2656116_+|type-I-B-CRISPR-associated-protein-Cas8b/Csh1
MLKDAIDTFKSIYEKKGESFITDSYIPADGDYVIVESYENTFRELDIVKIKQDKKTKEIDRSSEYFKFICNADYLSKLIDMNKPIDGKKIIHSNNYLSFFVKKENVNNGKLNDEVIDSYYEILKTPEIKYSKEKLRLYKEIEDKHGKVNEDLIENIKMWIKDNIKNYANEDSKDKSYLKIFFKYDIEEYKKENEKYLIPNIFNSVEFNVKIGEETYGLPNDNMGLNSKKPYLENKSRKTKVPYLISLEEVLLQKKFFDYLLNQVSIGKTNIYIDKKGIYTKSDKESMDNDFSGIYFRIKKGKEVEIHDFDTINHYKANINPIKLKNVINIDLNKSDLTYNINITKISTIKDLINKVFFSKFLSSNYFTESKDMNINDNNLKRNILLSRRTLFNWFYKGNEFTVWKVFGHSSLSLIKGSIENGYIFKAGEQFNLRCALKEYFVGGESMADVLLGVKASLRDKISQKDTASIDNDKEYYFAVGQVASYLISLSKAAKKTHSLANPIINAKSDDRIKAELKKLFKKYNYTMDRRISRRFDNLMYMVSAYIPDLEEKVNDDLIIAGYLHSSLIYEKSSKEENKNEQ
>NZ_CP027781.1|WP_106900620.1|2653659_2654352_+|CRISPR-associated-endoribonuclease-Cas6
MKVYELTLKIFLLKDLTVDKSYEKLTELIDKSLCKDDELLVLHNENKYKYYTFSLPYKLEKDKIYKAGNIYSVKIRTIDEKILKNFKTQLVNMYTSSIKALTIEVKVIPLKYISTIYSLTPVVIKTDKGYWKGNLSLNEYEKRIKENLIKKYNQFFDEKINEDFPLYDFIRFDNRKPIGIRYKNITLLGDKITLNIANDEVSQKIAYLAVGAGLGEMGPRGMGFVNYKWM
>NZ_CP027781.1|WP_106900619.1|2651511_2652006_+|hypothetical-protein
MILAIECFIACVLFTLMILPSLYKEPIKHIMSYPTEIRKRVESLPQYKDVIQKKEKKHLTVKIISVFMLAIILAVVAYFSGAKSFSKAYIHVFTLFFVVNIYDMIVLDIGLFCHSKKTRIPGTEDMDKEYRSPWHHIKGAGIGTIIGAVVALLSGGMVHFISII
>NZ_CP027781.1|WP_106900618.1|2650854_2651469_+|sugar-O-acetyltransferase
MNQKDRMLAGLPYKACLDGLPEERMANKKKIYEYNHCFPDEHEKIHKLIRDILGKVGADVHIEAPFYCDYGKNIQVGDNFFANYNCTILDVGKVIIGNNVQFAPNVSLYTAGHPIHPDSRNSGYEYGIGITIGDNVWLGGNVVVNPGVHIGNNVVIGSGSVVTKDIPDNVIAIGNPCKVIREITEEDRKYYYKNYEFDVDDYKE
>NZ_CP027781.1|WP_106900628.1|2666563_2667052_-|50S-ribosomal-protein-L7ae
MISKKIIAFIAMTIMMISLLIGCSNNTMDKVYNDNSKIASVYDTFGLDKSDEIIESGIYKGKLKLSGSGTIWTYESSSDFDLKVPYILSVKSGKAKIVLISPDNTVVNLVENTDKATMKGTTSLTLPIKKGNNRIKLVGYKKADIDIELHIEKGTFKKIGFN
>NZ_CP027781.1|WP_106900629.1|2667879_2668473_+|glycerol-3-phosphate-acyltransferase
MIIIITSVISFLLGSIPTGYFITKKTCGIDIRTKGSGNIGSTNVKRIVGTKISIITQTIDVLKGIIPVVLGIYLSKIIKLPVSIDTYLSIIAIAGILGHDYTPFLKFKGGKGVNTTLGVFIFIAPIPTLTGLAVYFILGLFTSIVSIRSIAIGITIPIMCIITKLPIQIIISTTIAGILMVFRHKDNLVRIMRKEEK
>NZ_CP027781.1|WP_106900630.1|2668814_2669468_+|transpeptidase-transglycosylase
MDKFRNMKKSHIALLVIMYMVLMGSFPRFTGWVTIFSAIAVGGYFLKNKKDLKELTRKKKNFIFAGIIILAIIGSFNVAVGNNIQNEKLLAEKSKQEQQIKKEQEEKKLAEEQKRIQEEVKKKAEEEKRKQEEENKVKAENEQAQAAFAQSTGKGNSNDQSNESENADDNQNYTVYKTRTGSKYHSSGCRYLKKSCYETTVSQARNEGLTPCSVCNP
>NZ_CP027781.1|WP_106900631.1|2669738_2670455_+|transaldolase
MKYNDLKIKIFADGADLNGMLDAYNKGIVKGFTTNPSLMKKAGITDYKEFAKEVLAKIKDMPVSFEVFSDDLETMEKEAEVLGNLSENVYIKIPVTNTKGESTAPLIKKLSEKGYHLNVTAIFTIDQVKEVVEALKSGVDSIVSVFAGRIADTGEDPVSIMKEASKICKTKEGVELLWASCREFYSIVEADKCGCEIITVTNDILKKMPNMGKDLKEYSIETVRGFYKDASSLGFSIL
>NZ_CP027781.1|WP_003485280.1|2670478_2670916_+|PTS-maltose-transporter-subunit-IIBC
MLKNYINDQVVEVNVEVKNWEEAVRLGGKLLEEDGAVEHSYIDAMVDTVKNMGPYIVIAPGIAMPHARPEAGAKNIRIGLLKLKNPVNFGNEEHDPVDIVIFLCAVDNKAHIEVLGELVQLIEDDDFLKIVRNASTKKEILDYIK
>NZ_CP027781.1|WP_003361919.1|2670944_2671229_+|PTS-maltose-transporter-subunit-IIBC
MNILTVCGNGIGSSLMLAMKIEEICKENGIAANVESTDFNSAQGKKADLIVTVKELAEQFEGRDVAVVRSYINKKKITEDVLEIIKQKDEELKK
>NZ_CP027781.1|WP_025776024.1|2671241_2672606_+|PTS-ascorbate-transporter-subunit-IIC
MLGLLQFLRDVLKQPALLMGIMALVGLVALKKPGHKVLTGTLKPILGYLMLGAGADFIVANLEPLGGMIQTGFNITGVVPNNEAIVAVAQKVLGVETMSILVVGLLINLVIARFTKYKYVFLTGHHSFFMACLLSAVLGTSGMKGTELILFGGFLLGAWSAISPAIGQKYTLKVTDGDEIAMGHFGSLAYYVSAWVGSKVGKPEESTENIEIPEKWGFLRDTTISTAITMMVFYIVAAVAAGPEYVSKLSDGMSPILFAIMSSLKFAVGVTIVYNGVRMILGDLIPAFQGIATKIIPDAIPAVDCAVFFPYAPTAVIIGFVSSFIGGIIGMVLLGVAGGVLIIPGLVPHFFCGSTAGIFGNATGGKKGAVIGSFVNGLLITFAPALLLPVLSTLGFKNTTFGDFDFGVLGIIIGKTSNLAGKTGIIIIAMLMLLALIVPNFIKTKSKALNNIEE
>NZ_CP027781.1|WP_106900632.1|2672817_2674911_+|sugar-transporter
MLNKRCSNILQMIVNNEKPITIKEISKKVNKSPRTVRYDLDKIDDYLTEIEFPKLERKSNLGISLDLKDEEIKKLFKIIGKINNYDYVLSQKERVFYIIYELLNKSEFVTINMLSDRMMVSRSTIINDLIEVKKWLSENKITLESSKGQGIKILGRERDLRRAAVKLFFQSMDSINFFNVTTLKLFNDIDIDFIRNTIKIAEEQMETSFSDDAFNNLVIHIAIAIKRIELSKDIIMDSEELKNLRKTAEYAIASGIAKMLEDRFKISIPEDEIGYITIHILGSNTSTLENIVKDDWIYLHLIVFKLIENVENITGVNFSKDNKLFDSLAQHIRPAIYRLKHDIKVKNPLIEEIKEKYFYIFESIEEGVKFIEEDIGDSVNQEEIGYLTLHFMASIERSKNKKHRKPNVLIVCATGIGTSKFISNKLKSIFDINIIDTISSHTMEKVLKYNKNIDLIVTTIPLKVKGIKCIEVNTFLTEKNISELGLYFAKFIRDNSEECNSSCKYEERDKVQEILNIIKENCTIHDYYKLRNKLALYLNIKDPTLTEDHKPSLKELLKPDFIKLNEEAKDWEDAVRKSGEILMNNGCVKESYIDAMVNTVKNMGPYIVIAPGIAMPHAAPEDGVLKTGISMLTLKNPISFGNAEHDPVSIIISICSIDKVNHMNALKELMSIMDQEDFLSKVKSMKTPSEIDSILYS
>NZ_CP027781.1|WP_003358205.1|2675235_2675589_+|zinc-ribbon-domain-containing-protein
MIIWGWGKVTKKIIGAVFERTCNYCNTDEVWNLCVVRTWFTLFFIPIIPYKKQYCIACPKCWSYIELTQEEFEKIKIDITSSSNNINEKVVTDNIKYAGKTETQINYLKQMEEYANK
>NZ_CP027781.1|WP_106900633.1|2675809_2676373_-|XRE-family-transcriptional-regulator
MGLSKKELGKLVKNARKLKSEKVGKRYTQQMLAQDINKSQSYIGDIEAGRTYPSFIVLNSIASACGISLSYFQDENKINKDIDKFINLQLHNMDKENVHNIREEIKKDPDAKLNYIYDSLTKDNNLLKESTTHSLDNLDGIIDFLINNTDLMTCLALDINKMSNKEICDFSKDLLHQLDLVSYKYKK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP027781_17

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP027781_17

3405775-3405845

Orphan

Consensus_repeat	Method
GGCGGAGGCTTTGGAGGTTTTGG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP027781_17

>merge|NZ_CP027781|17|3405775-3405845|CRISPRCasFinder
GGCGGAGGCTTTGGAGGTTTTGGAGGCTTCGGCGGTGGAGGATCATCTGGCGGAGGCTTTGGAGGTTTCGG

>NZ_CP027781|17|17|3405775-3405845|CRISPRCasFinder
GGCGGAGGCTTTGGAGGTTTTGG	AGGCTTCGGCGGTGGAGGATCATCT
GGCGGAGGCTTTGGAGGTTTCGG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP027781.1\|WP_106901101.1\|3409194_3409656_-\|DUF2975-domain-containing-protein	unknown	unknown	gnl\|CDD\|378586
NZ_CP027781.1\|WP_003488346.1\|3404446_3405016_+\|LemA-family-protein	unknown	unknown	gnl\|CDD\|377192
NZ_CP027781.1\|WP_106901103.1\|3411562_3415093_+\|exonuclease-SbcC	unknown	unknown	gnl\|CDD\|213246
NZ_CP027781.1\|WP_106901098.1\|3407737_3408262_+\|ECF-transporter-S-component	unknown	unknown	gnl\|CDD\|378961
NZ_CP027781.1\|WP_106901105.1\|3416532_3417384_+\|YitT-family-protein	unknown	unknown	gnl\|CDD\|224203
NZ_CP027781.1\|WP_106901104.1\|3415120_3415669_+\|NUDIX-hydrolase	unknown	unknown	gnl\|CDD\|239516
NZ_CP027781.1\|WP_106901097.1\|3406052_3406946_+\|NUDIX-hydrolase	unknown	unknown	gnl\|CDD\|239217
NZ_CP027781.1\|WP_106901092.1\|3399514_3400216_+\|branched-chain-amino-acid-ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|223487
NZ_CP027781.1\|WP_106901094.1\|3402192_3402636_+\|threonine/serine-exporter	unknown	unknown	gnl\|CDD\|378960
NZ_CP027781.1\|WP_106901091.1\|3398775_3399513_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|223488
NZ_CP027781.1\|WP_106901089.1\|3396946_3397819_+\|branched-chain-amino-acid-ABC-transporter-permease	unknown	unknown	gnl\|CDD\|119324
NZ_CP027781.1\|WP_106901095.1\|3402934_3404386_+\|PLP-dependent-aminotransferase-family-protein	unknown	unknown	gnl\|CDD\|224089
NZ_CP027781.1\|WP_030033365.1\|3407078_3407561_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP027781.1\|WP_106901093.1\|3400244_3401021_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|376845
NZ_CP027781.1\|WP_106901102.1\|3410358_3411588_+\|exonuclease-SbcCD-subunit-D	unknown	unknown	gnl\|CDD\|273178
NZ_CP027781.1\|WP_030033357.1\|3401440_3402199_+\|threonine/serine-exporter	unknown	unknown	gnl\|CDD\|377697
NZ_CP027781.1\|WP_106901100.1\|3408934_3409174_-\|transcriptional-regulator	unknown	unknown	gnl\|CDD\|226181
NZ_CP027781.1\|WP_106901090.1\|3397819_3398764_+\|branched-chain-amino-acid-ABC-transporter-permease	unknown	unknown	gnl\|CDD\|119323
NZ_CP027781.1\|WP_030033349.1\|3395800_3396943_+\|branched-chain-amino-acid-ABC-transporter-substrate-binding-protein	unknown	unknown	gnl\|CDD\|380572
NZ_CP027781.1\|WP_106901099.1\|3408263_3408854_+\|AraC-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|181382

Protein	Function_ID	Function_description	E-value
NZ_CP027781.1\|WP_106901101.1\|3409194_3409656_-\|DUF2975-domain-containing-protein	gnl\|CDD\|378586	pfam11188, DUF2975, Protein of unknown function (DUF2975). This family of bacterial proteins have no known function. These proteins are likely to be integral membrane proteins. The proteins contain a highly conserved glutamic acid close to their C-terminus.	5.47229e-10
NZ_CP027781.1\|WP_003488346.1\|3404446_3405016_+\|LemA-family-protein	gnl\|CDD\|377192	pfam04011, LemA, LemA family. The members of this family are related to the LemA protein. LemA contains an amino terminal predicted transmembrane helix. It has been predicted that the small amino terminus is extracellular. The exact molecular function of this protein is uncertain.	7.41006e-81
NZ_CP027781.1\|WP_106901103.1\|3411562_3415093_+\|exonuclease-SbcC	gnl\|CDD\|213246	cd03279, ABC_sbcCD, ATP-binding cassette domain of sbcCD. SbcCD and other Mre11/Rad50 (MR) complexes are implicated in the metabolism of DNA ends. They cleave ends sealed by hairpin structures and are thought to play a role in removing protein bound to DNA termini.	2.87109e-39
NZ_CP027781.1\|WP_106901098.1\|3407737_3408262_+\|ECF-transporter-S-component	gnl\|CDD\|378961	pfam12822, ECF_trnsprt, ECF transporter, substrate-specific component. Energy-coupling factor (ECF) transporters consist of a substrate-specific component (known as the S component), and an energy-coupling module. The substrate-binding component is a small integral membrane protein which captures specific substrates and forms an active transporter in the presence of the energy-coupling AT module.	5.68567e-06
NZ_CP027781.1\|WP_106901105.1\|3416532_3417384_+\|YitT-family-protein	gnl\|CDD\|224203	COG1284, COG1284, Uncharacterized conserved protein [Function unknown].	3.12834e-69
NZ_CP027781.1\|WP_106901097.1\|3406052_3406946_+\|NUDIX-hydrolase	gnl\|CDD\|239217	cd02883, Nudix_Hydrolase, Nudix hydrolase is a superfamily of enzymes found in all three kingdoms of life, and it catalyzes the hydrolysis of NUcleoside DIphosphates linked to other moieties, X. Enzymes belonging to this superfamily require a divalent cation, such as Mg2+ or Mn2+ for their activity. Members of this family are recognized by a highly conserved 23-residue nudix motif (GX5EX7REUXEEXGU, where U = I, L or V), which forms a structural motif that functions as a metal binding and catalytic site. Substrates of nudix hydrolase include intact and oxidatively damaged nucleoside triphosphates, dinucleoside polyphosphates, nucleotide-sugars and dinucleotide enzymes. These substrates are metabolites or cell signaling molecules that require regulation during different stages of the cell cycle or during periods of stress. In general, the role of the nudix hydrolase is to sanitize the nucleotide pools and to maintain cell viability, thereby serving as surveillance and "house-cleaning" enzymes. Substrate specificity is used to define child families within the superfamily. Differences in substrate specificity are determined by the N-terminal extension or by residues in variable loop regions. Mechanistically, substrate hydrolysis occurs by a nucleophilic substitution reaction, with variation in the numbers and roles of divalent cations required. This superfamily consists of at least nine families: IPP (isopentenyl diphosphate) isomerase, ADP ribose pyrophosphatase, mutT pyrophosphohydrolase, coenzyme-A pyrophosphatase, MTH1-7,8-dihydro-8-oxoguanine-triphosphatase, diadenosine tetraphosphate hydrolase, NADH pyrophosphatase, GDP-mannose hydrolase and the c-terminal portion of the mutY adenine glycosylase.	1.4731e-16
NZ_CP027781.1\|WP_106901092.1\|3399514_3400216_+\|branched-chain-amino-acid-ABC-transporter-ATP-binding-protein	gnl\|CDD\|223487	COG0410, LivF, ABC-type branched-chain amino acid transport systems, ATPase component [Amino acid transport and metabolism].	2.81082e-111
NZ_CP027781.1\|WP_106901094.1\|3402192_3402636_+\|threonine/serine-exporter	gnl\|CDD\|378960	pfam12821, ThrE_2, Threonine/Serine exporter, ThrE. ThrE_2 is a family of membrane proteins involved in the export of threonine and serine. L-threonine, L-serine are both substrates for the exporter. The exporter exhibits nine-ten predicted transmembrane-spanning helices with long charged C and N termini and an amphipathic helix present within the N-terminus. L-Threonine can be made by the amino acid-producing bacterium Corynebacterium glutamicum, but the potential for amino acid formation can be considerably improved by reducing its intracellular degradation into glycine and increasing its export by this exporter. Members of the family are found in Bacteria, Archaea, and the fungal kingdoms, and the family can exist either as a single long polypeptide chain or as two short polypeptides. All family members show an extended hydrophilic N-terminal domain with weak sequence similarity to portions of hydrolases (proteases, peptidases, and glycosidases); this suggests that since this region is cytoplasmic to the membrane it may be generating the transport substrate, so may imply that threonine may not be the primary substrate and the ThrE has a subsidiary function.	5.08308e-39
NZ_CP027781.1\|WP_106901091.1\|3398775_3399513_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|223488	COG0411, LivG, ABC-type branched-chain amino acid transport systems, ATPase component [Amino acid transport and metabolism].	9.53984e-119
NZ_CP027781.1\|WP_106901089.1\|3396946_3397819_+\|branched-chain-amino-acid-ABC-transporter-permease	gnl\|CDD\|119324	cd06582, TM_PBP1_LivH_like, Transmembrane subunit (TM) of Escherichia coli LivH and related proteins. LivH is one of two TMs of the E. coli LIV-1/LS transporter, a Periplasmic Binding Protein (PBP)-dependent ATP-Binding Cassette (ABC) transporter involved in the uptake of branched-chain amino acids (AAs). These types of transporters generally bind type 1 PBPs. PBP-dependent ABC transporters consist of a PBP, two TMs, and two cytoplasmic ABCs, and are mainly involved in importing solutes from the environment. The solute is captured by the PBP, which delivers it to a gated translocation pathway formed by the two TMs. The two ABCs bind and hydrolyze ATP and drive the transport reaction. E. coli LivH forms a heterodimer with another TM, LivM, to generate the transmembrane pore. LivM is not included in this subgroup. The LIV-1/LS transporter is comprised of two TMs (LivM and LivH), two ABCs (LivG and LivF), and one of two alternative PBPs, LivJ (LIV-BP) or LivK (LS-BP). In addition to transporting branched-chain AAs including leucine, isoleucine and valine, the E. coli LIV-1/LS transporter is involved in the uptake of the aromatic AA, phenylalanine.	9.55512e-72
NZ_CP027781.1\|WP_106901095.1\|3402934_3404386_+\|PLP-dependent-aminotransferase-family-protein	gnl\|CDD\|224089	COG1167, ARO8, Transcriptional regulators containing a DNA-binding HTH domain and an aminotransferase domain (MocR family) and their eukaryotic orthologs [Transcription / Amino acid transport and metabolism].	3.89489e-139
NZ_CP027781.1\|WP_106901104.1\|3415120_3415669_+\|NUDIX-hydrolase	gnl\|CDD\|239516	cd03424, ADPRase_NUDT5, ADP-ribose pyrophosphatase (ADPRase) catalyzes the hydrolysis of ADP-ribose and a variety of additional ADP-sugar conjugates to AMP and ribose-5-phosphate. Like other members of the Nudix hydrolase superfamily, it requires a divalent cation, such as Mg2+, for its activity. It also contains a highly conserved 23-residue Nudix motif (GX5EX7REUXEEXGU, where U = I, L or V) which functions as a metal binding site/catalytic site. In addition to the Nudix motif, there are additional conserved amino acid residues, distal from the signature sequence, that correlate with substrate specificity. In humans, there are four distinct ADPRase activities, three putative cytosolic enzymes (ADPRase-I, -II, and -Mn) and a single mitochondrial enzyme (ADPRase-m). Human ADPRase-II is also referred to as NUDT5. It lacks the N-terminal target sequence unique to mitochondrial ADPRase. The different cytosolic types are distinguished by their specificities for substrate and specific requirement for metal ions. NUDT5 forms a homodimer.	9.97045e-26
NZ_CP027781.1\|WP_106901093.1\|3400244_3401021_+\|hypothetical-protein	gnl\|CDD\|376845	pfam02596, DUF169, Uncharacterized ArCR, COG2043.	6.01416e-67
NZ_CP027781.1\|WP_106901102.1\|3410358_3411588_+\|exonuclease-SbcCD-subunit-D	gnl\|CDD\|273178	TIGR00619, Nuclease_SbcCD_subunit_D, exonuclease SbcD. All proteins in this family for which functions are known are double-stranded DNA exonuclease (as part of a complex with SbcC homologs). This complex functions in the initiation of recombination and recombinational repair and is particularly important in regulating the stability of DNA sections that can form secondary structures. This family is likely homologous to the MRE11 family. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). [DNA metabolism, DNA replication, recombination, and repair].	2.21733e-57
NZ_CP027781.1\|WP_030033357.1\|3401440_3402199_+\|threonine/serine-exporter	gnl\|CDD\|377697	pfam06738, ThrE, Putative threonine/serine exporter. ThrE is a family of bacterial and Archaeal proteins that catalyze the export of L-threonine from the cell. UniProtKB:Q79VD1 has been characterized as being necessary for this export. The domain exhibits 10 putative TMs and catalyzes the proton-motive-force-dependent efflux of threonine and serine.	5.23789e-72
NZ_CP027781.1\|WP_106901100.1\|3408934_3409174_-\|transcriptional-regulator	gnl\|CDD\|226181	COG3655, COG3655, Predicted transcriptional regulator [Transcription].	3.07643e-26
NZ_CP027781.1\|WP_106901090.1\|3397819_3398764_+\|branched-chain-amino-acid-ABC-transporter-permease	gnl\|CDD\|119323	cd06581, TM_PBP1_LivM_like, Transmembrane subunit (TM) of Escherichia coli LivM and related proteins. LivM is one of two TMs of the E. coli LIV-1/LS transporter, a Periplasmic Binding Protein (PBP)-dependent ATP-Binding Cassette (ABC) transporter involved in the uptake of branched-chain amino acids (AAs). These types of transporters generally bind type 1 PBPs. PBP-dependent ABC transporters consist of a PBP, two TMs, and two cytoplasmic ABCs, and are mainly involved in importing solutes from the environment. The solute is captured by the PBP, which delivers it to a gated translocation pathway formed by the two TMs. The two ABCs bind and hydrolyze ATP and drive the transport reaction. E. coli LivM forms a heterodimer with another TM, LivH, to generate the transmembrane pore. LivH is not included in this subgroup. The LIV-1/LS transporter is comprised of two TMs (LivM and LivH), two ABCs (LivG and LivF), and one of two alternative PBPs, LivJ (LIV-BP) or LivK (LS-BP). In addition to transporting branched-chain AAs including leucine, isoleucine and valine, the E. coli LIV-1/LS transporter is involved in the uptake of the aromatic AA, phenylalanine.	3.67152e-90
NZ_CP027781.1\|WP_030033349.1\|3395800_3396943_+\|branched-chain-amino-acid-ABC-transporter-substrate-binding-protein	gnl\|CDD\|380572	cd06349, PBP1_ABC_HAAT-like, type 1 periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems predicted to be involved in uptake of amino acids or peptides. This subgroup includes the type 1 periplasmic ligand-binding domain of uncharacterized ABC (Atpase Binding Cassette)-type active transport systems that are predicted to be involved in the uptake of amino acids or peptides. This subgroup has high sequence similarity to members of the family of hydrophobic amino acid transporters (HAAT), such as leucine-isoleucine-valine binding protein (LIVBP); however, its ligand specificity has not been determined experimentally.	3.90181e-130
NZ_CP027781.1\|WP_106901099.1\|3408263_3408854_+\|AraC-family-transcriptional-regulator	gnl\|CDD\|181382	PRK08317, PRK08317, hypothetical protein; Provisional.	3.74373e-16

>NZ_CP027781.1|WP_003488346.1|3404446_3405016_+|LemA-family-protein
MKKGLRNTLIVVGIILLILFPLIGTYNKLVSMEQNVNRAASNIDTNLQRRSDLISNLVETVKGYAAQEKDIFKGVADARSKLAGAQKIDEKAQANEELSGALSRLLVVVERYPDLKSSQNFKDLSVAIEGTENRIAIARQDYNESVNNYNTGIRKFPNSIIAGMFRFSEKPYFKAEAGASKAPKVDFSK
>NZ_CP027781.1|WP_106901095.1|3402934_3404386_+|PLP-dependent-aminotransferase-family-protein
MLFDIKLDKNSPVYIQISDYIKSMILKGMIRKDEKLPSTRELASMLKVSRNTIISAYEFLEDDGFIYMKKGKGAFVSNVNIHVEEKWEINWEKNINDYAKKAESLDIIKHEIPWEKGMISFKSISPDDNLFDLDEFKKAFLNRFSLEGEKILNYGYAIGYRDLINHIMKYMKNKGVDTSNKKILITNGFTEGFDIVLSSLIQKGDKVLCENPTHNTAIKIMKMHDIEIVGIDMDKDGINIDKLKETIGKNNIKLAYLVPSYHNPTGIVMSPEKRIKIYNILKDNNIPIVEDGFNEELRYSGDHVSPMIAFSGNGNSIIYIGSFSKVLFPGIRIGWVLGDEKLIDYLESVKRSRNIHTSFLDQAILYEYLKSGNFEKYIKKARKIYKEKYEFALKCAKKYIPAEYITGEGGLHIFVKLKNIKSRELLKECCKRGVIFTPGDIFYVDNKGEDTFRLGISRVSLEEIEKGFKIIGNSAKKLINNYI
>NZ_CP027781.1|WP_106901094.1|3402192_3402636_+|threonine/serine-exporter
MVIKQIILAFFGSVFPVVLFNIDRKKIIWTGFAGSIGWMAYLIVYNYIHSPVMSSFVGAFMVGVYSEFMARKLKTPAMQFSIPGIFPLVPGITAYYAINSIVEQNYALAYSKGFQTVAVGGAIAFGIMLSSTTVRFITKITQTKRVK
>NZ_CP027781.1|WP_030033357.1|3401440_3402199_+|threonine/serine-exporter
MEAKQVLEISLSVGKMLLSNGAESYRVEETIERICRAYNLQCECMVTAKGVFLSIIDDNNEKVTSLKKVKTRGVDLARIDRLNSFSRSLQDNPISYNEAKETLKEIDSLPFFSLPVRIVAAGMTSFVYSLFFNGTIYDAIVSTFISMGIYYMLDRVSKVGFFQFFQFFFAGFIIGISSLVAENIFPLVSRGNIITGGIMILVPGVPLTNGIKDIIYDDFMSGIVKFGEAMLVVTAMGAGIATALTLGVGVKW
>NZ_CP027781.1|WP_106901093.1|3400244_3401021_+|hypothetical-protein
MDIKNTCQNLYATLNLERKMVGIKFIFTKDHFEKLDIPKLNSKVTYCYMVKMVSNGKEFKANEENFKCLASARALGIISSNNYVDSGQHYGKHGLYDSLATAKKVQKDITFINHSIYGIEIRPLENFVEEPDVVVIITNPYGAMRIVQAYTYKYGVHKNITLGGNQGICSECTAIPYENNDINISTLCSGTRFFCKWDESDMGVGFPFNKLKDIEQGILKTLNPTEPNHKKKEIELKTKNIENNIDVKYNENYFVNYK
>NZ_CP027781.1|WP_106901092.1|3399514_3400216_+|branched-chain-amino-acid-ABC-transporter-ATP-binding-protein
MLIVKDINVNYGVIPALKQISINVNEGEIVTIIGNNGSGKSTLLKAIIAQLKYTGDISFYGESLKGMSTHKIAQKGICLVPEGRGIFPLITVEENLLLAFCNKINKGTKDEKLQEVYTRFPRLKERRTQLAGSLSGGEQQMLAIGRAILSSAKLILLDEPSMGLAPIMVEEVFETIKSINKEGTSILLIEQNASMALKVCNRGYALENGKIVLEGSTEELIKSNFIKKIYLGR
>NZ_CP027781.1|WP_106901091.1|3398775_3399513_+|ABC-transporter-ATP-binding-protein
MNILEVKDLNINFGGITAVDNLNFSVKKGEILGIIGPNGAGKTTLYNTITGIYKPSKGDIFLNNKKITGMKPYKISRLGIARTFQNIRLFNSLTVLENILVGRVSELKKLVKLNPYMEETFDILKVVGLEKVINNMASDLPYGQQRKVEIARALAISPKVLLLDEPAAGMNNYEKRDLKNLINILREDFNITVLIIEHDMGVIMELCDRILVLDYGKKIAEGSPEEISNDDNVIKAYMGKGIKEI
>NZ_CP027781.1|WP_106901090.1|3397819_3398764_+|branched-chain-amino-acid-ABC-transporter-permease
MKLFKNNKIMFLIILAILLVAPFMITNQYILHIIITILLYSILSMSLNFVSGNAGQISVGHAAFYGIGAYTTSILMINAHLSFITAMLLGGLLAGICGIFLGIPSLRVKGNYLCIITLGFGEIVKLILLNWDKVTGGPMGISSIPNPEFLNIFKDKNLGFYYLILFLFVIFFVILYKLTYSNYGLLMLAVRENEIAATSLGVNITSIKFFAFIISSFIAGIAGGFYATYVSFISPESFMFKESITILAMVIIGGKGNIVGSIIGAIVLAIIPEFLREFNDYRMLFYGLGLVLMIVFRPDGIYGLKYRKKFTYKS
>NZ_CP027781.1|WP_106901089.1|3396946_3397819_+|branched-chain-amino-acid-ABC-transporter-permease
MIIEVLVNGITLGSIYCLAALGFNMIFGVLKMLNFAHGEILMFGTFVFFTMVSIFKIPLILAIILTIVITGFIGVLLYLIAYKPVLKGDTMAPLLSSLGVSIMLEALGQLIWGTEIIPFPINIPKGTYSIASIKLSNIQIFIFLFSITLMIILYKFIMKSNIGLQIRALSYNRKYAELMGIETDKITMIVFSLATILAMVSGILSSMYYDALYVTMGSGVMIKAFAAAILGGIGSIPGALVGGYILGVSESLVGAYISTSYVDGIAFIILVLVLIIKPNGIFGEEIKEKV
>NZ_CP027781.1|WP_030033349.1|3395800_3396943_+|branched-chain-amino-acid-ABC-transporter-substrate-binding-protein
MKFAKFKKKSLIALSSILVLGSLVGCQSNSSEKEGTIKVGLVAPLSGAMAQDGKSILNAAQLAVDEVNKEGGINKKKIELVYEDDKGEPKEAASIANKYSSDKDIMAVMGSFSAPCTLAGIPIYTKAKIPMMGPCGSAPALSGSSEYYRKVTPSDLTTGKELSKWMLKDMNYKKVAIIYVNNDYGKGVAESVDNFYKENGGQVVAKESYMPKTQDFGSIITKVKSKNPDIIIMGSFYGDAGAFLKQAHNVGYNPKVAGPTPLLSKSLVDLAGKDAEGIFTIGSFSTNLENEKVKEFTEKYKKKYNQAPSSFAAYSYDATKILIEGIKKGGNDREKINEALKNMGTYTGVTGNTKFEKSGDAEKNLIRFIVKDGKFVEWKK
>NZ_CP027781.1|WP_106901097.1|3406052_3406946_+|NUDIX-hydrolase
MLKRDTRVQIVIVENGKYILLKHWVKSKNRYFWGLPGGGREKGESLEEAAIREAKEETGLDIELLPLTYESLPPIKNSMYKNMVTFIGYPVKGEAKVGYDPEEELKNIYGLVDIKWQDLGDKEGLTDVTIRDVDGILDKFEIEDIEEEKIFLIYREKNSIREYLVLNNINIIKEQCILSNINKSVSDNKIKFLCLNKDNEYTFCGDNCSLNLKSCSPEVYLQEILGIKLKNVTGQKKLGIFLYKKNNNFFKRNITLIPLKKEEKIYKEHSFIKEEDVLKEKISEDLVRIFTFIKDNI
>NZ_CP027781.1|WP_030033365.1|3407078_3407561_+|hypothetical-protein
MDVLERILLILVGVTFIFWIVLTFINLWYKSKEGGKVVLNIKRGIERNIMILMSLIIILFSLLNDNPNTYIEIIIGIVILYNGVERFEIMENGIFVEGNFKKWEDIESCKWHERLDHTLIIRGKEDVDYLRRFNTIKLRIKKEEQEQVFKIINKKIAQVS
>NZ_CP027781.1|WP_106901098.1|3407737_3408262_+|ECF-transporter-S-component
MVQSKNKQLVRGALLIAIGLLLPYLFHGIKNAGSIFLPMHIPILMGGFILSPYFALGVGVLTPLLSHLFTGMPPFPFVYVMVVELLTYGVVISILYNKKKMGIYPSLIIGMLSGRLANILCNYLVLHLIMTKPFKFPVVLAGLFVKGLPGIIIQLILIPILVKELGKVELGKAV
>NZ_CP027781.1|WP_106901099.1|3408263_3408854_+|AraC-family-transcriptional-regulator
MNDREFFNNLADKWDSMCFHSKEKIEYILSKVNLKEGDRVLDIGSGTGVLIPYLENIICNIGHITAMDIAENMLKVSKEKNTYSNLDFIVEDFLGYKSKKTFDCITAYSCYPHFKDKDKLADRAYELLEEGGRLVIAHSESKEKINSRHKDVDHKIKSHILPKVKYTAELMEKHNFKTIYTEDNEEYYIYIGTRNK
>NZ_CP027781.1|WP_106901100.1|3408934_3409174_-|transcriptional-regulator
MSIVVNLDVMMAKRKISLKELAEKINLTNANLSILKNNKAKAIRFSTLEAICKELNCQPGDILEYKEDQKGNEKEDESN
>NZ_CP027781.1|WP_106901101.1|3409194_3409656_-|DUF2975-domain-containing-protein
MKENFSINFIKILLVLIVFVCGIMLFQFVLMGLFAPKELFHNISSILASLLIIAVYFVIAWNLLKIVYSIESNPFTLKNVKSFKIIGYLMIFLSIIDGIVNFKKKSNFQIIGIGYGSIKGSCILYLVLGLMALVLAEIFKKAVQIKDENDLTI
>NZ_CP027781.1|WP_106901102.1|3410358_3411588_+|exonuclease-SbcCD-subunit-D
MRILHTSDWHLGKNLEGFSRMDEQERFIEDFINIVDKNNIDMVIIAGDVYDNGNPPARAEKMFYDCIKKVSNKGERLVLIIAGNHDNPERLVAASPLAYDEGIILMGTPKTIIPKGKYGDFKVINSDLGCLEIEIKGERAVIISLPYPSEKRLNEILSKEMDNDEDRRKTYSERIGGIFSNLQEKYYKDDTVNLAISHIFVDGSEETDSERPIQLGGSLAVDADKLPEKAQYIGLGHLHKPQKVRGLGNAYYSGSPLPYSKSERGYSKGCKIIDVHPGEKAIIEDVYFNNYKPIEVWSCNGIEDAINKCEENKEKDMWLYLHIKTKEYISTEDIKILKEIKKDIVEIVPEIEEKREETFKVNIKEKSMGELFKSFYLNQRGIEASEELMNLFLSIAQEEDAHETEETCD
>NZ_CP027781.1|WP_106901103.1|3411562_3415093_+|exonuclease-SbcC
MKPKKLVIKGLNSFIEKQEIDFETLVNRGLFGIFGPTGSGKSSILDAITMALYGDIARDSTQFINLDTDSLFVSYEFQIAFGGKREDYIVSRTVKRDKKGGYKTTAARLVKNSEGEEEIIADKPRDIQKNIESIIGLTAEDFTRSVVLPQGKFSEFLKLSGKSRRDMLERIFGLEKYGKKLLERIRKARNKEISSLTLIEGRLEQYKDISKEKLQELKMQYENLLKEKSKIAKEKEEMDKLYEKYKNIWELQEELDVYLNKLEDLKKGLLDIEGKKVKVEKGKNALNVKPYIDEINKIEGDKNINEKELNAAIEQLKNIDLNLKNLEDEYKKASNDKEEKIPLLMQKENNLLQAIEIKKKVETIKREKATLAQKYKEKDASIKNKNIEKRSIEDNINKISEEIKLKEEEINFLKIDGDRREKIQKLYEIDKEYKRLNLEVYNITEKINKKMGSLKNYELKYKDTLKIQKDINKKLEYVLDKKEELIKNSPGSNDTLLNKKDYINKLGETFNNLNKINDKKQELEKNLKEKQRVKLNLEKQYKEILEILKSREETVVSLDEKIKNIEKINMASILAANLKDQESCPVCGSMHHIKLAKEVDIKELEILKEEHGNILEELENIKIEENKKNILLISIKKEEELILEELENLKGQLKNRNLKDLREELQKEKNEFQKLNENIKTWEKEKLILEENINKLQKEKNNIDKEEAKNHEAISKEKELIVSIKKDREEREILFKKKEKEYLNLKEEIKVSNVEEEISRIRASDKKVEEYNKVIKSKRETLDTEKNKREEIIRYINTIEIELGKIIEAGKEKKNFIDKEEVEIKKLNVGEISKEHLDEVKKSIENIKGKEETLKSKLELEGKNREVLWENKISKEQIKINLEKLYNEKFIQLNRALEENKFHTLENAKLMLICKEEIKEFEKEIEEFEKKYNNLNMNIERVNKKLKGERIEEESWKDIRLKKENKEKELEDIIKNIVIEEKLISDMESNIKALKELLDEKEKVSHKKALLEDIDKLVQGNKFVEFVAMNQLEYIVFEASKRLKDITRGRYALELDCNGNFTMRDDFNGGGIRPTNTLSGGETFLTSLALALALSSQIQLKGSSPLEFFFLDEGFGTLDSELLDTVMTSLENLRSDRLSVGIISHVEELKNRVPIKLIVDPAVPGEGGSKIKIEYS
>NZ_CP027781.1|WP_106901104.1|3415120_3415669_+|NUDIX-hydrolase
MKKLEEKILYKGKWISFKEISYLNNEEELLKWEAVERTNTTKAVVIVAKLVPTERYVFIKQYRPAIDNYVIGFPAGLLEQEDIELEAKRELKEETGYIGKVVDISPEIRPNPALLTDYTILVQMEIDENDELNKNPKQELEPSEDIEVILVSKEESRDFLIEQKNKGVDVGVGPWYIFGFKL
>NZ_CP027781.1|WP_106901105.1|3416532_3417384_+|YitT-family-protein
MHLKKENAKRLLLVMMGSLIYAIGVNMFLIPHRLLSGGVAGIAIMLQYLTSIQSGYYILLINIPIFLIAFKEVDLDFSIFSFVGMISMSSFLILSRNYMDFYVMNDILLSCICGGVLSGAGMGLIFRNRASQGGTDVISVLVKRKLGIKISTIDFMINCVVVTIGALLGSFEVAIYTMISMFVKSQVMGKVIEGFDGKKILFVVTDHDEEIKKQLLEKLGVGATIMYGEGAYSGAKRKIIYCIMTSQQIVKAKKIIEDFDEHALISVSNTTECQGGGFKAAAF

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity
NZ_CP027781_1	1.1\|84847\|55\|NZ_CP027781\|CRISPRCasFinder	84847-84901	55	NZ_CP027781.1	84741-84795	0	1.0

1. spacer 1.1|84847|55|NZ_CP027781|CRISPRCasFinder matches to position: 84741-84795, mismatch: 0, identity: 1.0

aaggatttaccgcaaaaaatactccttttaaagcactcccataagttttttcaag	CRISPR spacer
aaggatttaccgcaaaaaatactccttttaaagcactcccataagttttttcaag	Protospacer
*******************************************************

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP027781_4	4.5\|2621918\|35\|NZ_CP027781\|CRISPRCasFinder	2621918-2621952	35	NZ_CP014152	Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence	113502-113536	0	1.0
NZ_CP027781_4	4.5\|2621918\|35\|NZ_CP027781\|CRISPRCasFinder	2621918-2621952	35	NC_025146	Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111	105578-105612	0	1.0
NZ_CP027781_4	4.5\|2621918\|35\|NZ_CP027781\|CRISPRCasFinder	2621918-2621952	35	NZ_CP013710	Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence	165849-165883	0	1.0
NZ_CP027781_4	4.11\|2621919\|35\|NZ_CP027781\|PILER-CR	2621919-2621953	35	NZ_CP014152	Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence	113502-113536	0	1.0
NZ_CP027781_4	4.11\|2621919\|35\|NZ_CP027781\|PILER-CR	2621919-2621953	35	NC_025146	Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111	105578-105612	0	1.0
NZ_CP027781_4	4.11\|2621919\|35\|NZ_CP027781\|PILER-CR	2621919-2621953	35	NZ_CP013710	Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence	165849-165883	0	1.0
NZ_CP027781_7	7.2\|2638274\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2638274-2638309	36	NZ_CP013848	Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence	37705-37740	0	1.0
NZ_CP027781_7	7.4\|2638406\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2638406-2638439	34	NZ_CP013848	Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence	13140-13173	0	1.0
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP031095	Clostridium botulinum strain CFSAN034200 plasmid p1_CDC51232, complete sequence	162454-162489	0	1.0
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP013700	Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence	8805-8840	0	1.0
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NC_012654	Clostridium botulinum Ba4 str. 657 plasmid pCLJ, complete sequence	219694-219729	0	1.0
NZ_CP027781_8	8.5\|2639540\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2639540-2639575	36	NZ_CP013700	Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence	94337-94372	0	1.0
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	NZ_CP013700	Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence	92113-92149	0	1.0
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP014152	Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence	190981-191016	1	0.972
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NC_025146	Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111	138221-138256	1	0.972
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP013710	Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence	88369-88404	1	0.972
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NC_010418	Clostridium botulinum A3 str. Loch Maree plasmid pCLK, complete sequence	265881-265916	1	0.972
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	NC_012654	Clostridium botulinum Ba4 str. 657 plasmid pCLJ, complete sequence	45475-45511	1	0.973
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	NC_025146	Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111	71359-71395	1	0.973
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	NZ_CP031095	Clostridium botulinum strain CFSAN034200 plasmid p1_CDC51232, complete sequence	66648-66684	1	0.973
NZ_CP027781_13	13.11\|2652981\|21\|NZ_CP027781\|CRISPRCasFinder,CRT	2652981-2653001	21	NZ_CP013682	Clostridium botulinum strain 1169 plasmid pRSJ8_1, complete sequence	193992-194012	1	0.952
NZ_CP027781_13	13.11\|2652981\|21\|NZ_CP027781\|CRISPRCasFinder,CRT	2652981-2653001	21	NZ_CP013295	Clostridium botulinum strain CDC_54064 plasmid pNPD1_1, complete sequence	7727-7747	1	0.952
NZ_CP027781_4	4.6\|2621983\|34\|NZ_CP027781\|CRISPRCasFinder	2621983-2622016	34	NZ_CP013848	Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence	21096-21129	2	0.941
NZ_CP027781_6	6.1\|2624448\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2624448-2624481	34	NZ_CP013709	Clostridium botulinum strain F634 plasmid pRSJ2_2, complete sequence	167859-167892	2	0.941
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP006909	Clostridium botulinum CDC_1436 plasmid pCBG, complete sequence	17589-17624	2	0.944
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NZ_CP013684	Clostridium botulinum strain AM282 plasmid pRSJ10_1, complete sequence	160196-160231	3	0.917
NZ_CP027781_17	17.1\|3405798\|25\|NZ_CP027781\|CRISPRCasFinder	3405798-3405822	25	NC_007706	Magnetospirillum magneticum plasmid pMGT, complete sequence	35-59	3	0.88
NZ_CP027781_17	17.1\|3405798\|25\|NZ_CP027781\|CRISPRCasFinder	3405798-3405822	25	NZ_CP022220	Bradyrhizobium guangxiense strain CCBAU 53363 plasmid p53363, complete sequence	502712-502736	4	0.84
NZ_CP027781_17	17.1\|3405798\|25\|NZ_CP027781\|CRISPRCasFinder	3405798-3405822	25	NZ_CP030052	Bradyrhizobium guangdongense strain CCBAU 51649 plasmid unnamed, complete sequence	112860-112884	4	0.84
NZ_CP027781_17	17.1\|3405798\|25\|NZ_CP027781\|CRISPRCasFinder	3405798-3405822	25	NZ_CP030054	Bradyrhizobium guangzhouense strain CCBAU 51670 plasmid unnamed1, complete sequence	295109-295133	4	0.84
NZ_CP027781_4	4.16\|2621918\|44\|NZ_CP027781\|CRT	2621918-2621961	44	NZ_CP014152	Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence	113493-113536	5	0.886
NZ_CP027781_4	4.16\|2621918\|44\|NZ_CP027781\|CRT	2621918-2621961	44	NZ_CP013710	Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence	165849-165892	5	0.886
NZ_CP027781_4	4.16\|2621918\|44\|NZ_CP027781\|CRT	2621918-2621961	44	NC_025146	Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111	105569-105612	5	0.886
NZ_CP027781_15	15.78\|2665022\|33\|NZ_CP027781\|PILER-CR	2665022-2665054	33	MF001357	Clostridium phage CP3, partial genome	17205-17237	6	0.818
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	NZ_CP031281	Staphylococcus pasteuri strain 3C plasmid unnamed1, complete sequence	31879-31914	6	0.833
NZ_CP027781_10	10.3\|2641225\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641225-2641260	36	LN681539	Clostridium phage phiCD505, complete genome	31828-31863	7	0.806
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MN694132	Marine virus AFVG_250M1196, complete genome	31470-31503	7	0.794
NZ_CP027781_15	15.78\|2665022\|33\|NZ_CP027781\|PILER-CR	2665022-2665054	33	NC_029024	Bacillus phage 250, complete genome	2956-2988	7	0.788
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	NC_015916	Borreliella bissettii DN127 plasmid lp28-3, complete sequence	6242-6277	7	0.806
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	LT960552	Yersinia phage fHe-Yen9-03 genome assembly, complete genome: monopartite	280061-280096	8	0.778
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	LR596615	Yersinia phage fHe-Yen9-04 genome assembly, chromosome: I	281824-281859	8	0.778
NZ_CP027781_7	7.11\|2638868\|36\|NZ_CP027781\|CRISPRCasFinder,CRT	2638868-2638903	36	NC_042116	Yersinia phage fHe-Yen9-04 genome assembly, complete genome: monopartite	281824-281859	8	0.778
NZ_CP027781_8	8.5\|2639540\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2639540-2639575	36	AP014333	Uncultured Mediterranean phage uvMED isolate uvMED-GF-U-MedDCM-OCT-S36-C55, * SEQUENCING IN PROGRESS *	32887-32922	8	0.778
NZ_CP027781_10	10.3\|2641225\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641225-2641260	36	MN698241	Pelagibacter phage HTVC027P, complete genome	5991-6026	8	0.778
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	CP019599	Staphylococcus cohnii strain SNUDS-2 plasmid pSC-SNUDS-2-2, complete sequence	7133-7166	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NC_016748	Marinitoga piezophila KA3 plasmid pMARPI01, complete sequence	3685-3718	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP014283	Bacillus thuringiensis strain Bt185 plasmid pBT1850636, complete sequence	601409-601442	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP032614	Bacillus thuringiensis strain QZL38 plasmid p.1, complete sequence	290593-290626	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP029455	Bacillus cereus strain FORC087 plasmid pFORC087.1, complete sequence	339062-339095	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NC_018516	Bacillus thuringiensis HD-789 plasmid pBTHD789-1, complete sequence	165747-165780	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP009334	Bacillus thuringiensis strain HD1011 plasmid 2, complete sequence	99944-99977	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_LR214986	Mycoplasma cynos strain NCTC10142 plasmid 13	549528-549561	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MN694369	Marine virus AFVG_250M682, complete genome	35046-35079	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP053970	Bacillus thuringiensis strain FDAARGOS_796 plasmid unnamed2, complete sequence	264697-264730	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP053979	Bacillus thuringiensis strain FDAARGOS_795 plasmid unnamed3, complete sequence	172909-172942	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP013277	Bacillus thuringiensis serovar israelensis strain AM65-52 plasmid pAM65-52-2-350K, complete sequence	41631-41664	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP039723	Bacillus thuringiensis strain BT-59 plasmid p2, complete sequence	158632-158665	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP009348	Bacillus thuringiensis HD1002 plasmid 2, complete sequence	41631-41664	8	0.765
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP045024	Bacillus thuringiensis strain JW-1 plasmid p2, complete sequence	41631-41664	8	0.765
NZ_CP027781_11	11.3\|2642097\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2642097-2642130	34	NZ_CP046630	Streptococcus equinus strain CNU G6 plasmid p1_CNU_G6, complete sequence	3650-3683	8	0.765
NZ_CP027781_11	11.3\|2642097\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2642097-2642130	34	NZ_CP046920	Streptococcus sp. CNU G2 plasmid p_CNU_G2, complete sequence	7314-7347	8	0.765
NZ_CP027781_13	13.4\|2652522\|33\|NZ_CP027781\|CRISPRCasFinder,CRT	2652522-2652554	33	MN694611	Marine virus AFVG_250M767, complete genome	9168-9200	8	0.758
NZ_CP027781_15	15.13\|2663901\|35\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663901-2663935	35	NZ_CP044980	Bacillus thuringiensis strain BT62 plasmid pBT62B, complete sequence	190164-190198	8	0.771
NZ_CP027781_15	15.30\|2665021\|34\|NZ_CP027781\|CRISPRCasFinder	2665021-2665054	34	NC_029024	Bacillus phage 250, complete genome	2956-2989	8	0.765
NZ_CP027781_15	15.30\|2665021\|34\|NZ_CP027781\|CRISPRCasFinder	2665021-2665054	34	MF001357	Clostridium phage CP3, partial genome	17205-17238	8	0.765
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	NC_019507	Campylobacter phage CP21, complete genome	135174-135209	8	0.778
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	MT932329	Campylobacter phage F379, complete genome	13726-13761	8	0.778
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	MK408758	Campylobacter phage CP20, complete genome	39684-39719	8	0.778
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	HE815464	Campylobacter phage CP21 complete sequence	135174-135209	8	0.778
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	FN667788	Campylobacter phage CP220, complete genome	39849-39884	8	0.778
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	FN667789	Campylobacter phage CPt10, complete genome	39684-39719	8	0.778
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	NZ_CP054262	Lactobacillus plantarum strain TCI507 plasmid unnamed3	8349-8382	8	0.765
NZ_CP027781_8	8.1\|2639280\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2639280-2639313	34	CP033533	Acinetobacter pittii strain 2014S07-126 plasmid p2014S07-126-3, complete sequence	16358-16391	9	0.735
NZ_CP027781_8	8.1\|2639280\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2639280-2639313	34	KJ081346	Bacillus phage BCP8-2, complete genome	123560-123593	9	0.735
NZ_CP027781_10	10.3\|2641225\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641225-2641260	36	NC_011247	Borrelia duttonii Ly plasmid pl165, complete sequence	83771-83806	9	0.75
NZ_CP027781_10	10.3\|2641225\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641225-2641260	36	JQ287645	Sulfolobus virus STSV2, complete genome	7602-7637	9	0.75
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP028373	Campylobacter jejuni subsp. jejuni strain huA17 plasmid unnamed1, complete sequence	43045-43078	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP018901	Campylobacter coli strain YH502 plasmid pCOS502, complete sequence	38251-38284	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP014745	Campylobacter jejuni strain OD267 plasmid pCJDM67 L, complete sequence	87116-87149	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP017026	Campylobacter coli plasmid pCC14983A-1, complete sequence	72465-72498	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP014345	Campylobacter jejuni strain RM3194 plasmid unnamed, complete sequence	17226-17259	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP014743	Campylobacter jejuni strain WP2202 plasmid pCJDM202, complete sequence	89777-89810	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP017417	Campylobacter jejuni strain MTVDSCj13 plasmid pMTVDSCj13-2, complete sequence	1689-1722	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP025282	Campylobacter coli strain YH503 plasmid pCOS503, complete sequence	40017-40050	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP048772	Campylobacter jejuni strain ZS007 plasmid pCJ145K, complete sequence	21586-21619	9	0.735
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP044174	Campylobacter jejuni strain AR-0412 plasmid pAR-0412, complete sequence	59340-59373	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP007513	Bacillus bombysepticus plasmid pBb, complete genome	408501-408534	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP009368	Bacillus cereus strain FM1 plasmid unnamed, complete sequence	232021-232054	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NC_011777	Bacillus cereus AH820 plasmid pAH820_272, complete sequence	156912-156945	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP020748	Bacillus mycoides strain Gnyt1 plasmid unnamed5, complete sequence	55793-55826	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	AP013430	Uncultured Mediterranean phage uvMED DNA, complete genome, group G16, isolate: uvMED-CGR-U-MedDCM-OCT-S25-C55	12097-12130	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MG592562	Vibrio phage 1.193.O._10N.286.52.C6, partial genome	80062-80095	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP014851	Bacillus thuringiensis strain HD12 plasmid pHD120112, complete sequence	25862-25895	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250021	Prevotella phage Lak-B2, complete genome	402218-402251	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250024	Prevotella phage Lak-B5, complete genome	394542-394575	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250028	Prevotella phage Lak-B9, complete genome	399432-399465	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250025	Prevotella phage Lak-B6, complete genome	398094-398127	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250022	Prevotella phage Lak-B3, complete genome	398185-398218	9	0.735
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	MK250020	Prevotella phage Lak-B1, complete genome	399415-399448	9	0.735
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	NZ_CP028250	Pediococcus acidilactici strain SRCM102732 plasmid unnamed1, complete sequence	5454-5490	9	0.757
NZ_CP027781_11	11.3\|2642097\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2642097-2642130	34	MT446416	UNVERIFIED: Escherichia virus TH47, complete genome	43536-43569	9	0.735
NZ_CP027781_13	13.7\|2652718\|35\|NZ_CP027781\|CRISPRCasFinder,CRT	2652718-2652752	35	NZ_CP041047	Citrobacter sp. CF971 plasmid pBM527-1, complete sequence	241094-241128	9	0.743
NZ_CP027781_13	13.7\|2652718\|35\|NZ_CP027781\|CRISPRCasFinder,CRT	2652718-2652752	35	NZ_CP050835	Klebsiella pneumoniae strain Bckp021 plasmid pBckp021-1, complete sequence	3286-3320	9	0.743
NZ_CP027781_13	13.7\|2652718\|35\|NZ_CP027781\|CRISPRCasFinder,CRT	2652718-2652752	35	NZ_CP035215	Klebsiella michiganensis strain M82255 plasmid pKOCBH-A, complete sequence	346453-346487	9	0.743
NZ_CP027781_15	15.1\|2663115\|37\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663115-2663151	37	MH931003	Termite gut associated microvirus 1 isolate Ter_359, complete genome	4677-4713	9	0.757
NZ_CP027781_15	15.1\|2663115\|37\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663115-2663151	37	MG967616	Bacillus phage v_B-Bak1, complete genome	40795-40831	9	0.757
NZ_CP027781_15	15.1\|2663115\|37\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663115-2663151	37	KC595511	Bacillus phage Basilisk, complete genome	41829-41865	9	0.757
NZ_CP027781_15	15.1\|2663115\|37\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663115-2663151	37	MG967618	Bacillus phage v_B-Bak10, complete genome	42104-42140	9	0.757
NZ_CP027781_15	15.1\|2663115\|37\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663115-2663151	37	MG967617	Bacillus phage v_B-Bak6, complete genome	40795-40831	9	0.757
NZ_CP027781_15	15.31\|2665085\|35\|NZ_CP027781\|CRISPRCasFinder	2665085-2665119	35	NZ_CP038016	Paenisporosarcina antarctica strain CGMCC 1.6503 plasmid unnamed, complete sequence	45671-45705	9	0.743
NZ_CP027781_15	15.63\|2665021\|35\|NZ_CP027781\|CRT	2665021-2665055	35	NC_029024	Bacillus phage 250, complete genome	2955-2989	9	0.743
NZ_CP027781_15	15.63\|2665021\|35\|NZ_CP027781\|CRT	2665021-2665055	35	MF001357	Clostridium phage CP3, partial genome	17204-17238	9	0.743
NZ_CP027781_15	15.79\|2665086\|34\|NZ_CP027781\|PILER-CR	2665086-2665119	34	NZ_CP038016	Paenisporosarcina antarctica strain CGMCC 1.6503 plasmid unnamed, complete sequence	45671-45704	9	0.735
NZ_CP027781_16	16.3\|2665698\|36\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665698-2665733	36	HM246721	Campylobacter phage vB_CcoM-IBB_35 clone Contig2, complete sequence	2444-2479	9	0.75
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	NZ_CP012385	Enterococcus durans strain KLDS 6.0930 plasmid unnamed 1, complete sequence	54076-54109	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	NZ_CP007625	Bacillus pseudomycoides strain 219298 plasmid unnamed, complete sequence	73891-73924	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	NZ_CP012367	Enterococcus durans strain KLDS 6.0933 plasmid unnamed 1, complete sequence	44373-44406	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	NZ_CP009650	Bacillus pseudomycoides strain BTZ plasmid pBTZ_1, complete sequence	153874-153907	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	MK308676	Vibrio phage vB_VmeM-Yong MS31, complete genome	134415-134448	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	MK308675	Vibrio phage vB_VmeM-Yong XC32, complete genome	134414-134447	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	MK308677	Vibrio phage vB_VmeM-Yong MS32, complete genome	134415-134448	9	0.735
NZ_CP027781_16	16.5\|2665829\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2665829-2665862	34	MK308674	Vibrio phage vB_VmeM-Yong XC31, complete genome	134414-134447	9	0.735
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025884	Escherichia coli strain 503440 plasmid p503440_78, complete sequence	67159-67192	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025893	Escherichia coli strain 503025 plasmid p503025_105, complete sequence	11458-11491	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025893	Escherichia coli strain 503025 plasmid p503025_105, complete sequence	91551-91584	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025866	Escherichia coli strain 504211 plasmid p504211_78, complete sequence	77372-77405	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025872	Escherichia coli strain 503829 plasmid p503829_77, complete sequence	29598-29631	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP025914	Escherichia coli strain 203740 plasmid p203740_80, complete sequence	4111-4144	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP010123	Escherichia coli strain C5 plasmid A, complete genome	20274-20307	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP006002	Escherichia coli B7A plasmid pEB4, complete sequence	6727-6760	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	CP025899	Escherichia coli strain 500465 plasmid p500465_77, complete sequence	4669-4702	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	LN908839	Escherichia coli plasmid pCss_E1189	31494-31527	10	0.706
NZ_CP027781_6	6.3\|2624579\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2624579-2624612	34	KY705252	Streptococcus phage P0092, complete genome	29542-29575	10	0.706
NZ_CP027781_7	7.4\|2638406\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2638406-2638439	34	NZ_CP025846	Escherichia coli strain 720632 plasmid p720632_86, complete sequence	51304-51337	10	0.706
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NZ_CP009417	Jeotgalibacillus malaysiensis strain malaysiensis plasmid unnamed, complete sequence	227005-227038	10	0.706
NZ_CP027781_10	10.4\|2641291\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641291-2641324	34	NC_003267	Nostoc sp. PCC 7120 = FACHB-418 plasmid pCC7120gamma, complete sequence	46721-46754	10	0.706
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_CP015632	Borrelia turicatae strain BTE5EL plasmid lp30	18758-18791	10	0.706
NZ_CP027781_10	10.8\|2641550\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2641550-2641586	37	KY554777	Lactococcus phage LW81, complete genome	59631-59667	10	0.73
NZ_CP027781_15	15.13\|2663901\|35\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663901-2663935	35	NC_019688	Clostridium perfringens plasmid pNetB-NE10, complete sequence	59755-59789	10	0.714
NZ_CP027781_15	15.13\|2663901\|35\|NZ_CP027781\|PILER-CR,CRISPRCasFinder	2663901-2663935	35	NZ_CP025502	Clostridium perfringens strain EHE-NE18 plasmid pJIR3535, complete sequence	43434-43468	10	0.714
NZ_CP027781_15	15.34\|2663115\|38\|NZ_CP027781\|CRT	2663115-2663152	38	MH931003	Termite gut associated microvirus 1 isolate Ter_359, complete genome	4676-4713	10	0.737
NZ_CP027781_15	15.79\|2665086\|34\|NZ_CP027781\|PILER-CR	2665086-2665119	34	KY290955	Aeromonas phage 65.2, complete genome	2482-2515	10	0.706
NZ_CP027781_15	15.79\|2665086\|34\|NZ_CP027781\|PILER-CR	2665086-2665119	34	NC_015251	Aeromonas phage 65, complete genome	2482-2515	10	0.706
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP053971	Bacillus thuringiensis strain FDAARGOS_796 plasmid unnamed3, complete sequence	94540-94573	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP013278	Bacillus thuringiensis serovar israelensis strain AM65-52 plasmid pAM65-52-3-235K, complete sequence	216327-216360	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NC_018509	Bacillus thuringiensis HD-789 plasmid pBTHD789-2, complete sequence	210211-210244	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP039724	Bacillus thuringiensis strain BT-59 plasmid p3, complete sequence	152399-152432	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP051859	Bacillus thuringiensis serovar israelensis strain BGSC 4Q7rifR plasmid pBtic235, complete sequence	87430-87463	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP009347	Bacillus thuringiensis HD1002 plasmid 3, complete sequence	126186-126219	11	0.676
NZ_CP027781_5	5.1\|2622329\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2622329-2622362	34	NZ_CP045025	Bacillus thuringiensis strain JW-1 plasmid p3, complete sequence	216327-216360	11	0.676
NZ_CP027781_6	6.4\|2624643\|37\|NZ_CP027781\|CRISPRCasFinder,CRT	2624643-2624679	37	NZ_LR214986	Mycoplasma cynos strain NCTC10142 plasmid 13	460430-460466	11	0.703
NZ_CP027781_10	10.5\|2641355\|34\|NZ_CP027781\|PILER-CR,CRISPRCasFinder,CRT	2641355-2641388	34	NZ_AP017918	Candidatus Azobacteroides pseudotrichonymphae plasmid pAPPJ4 DNA, complete sequence, phylotype ProJPt-1	10375-10408	11	0.676
NZ_CP027781_7	7.12\|2638934\|35\|NZ_CP027781\|CRISPRCasFinder,CRT	2638934-2638968	35	JQ801337	Vibrio phage VvAW1, complete genome	495-529	12	0.657

1. spacer 4.5|2621918|35|NZ_CP027781|CRISPRCasFinder matches to NZ_CP014152 (Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

2. spacer 4.5|2621918|35|NZ_CP027781|CRISPRCasFinder matches to NC_025146 (Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

3. spacer 4.5|2621918|35|NZ_CP027781|CRISPRCasFinder matches to NZ_CP013710 (Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

4. spacer 4.11|2621919|35|NZ_CP027781|PILER-CR matches to NZ_CP014152 (Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

5. spacer 4.11|2621919|35|NZ_CP027781|PILER-CR matches to NC_025146 (Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

6. spacer 4.11|2621919|35|NZ_CP027781|PILER-CR matches to NZ_CP013710 (Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence) position: , mismatch: 0, identity: 1.0

atgtttttaactgtattataaaaagcacagtgtgt	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt	Protospacer
***********************************

7. spacer 7.2|2638274|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013848 (Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence) position: , mismatch: 0, identity: 1.0

gacatatttggattaactgaaagaagagtaagacag	CRISPR spacer
gacatatttggattaactgaaagaagagtaagacag	Protospacer
************************************

8. spacer 7.4|2638406|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013848 (Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence) position: , mismatch: 0, identity: 1.0

aataaaatatcacctttacataaatatatagctt	CRISPR spacer
aataaaatatcacctttacataaatatatagctt	Protospacer
**********************************

9. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP031095 (Clostridium botulinum strain CFSAN034200 plasmid p1_CDC51232, complete sequence) position: , mismatch: 0, identity: 1.0

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataaattactttgctgaaacatataa	Protospacer
************************************

10. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013700 (Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence) position: , mismatch: 0, identity: 1.0

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataaattactttgctgaaacatataa	Protospacer
************************************

11. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_012654 (Clostridium botulinum Ba4 str. 657 plasmid pCLJ, complete sequence) position: , mismatch: 0, identity: 1.0

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataaattactttgctgaaacatataa	Protospacer
************************************

12. spacer 8.5|2639540|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013700 (Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence) position: , mismatch: 0, identity: 1.0

tctagttcttctattttatttccaacattttttaat	CRISPR spacer
tctagttcttctattttatttccaacattttttaat	Protospacer
************************************

13. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013700 (Clostridium botulinum strain AM1195 plasmid pRSJ11_1, complete sequence) position: , mismatch: 0, identity: 1.0

ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
ttcgtacaatctttagtaacttctttagttttatcta	Protospacer
*************************************

14. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP014152 (Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence) position: , mismatch: 1, identity: 0.972

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataagttactttgctgaaacatataa	Protospacer
**************.*********************

15. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_025146 (Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111) position: , mismatch: 1, identity: 0.972

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
atcaaatcaaataaattactttgctgaaacatataa	Protospacer
* **********************************

16. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013710 (Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence) position: , mismatch: 1, identity: 0.972

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataagttactttgctgaaacatataa	Protospacer
**************.*********************

17. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_010418 (Clostridium botulinum A3 str. Loch Maree plasmid pCLK, complete sequence) position: , mismatch: 1, identity: 0.972

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
agcaaatcaaataagttactttgctgaaacatataa	Protospacer
**************.*********************

18. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_012654 (Clostridium botulinum Ba4 str. 657 plasmid pCLJ, complete sequence) position: , mismatch: 1, identity: 0.973

ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
ttcgtacaatttttagtaacttctttagttttatcta	Protospacer
**********.**************************

19. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_025146 (Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111) position: , mismatch: 1, identity: 0.973

ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
ttcgtacaatttttagtaacttctttagttttatcta	Protospacer
**********.**************************

20. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP031095 (Clostridium botulinum strain CFSAN034200 plasmid p1_CDC51232, complete sequence) position: , mismatch: 1, identity: 0.973

ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
ttcgtacaatttttagtaacttctttagttttatcta	Protospacer
**********.**************************

21. spacer 13.11|2652981|21|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013682 (Clostridium botulinum strain 1169 plasmid pRSJ8_1, complete sequence) position: , mismatch: 1, identity: 0.952

attattacgtttattattaaa	CRISPR spacer
attattacgtttattaataaa	Protospacer
**************** ****

22. spacer 13.11|2652981|21|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013295 (Clostridium botulinum strain CDC_54064 plasmid pNPD1_1, complete sequence) position: , mismatch: 1, identity: 0.952

attattacgtttattattaaa	CRISPR spacer
attattacgtttattaataaa	Protospacer
**************** ****

23. spacer 4.6|2621983|34|NZ_CP027781|CRISPRCasFinder matches to NZ_CP013848 (Clostridium botulinum strain Af650 plasmid pRSJ14_1, complete sequence) position: , mismatch: 2, identity: 0.941

tataagaagtctgtaaatctaataaatttatatt	CRISPR spacer
tataagaggtttgtaaatctaataaatttatatt	Protospacer
*******.**.***********************

24. spacer 6.1|2624448|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013709 (Clostridium botulinum strain F634 plasmid pRSJ2_2, complete sequence) position: , mismatch: 2, identity: 0.941

atatttccataatcctttcttattctgtctttga	CRISPR spacer
atattaccataatcttttcttattctgtctttga	Protospacer
***** ********.*******************

25. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP006909 (Clostridium botulinum CDC_1436 plasmid pCBG, complete sequence) position: , mismatch: 2, identity: 0.944

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
aataaatcaaataaattactttgctgaaacatataa	Protospacer
*..*********************************

26. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP013684 (Clostridium botulinum strain AM282 plasmid pRSJ10_1, complete sequence) position: , mismatch: 3, identity: 0.917

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
ttaaaatcaaataaattactttgctgaaacatataa	Protospacer
   *********************************

27. spacer 17.1|3405798|25|NZ_CP027781|CRISPRCasFinder matches to NC_007706 (Magnetospirillum magneticum plasmid pMGT, complete sequence) position: , mismatch: 3, identity: 0.88

aggcttcggcggtggaggatcatct	CRISPR spacer
tggcttcggcgctggcggatcatct	Protospacer
 ********** *** *********

28. spacer 17.1|3405798|25|NZ_CP027781|CRISPRCasFinder matches to NZ_CP022220 (Bradyrhizobium guangxiense strain CCBAU 53363 plasmid p53363, complete sequence) position: , mismatch: 4, identity: 0.84

aggcttcggcggtggaggatcatct	CRISPR spacer
tggcttcgccggcggaggatcatcc	Protospacer
 ******* ***.***********.

29. spacer 17.1|3405798|25|NZ_CP027781|CRISPRCasFinder matches to NZ_CP030052 (Bradyrhizobium guangdongense strain CCBAU 51649 plasmid unnamed, complete sequence) position: , mismatch: 4, identity: 0.84

aggcttcggcggtggaggatcatct	CRISPR spacer
tggcttcgccggcggaggatcatcc	Protospacer
 ******* ***.***********.

30. spacer 17.1|3405798|25|NZ_CP027781|CRISPRCasFinder matches to NZ_CP030054 (Bradyrhizobium guangzhouense strain CCBAU 51670 plasmid unnamed1, complete sequence) position: , mismatch: 4, identity: 0.84

aggcttcggcggtggaggatcatct	CRISPR spacer
tggcttcgccggcggaggatcatcc	Protospacer
 ******* ***.***********.

31. spacer 4.16|2621918|44|NZ_CP027781|CRT matches to NZ_CP014152 (Clostridium botulinum strain BrDura plasmid pRSJ20_1, complete sequence) position: , mismatch: 5, identity: 0.886

atgtttttaactgtattataaaaagcacagtgtgtgttgaacat-----	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt-----acatttatc	Protospacer
***********************************     ****

32. spacer 4.16|2621918|44|NZ_CP027781|CRT matches to NZ_CP013710 (Clostridium botulinum strain F634 plasmid pRSJ2_3, complete sequence) position: , mismatch: 5, identity: 0.886

atgtttttaactgtattataaaaagcacagtgtgtgttgaacat-----	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt-----acatttatc	Protospacer
***********************************     ****

33. spacer 4.16|2621918|44|NZ_CP027781|CRT matches to NC_025146 (Clostridium botulinum plasmid pCB111 DNA, complete sequence, strain: 111) position: , mismatch: 5, identity: 0.886

atgtttttaactgtattataaaaagcacagtgtgtgttgaacat-----	CRISPR spacer
atgtttttaactgtattataaaaagcacagtgtgt-----acatttgtc	Protospacer
***********************************     ****

34. spacer 15.78|2665022|33|NZ_CP027781|PILER-CR matches to MF001357 (Clostridium phage CP3, partial genome) position: , mismatch: 6, identity: 0.818

ttaaaga---tttttttaatttatccctaactttta	CRISPR spacer
---aagagcctttctttaatttatccctagcttttt	Protospacer
   ****   ***.***************.*****

35. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP031281 (Staphylococcus pasteuri strain 3C plasmid unnamed1, complete sequence) position: , mismatch: 6, identity: 0.833

atgtgtct-taatatttaaaaatatatctttttattt	CRISPR spacer
-tatgtttattatatttaaaaatatatcctcttattt	Protospacer
 *.***.* * *****************.*.******

36. spacer 10.3|2641225|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to LN681539 (Clostridium phage phiCD505, complete genome) position: , mismatch: 7, identity: 0.806

gaagaacaaataaaagaatataaagaaaaagttaag	CRISPR spacer
gaagaacaaataaaaaaatatatagaaaatatggaa	Protospacer
***************.****** ****** .* .*.

37. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MN694132 (Marine virus AFVG_250M1196, complete genome) position: , mismatch: 7, identity: 0.794

----aattttaatattatttctttattatccattttat	CRISPR spacer
gcataatc----tattatttctttattattaattttat	Protospacer
    ***.    *****************. *******

38. spacer 15.78|2665022|33|NZ_CP027781|PILER-CR matches to NC_029024 (Bacillus phage 250, complete genome) position: , mismatch: 7, identity: 0.788

ttaaagatttttttaatttatccctaactttta	CRISPR spacer
ttaaatctttttttaatttatccctttctctgt	Protospacer
*****  ******************  **.*

39. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_015916 (Borreliella bissettii DN127 plasmid lp28-3, complete sequence) position: , mismatch: 7, identity: 0.806

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
atcctgattagtatttaaaaatatatctttttaatt	Protospacer
** .   ***.********************** **

40. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to LT960552 (Yersinia phage fHe-Yen9-03 genome assembly, complete genome: monopartite) position: , mismatch: 8, identity: 0.778

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
ttgaaatcaaataaagtactttgctgaaaataatat	Protospacer
   ************ *************   ***

41. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to LR596615 (Yersinia phage fHe-Yen9-04 genome assembly, chromosome: I) position: , mismatch: 8, identity: 0.778

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
ttgaaatcaaataaagtactttgctgaaaataatat	Protospacer
   ************ *************   ***

42. spacer 7.11|2638868|36|NZ_CP027781|CRISPRCasFinder,CRT matches to NC_042116 (Yersinia phage fHe-Yen9-04 genome assembly, complete genome: monopartite) position: , mismatch: 8, identity: 0.778

agcaaatcaaataaattactttgctgaaacatataa	CRISPR spacer
ttgaaatcaaataaagtactttgctgaaaataatat	Protospacer
   ************ *************   ***

43. spacer 8.5|2639540|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to AP014333 (Uncultured Mediterranean phage uvMED isolate uvMED-GF-U-MedDCM-OCT-S36-C55, *** SEQUENCING IN PROGRESS ***) position: , mismatch: 8, identity: 0.778

tctagt-tcttctattttatttccaacattttttaat	CRISPR spacer
-atagcattttctattttatttttaacattttttaca	Protospacer
  ***. *.*************..***********

44. spacer 10.3|2641225|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MN698241 (Pelagibacter phage HTVC027P, complete genome) position: , mismatch: 8, identity: 0.778

gaagaacaaataaaagaatataaagaaaaagttaag	CRISPR spacer
gaaaaactaataaaagaatataaagattatgaggag	Protospacer
***.*** ******************  * *  .**

45. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to CP019599 (Staphylococcus cohnii strain SNUDS-2 plasmid pSC-SNUDS-2-2, complete sequence) position: , mismatch: 8, identity: 0.765

tctatacaacattataaagaaaaatatggagttt	CRISPR spacer
acaatggaaaattataaagaaaaatatgaagcct	Protospacer
 * **. ** ******************.**..*

46. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_016748 (Marinitoga piezophila KA3 plasmid pMARPI01, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
atttttaataaaatttctttattatccataaata	Protospacer
* ********  *****************

47. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP014283 (Bacillus thuringiensis strain Bt185 plasmid pBT1850636, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatattttttctttattttctggttgta	Protospacer
************ ********** **.. **

48. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP032614 (Bacillus thuringiensis strain QZL38 plasmid p.1, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatattttttctttattttctggttgta	Protospacer
************ ********** **.. **

49. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP029455 (Bacillus cereus strain FORC087 plasmid pFORC087.1, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatattttttctttattttctggttgta	Protospacer
************ ********** **.. **

50. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_018516 (Bacillus thuringiensis HD-789 plasmid pBTHD789-1, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

51. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009334 (Bacillus thuringiensis strain HD1011 plasmid 2, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

52. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_LR214986 (Mycoplasma cynos strain NCTC10142 plasmid 13) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
cattttaattttatttctttactataaatgattt	Protospacer
 ******** ***********.***  **  * *

53. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MN694369 (Marine virus AFVG_250M682, complete genome) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
agtctatctatcatttctttgttatccatttttt	Protospacer
*.*.*   ***.********.*********** *

54. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP053970 (Bacillus thuringiensis strain FDAARGOS_796 plasmid unnamed2, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

55. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP053979 (Bacillus thuringiensis strain FDAARGOS_795 plasmid unnamed3, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

56. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013277 (Bacillus thuringiensis serovar israelensis strain AM65-52 plasmid pAM65-52-2-350K, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

57. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP039723 (Bacillus thuringiensis strain BT-59 plasmid p2, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

58. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009348 (Bacillus thuringiensis HD1002 plasmid 2, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

59. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP045024 (Bacillus thuringiensis strain JW-1 plasmid p2, complete sequence) position: , mismatch: 8, identity: 0.765

aattttaatattatttctttattatccattttat	CRISPR spacer
aattttaatatcatttctttcttaaactgttctt	Protospacer
***********.******** ***  *  **. *

60. spacer 11.3|2642097|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP046630 (Streptococcus equinus strain CNU G6 plasmid p1_CNU_G6, complete sequence) position: , mismatch: 8, identity: 0.765

attatttcaaatttaaaattagattcttttttac	CRISPR spacer
ttagcatcaaatttaaaagtagattcatttttaa	Protospacer
 * .. ************ ******* ******

61. spacer 11.3|2642097|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP046920 (Streptococcus sp. CNU G2 plasmid p_CNU_G2, complete sequence) position: , mismatch: 8, identity: 0.765

attatttcaaatttaaaattagattcttttttac	CRISPR spacer
ttagcatcaaatttaaaagtagattcatttttaa	Protospacer
 * .. ************ ******* ******

62. spacer 13.4|2652522|33|NZ_CP027781|CRISPRCasFinder,CRT matches to MN694611 (Marine virus AFVG_250M767, complete genome) position: , mismatch: 8, identity: 0.758

gctttacattctccatatttaaaagggccttta	CRISPR spacer
tctttacattccccacatttaaaaggaatattt	Protospacer
 **********.***.**********. . **

63. spacer 15.13|2663901|35|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to NZ_CP044980 (Bacillus thuringiensis strain BT62 plasmid pBT62B, complete sequence) position: , mismatch: 8, identity: 0.771

aaattagaatttattatttttatagtacttatatc	CRISPR spacer
attctaatatttattatttgtatagtatttatacc	Protospacer
*  .**. *********** *******.*****.*

64. spacer 15.30|2665021|34|NZ_CP027781|CRISPRCasFinder matches to NC_029024 (Bacillus phage 250, complete genome) position: , mismatch: 8, identity: 0.765

gttaaagatttttttaatttatccctaactttta	CRISPR spacer
attaaatctttttttaatttatccctttctctgt	Protospacer
.*****  ******************  **.*

65. spacer 15.30|2665021|34|NZ_CP027781|CRISPRCasFinder matches to MF001357 (Clostridium phage CP3, partial genome) position: , mismatch: 8, identity: 0.765

gttaaaga--tttttttaatttatccctaactttta	CRISPR spacer
--taagagcctttctttaatttatccctagcttttt	Protospacer
  ***...  ***.***************.*****

66. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_019507 (Campylobacter phage CP21, complete genome) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatccatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

67. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MT932329 (Campylobacter phage F379, complete genome) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatccatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

68. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK408758 (Campylobacter phage CP20, complete genome) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatctatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

69. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to HE815464 (Campylobacter phage CP21 complete sequence) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatccatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

70. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to FN667788 (Campylobacter phage CP220, complete genome) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatctatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

71. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to FN667789 (Campylobacter phage CPt10, complete genome) position: , mismatch: 8, identity: 0.778

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
actagtatctatatttaataatatatctttatattt	Protospacer
*.  ** *. ******** *********** *****

72. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP054262 (Lactobacillus plantarum strain TCI507 plasmid unnamed3) position: , mismatch: 8, identity: 0.765

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
aaaacttgttgcaataaaaaaagacctatccaat	Protospacer
*********** *****.******  *  ..***

73. spacer 8.1|2639280|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to CP033533 (Acinetobacter pittii strain 2014S07-126 plasmid p2014S07-126-3, complete sequence) position: , mismatch: 9, identity: 0.735

ggtacagtccttaggttctagtgggtatagaaaa	CRISPR spacer
tatatttttctgaagttctagtgggtatagaaat	Protospacer
 .**.  *.** *.*******************

74. spacer 8.1|2639280|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to KJ081346 (Bacillus phage BCP8-2, complete genome) position: , mismatch: 9, identity: 0.735

ggtacagtccttaggttctagtggg-----tatagaaaa	CRISPR spacer
agtccagtccttatgttctagtgggatggttaca-----	Protospacer
.** ********* ***********     **.*

75. spacer 10.3|2641225|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_011247 (Borrelia duttonii Ly plasmid pl165, complete sequence) position: , mismatch: 9, identity: 0.75

gaagaacaaataaaagaatataaagaaaaagttaag	CRISPR spacer
aaggttttattacaagaatataaagataaagttaag	Protospacer
.*.*  . * ** ************* *********

76. spacer 10.3|2641225|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to JQ287645 (Sulfolobus virus STSV2, complete genome) position: , mismatch: 9, identity: 0.75

gaagaacaaataaaagaatataaagaaaaagttaag	CRISPR spacer
aaagaaaaaataaaagaatatatagaagatttggaa	Protospacer
.***** *************** ****.*  * .*.

77. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP028373 (Campylobacter jejuni subsp. jejuni strain huA17 plasmid unnamed1, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

78. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP018901 (Campylobacter coli strain YH502 plasmid pCOS502, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

79. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP014745 (Campylobacter jejuni strain OD267 plasmid pCJDM67 L, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

80. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP017026 (Campylobacter coli plasmid pCC14983A-1, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

81. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP014345 (Campylobacter jejuni strain RM3194 plasmid unnamed, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

82. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP014743 (Campylobacter jejuni strain WP2202 plasmid pCJDM202, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

83. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP017417 (Campylobacter jejuni strain MTVDSCj13 plasmid pMTVDSCj13-2, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

84. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025282 (Campylobacter coli strain YH503 plasmid pCOS503, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

85. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP048772 (Campylobacter jejuni strain ZS007 plasmid pCJ145K, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

86. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP044174 (Campylobacter jejuni strain AR-0412 plasmid pAR-0412, complete sequence) position: , mismatch: 9, identity: 0.735

tctatacaacattataaagaaaaatatggagttt----	CRISPR spacer
aaaatacaaaataataaagaaaaatat----ttttgga	Protospacer
   ****** ** **************    ***

87. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP007513 (Bacillus bombysepticus plasmid pBb, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tattttaatattttttctttattttctggttgta	Protospacer
 *********** ********** **.. **

88. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009368 (Bacillus cereus strain FM1 plasmid unnamed, complete sequence) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tattttaatattttttctttattttctggttgta	Protospacer
 *********** ********** **.. **

89. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_011777 (Bacillus cereus AH820 plasmid pAH820_272, complete sequence) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
actgttattattatttctttattttccaatgaca	Protospacer
* * *** *************** **** *

90. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP020748 (Bacillus mycoides strain Gnyt1 plasmid unnamed5, complete sequence) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatagtttttctttattatctaaagttt	Protospacer
  ******** * *************.*   * *

91. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to AP013430 (Uncultured Mediterranean phage uvMED DNA, complete genome, group G16, isolate: uvMED-CGR-U-MedDCM-OCT-S25-C55) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttctaatagtatttctttattatctaatcatt	Protospacer
  **.***** ***************.* *.  *

92. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MG592562 (Vibrio phage 1.193.O._10N.286.52.C6, partial genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
atttttaatataatttctttattgtcaagtaata	Protospacer
* ********* ***********.** * *

93. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP014851 (Bacillus thuringiensis strain HD12 plasmid pHD120112, complete sequence) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatagtttttctttattatctaaagttt	Protospacer
  ******** * *************.*   * *

94. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250021 (Prevotella phage Lak-B2, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

95. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250024 (Prevotella phage Lak-B5, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

96. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250028 (Prevotella phage Lak-B9, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

97. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250025 (Prevotella phage Lak-B6, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

98. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250022 (Prevotella phage Lak-B3, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

99. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK250020 (Prevotella phage Lak-B1, complete genome) position: , mismatch: 9, identity: 0.735

aattttaatattatttctttattatccattttat	CRISPR spacer
tcttttaatattatttgtttattttctttaattt	Protospacer
  ************** ****** **. *  * *

100. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP028250 (Pediococcus acidilactici strain SRCM102732 plasmid unnamed1, complete sequence) position: , mismatch: 9, identity: 0.757

---ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
acatttgt---atcattagtaacttcttttgttttattct	Protospacer
   **.**   *** ************** *******..

101. spacer 11.3|2642097|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MT446416 (UNVERIFIED: Escherichia virus TH47, complete genome) position: , mismatch: 9, identity: 0.735

attatttcaaatttaaaattagattcttttttac	CRISPR spacer
attaattcaaaattaaaattagatatttccacat	Protospacer
**** ****** ************ .**.. .*.

102. spacer 13.7|2652718|35|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP041047 (Citrobacter sp. CF971 plasmid pBM527-1, complete sequence) position: , mismatch: 9, identity: 0.743

aaaagaagggaaaccagttatagacaagatattga	CRISPR spacer
cattggataaaaacccgttatagataagatattga	Protospacer
 *  *.* ..***** ********.**********

103. spacer 13.7|2652718|35|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP050835 (Klebsiella pneumoniae strain Bckp021 plasmid pBckp021-1, complete sequence) position: , mismatch: 9, identity: 0.743

aaaagaagggaaaccagttatagacaagatattga	CRISPR spacer
cattggataaaaacccgttatagataagatattga	Protospacer
 *  *.* ..***** ********.**********

104. spacer 13.7|2652718|35|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_CP035215 (Klebsiella michiganensis strain M82255 plasmid pKOCBH-A, complete sequence) position: , mismatch: 9, identity: 0.743

aaaagaagggaaaccagttatagacaagatattga	CRISPR spacer
cattggataaaaacccgttatagataagatattga	Protospacer
 *  *.* ..***** ********.**********

105. spacer 15.1|2663115|37|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to MH931003 (Termite gut associated microvirus 1 isolate Ter_359, complete genome) position: , mismatch: 9, identity: 0.757

tgcactgtaatatcaactccttttaatttgattaatc	CRISPR spacer
gacatattaagatcaactccttataatttgattaaca	Protospacer
 .**.  *** *********** ************.

106. spacer 15.1|2663115|37|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to MG967616 (Bacillus phage v_B-Bak1, complete genome) position: , mismatch: 9, identity: 0.757

tgcactgtaatatcaactccttttaatttgattaatc	CRISPR spacer
tgtccattcttaacaactccttttaattttattaatt	Protospacer
**. *  *  ** **************** ******.

107. spacer 15.1|2663115|37|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to KC595511 (Bacillus phage Basilisk, complete genome) position: , mismatch: 9, identity: 0.757

tgcactgtaatatcaactccttttaatttgattaatc	CRISPR spacer
tgtccattcttaacaactccttttaattttattaatt	Protospacer
**. *  *  ** **************** ******.

108. spacer 15.1|2663115|37|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to MG967618 (Bacillus phage v_B-Bak10, complete genome) position: , mismatch: 9, identity: 0.757

tgcactgtaatatcaactccttttaatttgattaatc	CRISPR spacer
tgtccattcttaacaactccttttaattttattaatt	Protospacer
**. *  *  ** **************** ******.

109. spacer 15.1|2663115|37|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to MG967617 (Bacillus phage v_B-Bak6, complete genome) position: , mismatch: 9, identity: 0.757

tgcactgtaatatcaactccttttaatttgattaatc	CRISPR spacer
tgtccattcttaacaactccttttaattttattaatt	Protospacer
**. *  *  ** **************** ******.

110. spacer 15.31|2665085|35|NZ_CP027781|CRISPRCasFinder matches to NZ_CP038016 (Paenisporosarcina antarctica strain CGMCC 1.6503 plasmid unnamed, complete sequence) position: , mismatch: 9, identity: 0.743

gaaattgaaaatcgtaaacaagaatgtatagctcg	CRISPR spacer
gaaattgaaaatcgaaaaaaagaatattttacaga	Protospacer
************** *** ******.* * .*  .

111. spacer 15.63|2665021|35|NZ_CP027781|CRT matches to NC_029024 (Bacillus phage 250, complete genome) position: , mismatch: 9, identity: 0.743

gttaaagatttttttaatttatccctaacttttag	CRISPR spacer
attaaatctttttttaatttatccctttctctgtt	Protospacer
.*****  ******************  **.*

112. spacer 15.63|2665021|35|NZ_CP027781|CRT matches to MF001357 (Clostridium phage CP3, partial genome) position: , mismatch: 9, identity: 0.743

gttaaaga--tttttttaatttatccctaacttttag	CRISPR spacer
--taagagcctttctttaatttatccctagctttttt	Protospacer
  ***...  ***.***************.*****

113. spacer 15.79|2665086|34|NZ_CP027781|PILER-CR matches to NZ_CP038016 (Paenisporosarcina antarctica strain CGMCC 1.6503 plasmid unnamed, complete sequence) position: , mismatch: 9, identity: 0.735

aaattgaaaatcgtaaacaagaatgtatagctcg	CRISPR spacer
aaattgaaaatcgaaaaaaagaatattttacaga	Protospacer
************* *** ******.* * .*  .

114. spacer 16.3|2665698|36|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to HM246721 (Campylobacter phage vB_CcoM-IBB_35 clone Contig2, complete sequence) position: , mismatch: 9, identity: 0.75

atgtgtcttaatatttaaaaatatatctttttattt	CRISPR spacer
gctagtatctatatttaataatatatctttatattt	Protospacer
..  ** *. ******** *********** *****

115. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP012385 (Enterococcus durans strain KLDS 6.0930 plasmid unnamed 1, complete sequence) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
tagatctcacgaagtaagaaaagagattattaat	Protospacer
 *.*..*  .***.***********.********

116. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP007625 (Bacillus pseudomycoides strain 219298 plasmid unnamed, complete sequence) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
ttagattgtagaaataacaaaagaggttaatgct	Protospacer
  *. **** ******* *********** *. *

117. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP012367 (Enterococcus durans strain KLDS 6.0933 plasmid unnamed 1, complete sequence) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
tagatctcacgaagtaagaaaagagattattaat	Protospacer
 *.*..*  .***.***********.********

118. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009650 (Bacillus pseudomycoides strain BTZ plasmid pBTZ_1, complete sequence) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
ttagattgtagaaataacaaaagaggttaatgct	Protospacer
  *. **** ******* *********** *. *

119. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK308676 (Vibrio phage vB_VmeM-Yong MS31, complete genome) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
aaaacttgttgaaattagaatagatgacctggtt	Protospacer
*************** **** *** * . * . *

120. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK308675 (Vibrio phage vB_VmeM-Yong XC32, complete genome) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
aaaacttgttgaaattagaatagatgacctggtt	Protospacer
*************** **** *** * . * . *

121. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK308677 (Vibrio phage vB_VmeM-Yong MS32, complete genome) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
aaaacttgttgaaattagaatagatgacctggtt	Protospacer
*************** **** *** * . * . *

122. spacer 16.5|2665829|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to MK308674 (Vibrio phage vB_VmeM-Yong XC31, complete genome) position: , mismatch: 9, identity: 0.735

aaaacttgttgaaataagaaaagaggttattaat	CRISPR spacer
aaaacttgttgaaattagaatagatgacctggtt	Protospacer
*************** **** *** * . * . *

123. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025884 (Escherichia coli strain 503440 plasmid p503440_78, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

124. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025893 (Escherichia coli strain 503025 plasmid p503025_105, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

125. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025893 (Escherichia coli strain 503025 plasmid p503025_105, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

126. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025866 (Escherichia coli strain 504211 plasmid p504211_78, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

127. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025872 (Escherichia coli strain 503829 plasmid p503829_77, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

128. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025914 (Escherichia coli strain 203740 plasmid p203740_80, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

129. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP010123 (Escherichia coli strain C5 plasmid A, complete genome) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

130. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP006002 (Escherichia coli B7A plasmid pEB4, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

131. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to CP025899 (Escherichia coli strain 500465 plasmid p500465_77, complete sequence) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

132. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to LN908839 (Escherichia coli plasmid pCss_E1189) position: , mismatch: 10, identity: 0.706

gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
attgaggatctttttaagacactagaggatttat	Protospacer
.  .*. * ***** ********* ********

133. spacer 6.3|2624579|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to KY705252 (Streptococcus phage P0092, complete genome) position: , mismatch: 10, identity: 0.706

tggtattagcctttagttctctaattgcttcctc	CRISPR spacer
gagccatttcctttagtgatctaattgcttcctg	Protospacer
 .*.  *  ********  **************

134. spacer 7.4|2638406|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP025846 (Escherichia coli strain 720632 plasmid p720632_86, complete sequence) position: , mismatch: 10, identity: 0.706

aataaaatatcacctttacataaatatatagctt	CRISPR spacer
cttaaaatatcaactttagataaatactcataat	Protospacer
  ********** ***** *******. .*   *

135. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009417 (Jeotgalibacillus malaysiensis strain malaysiensis plasmid unnamed, complete sequence) position: , mismatch: 10, identity: 0.706

tctatacaacattataaagaaaaatatggagttt	CRISPR spacer
ggaatccaacattataaagaaaaagatttttttg	Protospacer
   ** ****************** **    **

136. spacer 10.4|2641291|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_003267 (Nostoc sp. PCC 7120 = FACHB-418 plasmid pCC7120gamma, complete sequence) position: , mismatch: 10, identity: 0.706

tctatacaacattataaagaaaaatatggagttt	CRISPR spacer
aatgcccaagagtataaagaaaaatatggattac	Protospacer
  *.. *** * ****************** * .

137. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP015632 (Borrelia turicatae strain BTE5EL plasmid lp30) position: , mismatch: 10, identity: 0.706

aattttaatattatttctttattatccattttat	CRISPR spacer
ggttttaattttatttctttattttctactaacc	Protospacer
..******* ************* **.*.*   .

138. spacer 10.8|2641550|37|NZ_CP027781|CRISPRCasFinder,CRT matches to KY554777 (Lactococcus phage LW81, complete genome) position: , mismatch: 10, identity: 0.73

----ttcgtacaatctttagtaacttctttagttttatcta	CRISPR spacer
ccatcttcta----ctttagtaacttctttaagtttatctt	Protospacer
    .*. **    *****************. *******

139. spacer 15.13|2663901|35|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to NC_019688 (Clostridium perfringens plasmid pNetB-NE10, complete sequence) position: , mismatch: 10, identity: 0.714

--aaattagaatttattatttttatagtacttatatc	CRISPR spacer
ttcgat--gaatttattatttttaaaggacttaatga	Protospacer
   .**  **************** ** *****

140. spacer 15.13|2663901|35|NZ_CP027781|PILER-CR,CRISPRCasFinder matches to NZ_CP025502 (Clostridium perfringens strain EHE-NE18 plasmid pJIR3535, complete sequence) position: , mismatch: 10, identity: 0.714

--aaattagaatttattatttttatagtacttatatc	CRISPR spacer
ttcgat--gaatttattatttttaaaggacttaatga	Protospacer
   .**  **************** ** *****

141. spacer 15.34|2663115|38|NZ_CP027781|CRT matches to MH931003 (Termite gut associated microvirus 1 isolate Ter_359, complete genome) position: , mismatch: 10, identity: 0.737

tgcactgtaatatcaactccttttaatttgattaatca	CRISPR spacer
gacatattaagatcaactccttataatttgattaacac	Protospacer
 .**.  *** *********** ************.

142. spacer 15.79|2665086|34|NZ_CP027781|PILER-CR matches to KY290955 (Aeromonas phage 65.2, complete genome) position: , mismatch: 10, identity: 0.706

aaattgaaaatcgtaaacaagaatgtatagctcg	CRISPR spacer
aaagtgaaaatcataaacaagaattcgcaagtga	Protospacer
*** ********.*********** ...*. * .

143. spacer 15.79|2665086|34|NZ_CP027781|PILER-CR matches to NC_015251 (Aeromonas phage 65, complete genome) position: , mismatch: 10, identity: 0.706

aaattgaaaatcgtaaacaagaatgtatagctcg	CRISPR spacer
aaagtgaaaatcataaacaagaattcgcaagtga	Protospacer
*** ********.*********** ...*. * .

144. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP053971 (Bacillus thuringiensis strain FDAARGOS_796 plasmid unnamed3, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

145. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP013278 (Bacillus thuringiensis serovar israelensis strain AM65-52 plasmid pAM65-52-3-235K, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

146. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NC_018509 (Bacillus thuringiensis HD-789 plasmid pBTHD789-2, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

147. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP039724 (Bacillus thuringiensis strain BT-59 plasmid p3, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

148. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP051859 (Bacillus thuringiensis serovar israelensis strain BGSC 4Q7rifR plasmid pBtic235, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

149. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP009347 (Bacillus thuringiensis HD1002 plasmid 3, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

150. spacer 5.1|2622329|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_CP045025 (Bacillus thuringiensis strain JW-1 plasmid p3, complete sequence) position: , mismatch: 11, identity: 0.676

---------gaaaaataacttttgaagacactataggatttaa	CRISPR spacer
tctttggttg---------ttttgaagtcactattggatttaa	Protospacer
         *         ******** ****** ********

151. spacer 6.4|2624643|37|NZ_CP027781|CRISPRCasFinder,CRT matches to NZ_LR214986 (Mycoplasma cynos strain NCTC10142 plasmid 13) position: , mismatch: 11, identity: 0.703

tagagggaaaaataaaagcatgcacaaaacataagca	CRISPR spacer
tgaactaaaaaataaaatcatgcataaaacatacatg	Protospacer
*..*  .********** ******.******** ...

152. spacer 10.5|2641355|34|NZ_CP027781|PILER-CR,CRISPRCasFinder,CRT matches to NZ_AP017918 (Candidatus Azobacteroides pseudotrichonymphae plasmid pAPPJ4 DNA, complete sequence, phylotype ProJPt-1) position: , mismatch: 11, identity: 0.676

aattttaatattatttctttattatccattttat	CRISPR spacer
tattttaatattataactttattattttggccgt	Protospacer
 *************  *********..   ...*

153. spacer 7.12|2638934|35|NZ_CP027781|CRISPRCasFinder,CRT matches to JQ801337 (Vibrio phage VvAW1, complete genome) position: , mismatch: 12, identity: 0.657

gtattagaacatagagcaaataacccttcatgggc	CRISPR spacer
acgcctcaacatagcgcaagtaacccttcatgtag	Protospacer
.....  ******* ****.************ .

Prophage detection

Region

Region Position

Protein_number

Hit_taxonomy

Key_proteins

Att_site

Prophage annotation

DBSCAN-SWA_1

1490966 : 1500548

Synechococcus_phage(42.86%)

The bacterium proteins that are colored denote the protein is present at specific phage-related keywords (such as 'capsid', 'head', 'integrase', 'plate', 'tail', 'fiber', 'coat', 'transposase', 'portal', 'terminase', 'protease' or 'lysin' and 'tRNA')

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_106899820.1\|1490966_1492466_-	bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/inosine monophosphate cyclohydrolase	Q58MG4	Prochlorococcus_phage	2.1e-68	46.3
WP_106899821.1\|1492679_1493297_-	phosphoribosylglycinamide formyltransferase	M4QRX9	Synechococcus_phage	9.0e-26	40.6
WP_106899822.1\|1493424_1494420_-	phosphoribosylformylglycinamidine cyclo-ligase	M4QRQ6	Synechococcus_phage	4.5e-67	44.0
WP_106899823.1\|1494590_1496039_-	amidophosphoribosyltransferase	A0A0M3SGR2	Mollivirus	3.6e-57	34.9
WP_072586432.1\|1496129_1496834_-	phosphoribosylaminoimidazolesuccinocarboxamide synthase	G8EYA2	Synechococcus_phage	4.6e-42	42.1
WP_003484098.1\|1496833_1497313_-	5-(carboxyamino)imidazole ribonucleotide mutase	A0A2P0VNU7	Tetraselmis_virus	3.7e-27	48.7
WP_106899824.1\|1497977_1500548_-	selenium-dependent xanthine dehydrogenase	A0A0P0IVM8	Acinetobacter_phage	1.3e-09	32.4

DBSCAN-SWA_2

1656881 : 1676435

Clostridium_phage(75.0%)

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_106899927.1\|1656881_1657880_-	hypothetical protein	A0A0A7RW91	Clostridium_phage	2.1e-141	71.7
WP_106899928.1\|1657891_1658167_-	hypothetical protein	NA	NA	NA	NA
WP_106899929.1\|1658169_1660140_-	hypothetical protein	A0A0A7RU09	Clostridium_phage	2.3e-54	46.9
WP_106899930.1\|1660151_1661660_-	hypothetical protein	A0A0A7RU28	Clostridium_phage	5.9e-95	38.4
WP_106899931.1\|1661682_1662663_-	hypothetical protein	A0A0A7RU61	Clostridium_phage	1.4e-110	60.8
WP_106899932.1\|1662666_1663212_-	hypothetical protein	A0A0A7RW86	Clostridium_phage	5.8e-77	75.8
WP_106899933.1\|1663226_1663568_-	hypothetical protein	A0A0A7S0S4	Clostridium_phage	1.6e-16	55.7
WP_106899934.1\|1663580_1664666_-	hypothetical protein	NA	NA	NA	NA
WP_106899935.1\|1664652_1665087_-	hypothetical protein	NA	NA	NA	NA
WP_106899936.1\|1665099_1666641_-	hypothetical protein	A0A0A7RU22	Clostridium_phage	1.6e-23	28.4
WP_106899937.1\|1666716_1666884_-	hypothetical protein	A0A0A7RW80	Clostridium_phage	1.2e-14	64.8
WP_106899938.1\|1666918_1667335_-	esterase	A0A0A7S0S0	Clostridium_phage	9.9e-45	67.4
WP_106899939.1\|1667350_1668238_-	hypothetical protein	A0A0A7RTZ9	Clostridium_phage	9.0e-120	75.0
WP_061319102.1\|1668242_1668662_-	hypothetical protein	A0A0A7RU17	Clostridium_phage	2.1e-58	74.1
WP_106899940.1\|1668667_1669015_-	hypothetical protein	A0A0A7RU51	Clostridium_phage	2.1e-32	58.9
WP_012048059.1\|1669019_1669385_-	hypothetical protein	A0A0A7RW73	Clostridium_phage	5.0e-32	56.2
WP_003396354.1\|1669384_1669669_-	hypothetical protein	A0A0A7S0R4	Clostridium_phage	2.7e-25	61.2
WP_106899941.1\|1670302_1670824_-	hypothetical protein	A0A0A7RVS1	Clostridium_phage	4.7e-36	50.0
WP_106899942.1\|1670949_1671258_-	hypothetical protein	NA	NA	NA	NA
WP_106899943.1\|1671314_1672163_-	DNA replication protein	A0A2K9V3L7	Faecalibacterium_phage	2.8e-33	35.3
WP_106899944.1\|1672104_1673019_-	hypothetical protein	A8ASN4	Listeria_phage	1.2e-39	40.4
WP_045896409.1\|1673102_1673315_-	XRE family transcriptional regulator	NA	NA	NA	NA
WP_106899945.1\|1673376_1673586_-	transcriptional regulator	NA	NA	NA	NA
WP_106899946.1\|1673778_1674189_+	transcriptional regulator	X2CXD8	Lactobacillus_phage	6.6e-09	36.6
WP_043032293.1\|1674490_1674640_+	hypothetical protein	NA	NA	NA	NA
WP_106899947.1\|1675076_1675712_-	hypothetical protein	A0A1V0DZX6	Clostridioides_phage	9.9e-20	41.8
WP_106899948.1\|1676108_1676435_-	hypothetical protein	Q5YA51	Bacillus_phage	1.7e-07	40.7

DBSCAN-SWA_3

3497878 : 3511835

uncultured_Mediterranean_phage(37.5%)

tRNA

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_106901147.1\|3497878_3499126_-\|tRNA	histidine--tRNA ligase	A0A2I2L577	Orpheovirus	4.6e-29	28.1
WP_106901148.1\|3499144_3500575_-	coproporphyrinogen dehydrogenase HemZ	NA	NA	NA	NA
WP_106901149.1\|3500613_3501213_-	MBL fold metallo-hydrolase	A0A1X9I5D3	Streptococcus_phage	2.4e-23	32.5
WP_030036564.1\|3501265_3501715_-\|tRNA	D-aminoacyl-tRNA deacylase	NA	NA	NA	NA
WP_003483798.1\|3501756_3503928_-	bifunctional (p)ppGpp synthetase/guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase	A0A2I2L310	Orpheovirus	7.3e-14	38.4
WP_003490675.1\|3504052_3504571_-	adenine phosphoribosyltransferase	A0A1V0SKE5	Klosneuvirus	2.3e-30	45.2
WP_003483796.1\|3504679_3505558_-	delta(24)-sterol C-methyltransferase	NA	NA	NA	NA
WP_106901150.1\|3505787_3506651_-	protein translocase subunit SecF	A0A1B1IVP7	uncultured_Mediterranean_phage	1.7e-38	39.2
WP_003483794.1\|3506652_3507921_-	protein translocase subunit SecD	A0A1B1IVP7	uncultured_Mediterranean_phage	8.1e-05	29.2
WP_106901151.1\|3508014_3509382_-	thioether cross-link-forming SCIFF peptide maturase	G5DEQ6	Salmonella_phage	4.5e-09	33.6
WP_003357718.1\|3509538_3509676_-	six-cysteine peptide SCIFF	NA	NA	NA	NA
WP_106901152.1\|3509766_3510135_-	TIGR04086 family membrane protein	NA	NA	NA	NA
WP_045887524.1\|3510189_3510525_-	preprotein translocase subunit YajC	NA	NA	NA	NA
WP_106901153.1\|3510704_3511835_-\|tRNA	tRNA guanosine(34) transglycosylase Tgt	A0A1B1IVQ4	uncultured_Mediterranean_phage	9.2e-93	46.6

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage

Overview of predicted results

Overview of the results

Cas Category Instructions

Results visualization

1. NZ_CP027781

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Self-targeting detection

MGE targeting detection<

Prophage detection

Anti-CRISPR protein detection